data_1okd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1okd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 2.4 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.615 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 68' ' ' CYS . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' CD2' ' CD1' ' A' ' 63' ' ' PHE . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' NZ ' ' CD2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.645 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.413 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.55 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.638 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.459 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' CD1' HG22 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.415 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.761 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.761 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 66' ' ' VAL . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.495 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.521 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.437 ' HA2' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.552 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.552 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.669 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.556 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.751 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.751 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.4 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.491 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.514 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HG ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.676 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.424 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.473 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.676 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.491 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HD11 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.443 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.582 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.544 ' HE2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 HG21 ' HE2' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 31' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HG ' ' CZ2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 86' ' ' TRP . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.408 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.532 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.532 ' H ' ' HD1' ' A' ' 86' ' ' TRP . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CG ' HD11 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.674 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 113' ' ' ILE . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.716 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.716 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 100' ' ' LEU . 2.6 t80 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.624 ' HB2' HD23 ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 71' ' ' ASP . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.61 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.43 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 54' ' ' TYR . 2.2 p80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.481 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.437 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.439 ' HE3' ' CD1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.527 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 17.4 mm100 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 104' ' ' PHE . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 132' ' ' VAL . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.758 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.758 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.467 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.41 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' CB ' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.51 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.48 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' ' CG ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.46 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.467 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.659 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.422 HG22 ' CE1' ' A' ' 104' ' ' PHE . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.659 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.736 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.736 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 141' ' ' PRO . 5.9 mttm . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.586 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.601 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.404 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.627 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 100' ' ' LEU . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.417 HG11 ' CD2' ' A' ' 35' ' ' PHE . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' A' ' 113' ' ' ILE . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.437 HG23 ' CG ' ' A' ' 104' ' ' PHE . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.597 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.435 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.784 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 142' ' ' TRP . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.784 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.551 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.47 ' CB ' HD21 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.422 ' CE1' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.522 ' HB3' HD23 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' CG1' ' HG2' ' A' ' 84' ' ' MET . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.469 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.457 ' CG ' ' N ' ' A' ' 59' ' ' GLU . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' CZ2' ' A' ' 86' ' ' TRP . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.532 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.541 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.541 ' H ' ' HD1' ' A' ' 86' ' ' TRP . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 99' ' ' LYS . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 100' ' ' LEU . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.543 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.748 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.625 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.748 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.417 HG13 ' CZ ' ' A' ' 33' ' ' PHE . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.444 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 67' ' ' PHE . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.42 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.524 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 47' ' ' THR . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HB3' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 58' ' ' HIS . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.0 p30 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.427 HG23 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.656 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 104' ' ' PHE . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' HD11 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.656 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.3 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 HD22 ' A' ' 87' ' ' LEU . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.532 ' CE1' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.409 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 54' ' ' TYR . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.478 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.577 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 HD12 ' CG ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.624 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.405 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.724 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.724 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' CG1' ' CD ' ' A' ' 93' ' ' GLN . 3.5 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CD1' ' CA ' ' A' ' 114' ' ' GLY . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.577 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CE1' HD22 ' A' ' 112' ' ' LEU . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.446 ' CG1' ' CG ' ' A' ' 84' ' ' MET . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.602 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.486 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' CD2' HG13 ' A' ' 113' ' ' ILE . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.456 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.584 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.517 ' CD1' ' H ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.401 ' N ' HD21 ' A' ' 4' ' ' LEU . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 88' ' ' ALA . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HG3' ' CG2' ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG2' ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CD2' HG11 ' A' ' 97' ' ' VAL . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HB3' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' CD1' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 HG13 ' CH2' ' A' ' 86' ' ' TRP . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' NZ ' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 77' ' ' PHE . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 69' ' ' THR . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.449 ' NZ ' ' CZ ' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 67' ' ' PHE . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 15' ' ' ARG . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 35' ' ' PHE . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 7' ' ' TYR . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.419 ' N ' HD11 ' A' ' 112' ' ' LEU . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 143' ' ' LYS . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.44 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.447 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.708 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.647 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.708 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mt . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' CG2' ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' N ' HD21 ' A' ' 26' ' ' LEU . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' CD2' ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.456 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CD2' HG22 ' A' ' 66' ' ' VAL . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB2' HG23 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.5 p80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 86' ' ' TRP . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.447 ' CG ' HG23 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.574 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.574 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' ARG . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.667 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.667 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.431 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.477 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.754 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.754 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 141' ' ' PRO . 2.8 ptmm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HA ' HG21 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 140' ' ' PHE . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.414 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 47' ' ' THR . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.432 ' CG ' ' N ' ' A' ' 59' ' ' GLU . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CE2' HG22 ' A' ' 47' ' ' THR . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB3' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.403 ' OG ' ' CD1' ' A' ' 35' ' ' PHE . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 100' ' ' LEU . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.596 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.596 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.62 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.62 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 142' ' ' TRP . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.76 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.434 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CD2' HD12 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.413 ' OG ' ' CG ' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.528 ' CG1' ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.452 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.507 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.528 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CG ' HD13 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' CG ' ' A' ' 104' ' ' PHE . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.813 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 54' ' ' TYR . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.754 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.754 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 141' ' ' PRO . 16.0 pttm . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 7' ' ' TYR . 4.6 mt . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 100' ' ' LEU . 2.5 t80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 16' ' ' ARG . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.605 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.64 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.49 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 122' ' ' VAL . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.612 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 114' ' ' GLY . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG21 ' A' ' 113' ' ' ILE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 104' ' ' PHE . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.612 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.716 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 115' ' ' VAL . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.529 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 ' CG ' ' A' ' 84' ' ' MET . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.455 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.438 ' CB ' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.533 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CZ ' ' CD ' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 80' ' ' TYR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.555 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.433 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 113' ' ' ILE . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.41 HG23 ' CE2' ' A' ' 33' ' ' PHE . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.437 ' C ' ' HG3' ' A' ' 126' ' ' ARG . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.437 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.646 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.433 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.755 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . 96.7 mt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.424 HG11 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.466 ' OH ' ' CZ2' ' A' ' 86' ' ' TRP . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' CZ3' ' A' ' 86' ' ' TRP . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.545 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.544 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.655 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 104' ' ' PHE . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 100' ' ' LEU . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.632 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.402 HD11 ' CG ' ' A' ' 104' ' ' PHE . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.632 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.581 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 13' ' ' LYS . 43.9 mt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CB ' ' HB3' ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.441 ' CZ ' ' CG2' ' A' ' 66' ' ' VAL . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.494 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 68' ' ' CYS . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.442 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.493 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 p80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.809 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.418 ' CZ ' HG22 ' A' ' 47' ' ' THR . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.476 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.809 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HG ' ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 113' ' ' ILE . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 104' ' ' PHE . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HG11 ' A' ' 132' ' ' VAL . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.752 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.565 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.752 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 141' ' ' PRO . 51.2 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' O ' ' C ' ' A' ' 12' ' ' GLU . 16.7 mt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.453 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 43' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HB3' ' CZ3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.402 HD13 ' CZ3' ' A' ' 86' ' ' TRP . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.544 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.519 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.597 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.416 HD13 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.683 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.683 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.591 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.591 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.765 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA2' ' CZ ' ' A' ' 7' ' ' TYR . . . -78.99 -49.29 6.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.9 mp -52.86 -25.6 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.418 ' CZ ' ' HA2' ' A' ' 3' ' ' GLY . 3.7 m-85 -50.9 -33.7 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 96' ' ' ALA . 1.4 mt -106.01 175.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -74.32 7.28 2.65 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.955 2.436 . . . . 0.0 113.24 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.56 50.82 1.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.817 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 2.4 mp -60.04 134.52 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.615 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.615 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.645 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.435 ' CE2' ' HA2' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.424 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.462 ' CD1' ' HB2' ' A' ' 68' ' ' CYS . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.422 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.422 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD12 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' CD2' ' CD1' ' A' ' 63' ' ' PHE . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' NZ ' ' CD2' ' A' ' 140' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.645 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.518 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.462 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.413 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.417 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.55 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.638 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.417 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.401 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' CD1' HG22 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.415 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.672 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.423 HG22 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.672 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.623 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.761 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.761 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm -58.98 -162.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -47.24 169.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.16 100.5 21.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.94 12.77 2.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 112.916 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.67 51.48 2.0 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.1 8.86 1.62 Allowed 'General case' 0 C--O 1.25 1.08 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.516 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.35 31.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.0 mp -49.89 -27.91 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -54.1 -29.05 43.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mp -139.15 79.84 25.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.97 112.29 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.505 2.136 . . . . 0.0 112.087 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.81 -19.86 6.11 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.5 mm -60.65 137.24 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.481 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.44 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.487 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.435 ' CE1' ' HB ' ' A' ' 66' ' ' VAL . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.408 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.495 ' CD1' ' N ' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.549 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.521 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.437 ' HA2' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.552 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.552 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.617 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.669 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.669 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.556 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.556 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.449 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.428 ' HG ' ' CD2' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.751 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.751 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -93.09 168.17 11.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -60.11 -172.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.85 108.24 1.1 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.94 -167.85 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.304 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -59.06 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.997 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 164.32 4.54 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.251 -3.715 0 CA-C-N 118.288 0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.04 -28.72 64.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.574 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.545 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.96 -26.82 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -81.28 -55.07 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp -98.53 155.13 37.14 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.079 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.48 -169.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.549 2.166 . . . . 0.0 112.066 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 49.07 3.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.381 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.4 mt -51.75 158.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.409 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.491 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.514 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' HG ' HG13 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.676 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.425 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.438 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.45 ' H ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.473 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.676 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.425 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.453 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.425 ' CE1' HG22 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.485 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.485 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.582 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.466 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.491 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.444 ' HA ' HD11 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.443 ' C ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.582 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.419 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt -102.34 137.01 41.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.3 p30 36.47 -163.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.541 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.488 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . . . -151.77 -66.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.213 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 145' ' ' ALA . 58.9 Cg_endo -71.51 -165.89 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.387 2.058 . . . . 0.0 112.277 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tt 68.14 105.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.39 2.49 3.0 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.764 0 O-C-N 123.505 0.503 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.819 0.342 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.79 -24.71 76.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 44.1 mt -66.09 -34.17 77.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -48.01 -43.43 29.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.9 79.58 41.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.25 156.09 52.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.645 2.23 . . . . 0.0 112.306 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.78 69.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.708 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.6 mt -130.16 118.9 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.536 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.544 ' HE2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 HG21 ' HE2' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.414 ' CE2' HG13 ' A' ' 31' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.464 ' HG ' ' CZ2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.469 ' O ' ' CD1' ' A' ' 86' ' ' TRP . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.433 ' CE1' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.434 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.442 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.433 ' HD2' ' CE1' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.408 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.532 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.532 ' H ' ' HD1' ' A' ' 86' ' ' TRP . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' CG ' HD11 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.674 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.454 HD12 HG22 ' A' ' 113' ' ' ILE . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.426 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.674 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.716 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.613 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.716 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt -68.21 -176.74 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 -21.8 13.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.219 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.41 154.6 79.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.49 13.45 2.75 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.831 2.354 . . . . 0.0 112.902 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.65 -177.69 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.69 102.92 0.02 OUTLIER 'General case' 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.774 0 O-C-N 123.517 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.831 0.348 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -58.99 -24.2 57.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -80.44 -31.54 37.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.44 ' CZ ' HD11 ' A' ' 100' ' ' LEU . 2.6 t80 -55.91 -76.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -152.93 101.76 2.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.48 124.41 10.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.428 2.085 . . . . 0.0 112.299 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 -26.86 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.635 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm -52.36 -37.46 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.437 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.448 ' CD1' ' CD1' ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.624 ' HB2' HD23 ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.424 ' CD1' ' HA ' ' A' ' 71' ' ' ASP . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.423 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.61 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.594 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.43 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 54' ' ' TYR . 2.2 p80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.481 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.437 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.425 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.439 ' HE3' ' CD1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.527 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.409 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 17.4 mm100 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.437 ' CG1' ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.41 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 104' ' ' PHE . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.448 ' CE2' ' CD1' ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.417 ' O ' ' CD1' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.624 HD23 ' HB2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.414 ' HA ' ' CD1' ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 132' ' ' VAL . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.498 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.758 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.547 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.758 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -95.36 -168.29 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.7 -169.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.23 56.26 2.45 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.294 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.402 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 58.0 Cg_endo -70.91 76.24 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 112.232 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 40.51 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.684 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 59.41 92.4 0.04 OUTLIER 'General case' 0 C--O 1.248 1.021 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.007 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.789 0 O-C-N 123.51 0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.772 0.32 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.95 -32.99 38.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.706 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -50.58 -26.02 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -65.09 -27.16 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.13 167.56 9.36 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.04 -166.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.643 2.229 . . . . 0.0 111.783 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.3 44.42 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.923 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.467 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt -56.43 94.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' CG ' ' N ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.41 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.445 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.449 ' CD1' ' CB ' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.51 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.48 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.407 ' HB3' ' CG ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.454 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.46 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.522 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.593 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.402 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.467 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' CE1' HG22 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.44 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.659 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 HG22 ' CE1' ' A' ' 104' ' ' PHE . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.659 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.417 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.417 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.736 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.736 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 141' ' ' PRO . 5.9 mttm -80.4 130.05 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -101.32 133.13 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.474 ' CB ' ' HD2' ' A' ' 146' ' ' PRO . . . 48.15 179.44 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 145' ' ' ALA . 70.6 Cg_endo -76.29 112.64 3.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.219 1.946 . . . . 0.0 112.429 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.1 tp 62.19 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.04 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.6 167.29 3.22 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.911 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.809 0 O-C-N 123.502 0.501 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.43 97.08 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.524 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp -59.42 -30.33 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' CD2' HD12 ' A' ' 100' ' ' LEU . 22.9 m-85 -53.94 -43.61 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.5 105.71 0.85 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.77 8.27 2.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.885 2.39 . . . . 0.0 113.25 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.76 -19.26 34.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.91 100.7 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.586 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.49 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.601 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.404 ' C ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.515 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.515 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD23 ' CD1' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 HD13 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.553 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.482 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.627 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' HB2' ' CD2' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.424 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 100' ' ' LEU . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.417 HG11 ' CD2' ' A' ' 35' ' ' PHE . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.437 ' CG ' HG23 ' A' ' 113' ' ' ILE . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.423 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' CD2' ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.437 HG23 ' CG ' ' A' ' 104' ' ' PHE . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.586 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.597 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.435 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.784 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.484 ' O ' ' C ' ' A' ' 142' ' ' TRP . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.784 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt -57.26 175.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -109.15 167.76 9.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.404 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . . . -73.73 -61.76 1.28 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 145' ' ' ALA . 56.8 Cg_endo -70.94 167.42 26.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.535 2.157 . . . . 0.0 112.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -93.79 159.24 15.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -141.84 162.39 35.59 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.914 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.781 0 O-C-N 123.526 0.516 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.805 0.336 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.46 -37.92 79.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.551 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -52.2 -29.45 22.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -75.31 -36.67 61.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.41 76.04 78.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.29 163.71 37.7 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.823 2.349 . . . . 0.0 112.187 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.2 45.77 92.31 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mm -126.27 105.12 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.47 ' CB ' HD21 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 ' CG1' ' HG3' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CE1' ' A' ' 32' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.458 ' CE1' ' HA2' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.422 ' CE1' ' O ' ' A' ' 31' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.522 ' HB3' HD23 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.413 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.542 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD22 ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' CG1' ' HG2' ' A' ' 84' ' ' MET . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.469 ' HA ' ' CE1' ' A' ' 57' ' ' PHE . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CD1' ' C ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.457 ' CG ' ' N ' ' A' ' 59' ' ' GLU . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.484 HG13 ' CZ2' ' A' ' 86' ' ' TRP . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.501 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.458 ' N ' ' CD1' ' A' ' 67' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.406 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.532 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.541 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.541 ' H ' ' HD1' ' A' ' 86' ' ' TRP . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.46 ' N ' ' HG3' ' A' ' 99' ' ' LYS . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB3' ' CE2' ' A' ' 35' ' ' PHE . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.42 ' CE2' HD13 ' A' ' 100' ' ' LEU . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.421 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 HG22 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.543 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.543 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.42 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.748 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.625 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.748 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -43.67 166.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.77 125.1 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.438 ' CB ' ' HD3' ' A' ' 146' ' ' PRO . . . -104.37 -65.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 145' ' ' ALA . 97.1 Cg_endo -79.29 76.96 4.27 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.328 2.019 . . . . 0.0 112.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.99 140.61 30.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -81.95 -13.31 57.66 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.817 0 O-C-N 123.542 0.526 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.826 0.346 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 -24.55 58.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.563 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.9 mt -54.28 -24.82 20.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -64.1 -30.7 71.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.43 ' HB3' ' CD ' ' A' ' 9' ' ' PRO . 4.0 mp -123.11 169.32 10.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.696 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.43 ' CD ' ' HB3' ' A' ' 8' ' ' LEU . 12.5 Cg_exo -70.94 9.06 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.931 2.421 . . . . 0.0 113.472 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.13 82.12 1.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.673 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 14.9 mm -87.82 104.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.444 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.417 HG13 ' CZ ' ' A' ' 33' ' ' PHE . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.444 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.428 ' CE1' ' HA ' ' A' ' 67' ' ' PHE . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.42 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.515 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.524 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 47' ' ' THR . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HB3' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.41 ' N ' ' O ' ' A' ' 58' ' ' HIS . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.499 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.45 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.553 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.553 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CE1' HG22 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.0 p30 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG23 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.427 HG23 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.656 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.416 HG22 ' CE1' ' A' ' 104' ' ' PHE . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.414 ' O ' HD11 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.656 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.711 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 144' ' ' ASP . 3.3 ptpt -62.95 -176.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 143' ' ' LYS . 11.0 t0 49.16 159.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.511 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.55 64.45 6.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.009 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.96 12.99 2.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.742 2.295 . . . . 0.0 113.031 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -131.49 118.6 20.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 61.88 169.22 0.11 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.792 0 O-C-N 123.528 0.517 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.766 0.317 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.03 -35.65 79.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.608 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 mt -49.94 -25.89 3.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.486 ' CG ' HD12 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -52.58 -68.92 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -172.57 93.36 0.38 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.246 . . . . 0.0 111.388 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.66 111.37 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.381 2.054 . . . . 0.0 112.016 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.25 -35.31 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.342 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.78 84.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.467 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 HD22 ' A' ' 87' ' ' LEU . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.482 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.532 ' CE1' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.463 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.459 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.409 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.431 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' CD2' ' CE2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.476 ' O ' ' N ' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 54' ' ' TYR . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.478 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.43 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.577 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 67' ' ' PHE . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.407 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.447 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.412 ' CG1' ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.407 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.486 HD12 ' CG ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.466 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.624 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.624 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.405 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.724 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.724 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt -111.6 167.25 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -67.18 -47.31 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.151 0.5 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.04 102.21 16.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.169 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.25 169.11 19.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.438 2.092 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -148.1 17.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.443 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.89 98.99 0.03 OUTLIER 'General case' 0 C--O 1.248 1.016 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.939 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.807 0 O-C-N 123.539 0.524 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.07 -12.86 83.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.669 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.75 -48.15 82.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -93.12 -6.33 48.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.09 73.63 81.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.667 0.27 . . . . 0.0 111.129 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.72 122.37 8.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.863 2.375 . . . . 0.0 112.301 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.71 -49.45 3.12 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.458 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' CG1' ' CD ' ' A' ' 93' ' ' GLN . 3.5 mp -45.0 110.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.403 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.54 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.43 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CD1' ' CA ' ' A' ' 114' ' ' GLY . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.577 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.577 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CE1' HD22 ' A' ' 112' ' ' LEU . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.51 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.446 ' CG1' ' CG ' ' A' ' 84' ' ' MET . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.429 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.485 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' H ' ' C ' ' A' ' 78' ' ' ALA . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.602 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.602 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.445 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.403 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.445 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.486 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.486 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' CD2' HG13 ' A' ' 113' ' ' ILE . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.419 HG23 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 126' ' ' ARG . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.528 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.528 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.456 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.48 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.584 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -50.98 179.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -57.9 -21.57 43.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.35 107.67 0.91 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.22 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.57 102.84 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.48 2.12 . . . . 0.0 112.325 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.24 -82.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.67 179.27 9.26 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.799 0 O-C-N 123.547 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.857 0.36 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.35 87.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.517 ' CD1' ' H ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -70.58 -18.58 62.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.401 ' N ' HD21 ' A' ' 4' ' ' LEU . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -56.78 -46.96 81.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.35 79.62 42.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.828 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.95 120.89 7.28 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.54 2.16 . . . . 0.0 112.44 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.33 -9.31 4.39 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.005 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.42 -41.37 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 88' ' ' ALA . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.465 ' HG3' ' CG2' ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.465 ' CG2' ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.422 ' CD2' HG11 ' A' ' 97' ' ' VAL . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' CYS . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 80' ' ' TYR . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.584 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CE2' HD22 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.456 ' HB3' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.412 ' HG2' ' CD1' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG13 ' CH2' ' A' ' 86' ' ' TRP . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.449 ' CZ ' ' NZ ' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 77' ' ' PHE . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.428 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.429 ' CE1' ' HB ' ' A' ' 69' ' ' THR . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CD2' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.449 ' NZ ' ' CZ ' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.452 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 67' ' ' PHE . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 15' ' ' ARG . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.414 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 35' ' ' PHE . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.406 ' CD1' ' CD1' ' A' ' 7' ' ' TYR . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' HB3' ' CD1' ' A' ' 113' ' ' ILE . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.45 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.45 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.538 ' CD2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.419 ' N ' HD11 ' A' ' 112' ' ' LEU . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.456 ' HA ' ' HB2' ' A' ' 143' ' ' LYS . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.515 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.515 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.44 ' CD1' HD23 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.447 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.447 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.708 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.647 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.708 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt -58.93 -179.39 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -49.1 125.74 11.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.6 89.68 11.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.111 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.85 108.6 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.539 2.159 . . . . 0.0 112.245 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.63 -81.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -131.16 113.15 13.52 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.822 0 O-C-N 123.494 0.496 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.6 62.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.6 mt -50.05 -26.61 4.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -56.68 -48.0 78.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -166.66 129.82 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 8' ' ' LEU . 2.7 Cg_exo -76.42 7.48 3.39 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.658 2.239 . . . . 0.0 113.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 36.52 4.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.594 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.0 mm -118.0 150.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' CD2' ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' CG2' ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' N ' HD21 ' A' ' 26' ' ' LEU . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' CD2' ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.456 ' CE2' ' CD2' ' A' ' 30' ' ' LEU . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.454 ' CD2' HG22 ' A' ' 66' ' ' VAL . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.406 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB2' HG23 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.406 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.429 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.402 ' O ' ' CB ' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.5 p80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.406 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.48 ' HB ' ' CE2' ' A' ' 86' ' ' TRP . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' CG1' ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.447 ' CG ' HG23 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.417 ' O ' ' CD1' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.574 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.574 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 15' ' ' ARG . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.457 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.408 ' CG1' ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.416 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.428 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.492 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.492 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.667 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.667 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.431 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.477 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.452 HG11 ' O ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.754 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.754 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.418 ' O ' ' O ' ' A' ' 144' ' ' ASP . 2.8 ptmm? -56.11 162.89 1.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.9 t0 38.43 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.167 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.483 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . . . -150.55 -67.26 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.483 ' CD ' ' CB ' ' A' ' 145' ' ' ALA . 65.8 Cg_endo -73.3 -166.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.287 1.992 . . . . 0.0 112.185 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.55 126.1 37.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -135.39 -51.72 0.76 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.721 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.75 0.31 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.7 -23.34 72.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.624 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 mt -52.81 -26.24 13.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -85.76 -6.5 59.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.441 ' HB3' HG13 ' A' ' 11' ' ' ILE . 4.4 mt -116.67 88.85 26.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.06 112.35 3.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.928 2.419 . . . . 0.0 112.902 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.13 86.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.452 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.441 HG13 ' HB3' ' A' ' 8' ' ' LEU . 35.4 mm -133.03 127.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.402 ' HA ' HG21 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 14' ' ' LEU . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.461 ' CD2' ' CE1' ' A' ' 140' ' ' PHE . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' CG1' ' CG2' ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.427 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.414 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 47' ' ' THR . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' CD1' ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' O ' ' N ' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.432 ' CG ' ' N ' ' A' ' 59' ' ' GLU . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.422 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.404 ' CE2' HG22 ' A' ' 47' ' ' THR . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.527 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.405 ' HB3' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 104' ' ' PHE . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.403 ' OG ' ' CD1' ' A' ' 35' ' ' PHE . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.456 ' CE1' ' CD1' ' A' ' 100' ' ' LEU . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.437 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.596 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 ' N ' HD13 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.434 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.423 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.404 ' HG2' ' CB ' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.596 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.62 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.62 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.404 ' CD1' ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' A' ' 142' ' ' TRP . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.76 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.592 ' O ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -74.85 -169.08 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.592 ' O ' ' O ' ' A' ' 143' ' ' LYS . 30.9 p-10 16.79 120.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.487 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . . . -147.3 -67.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.179 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 145' ' ' ALA . 61.4 Cg_endo -72.63 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.266 1.977 . . . . 0.0 112.294 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.0 -78.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -148.42 22.06 1.05 Allowed 'General case' 0 C--O 1.249 1.061 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.786 0 O-C-N 123.553 0.533 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.854 0.359 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.97 -12.05 84.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.84 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.1 mt -65.73 -30.21 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -69.81 -32.21 70.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mt -126.19 76.23 72.43 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.78 112.9 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.604 2.202 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.98 74.43 0.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.818 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.8 mm -133.53 153.61 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.485 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 115' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.434 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.542 HD12 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' ' CH2' ' A' ' 86' ' ' TRP . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.542 ' CD2' HD12 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.413 ' CG ' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.413 ' OG ' ' CG ' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.528 ' CG1' ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.414 ' SG ' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 77' ' ' PHE . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.452 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.423 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.507 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.528 ' CZ2' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.412 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.462 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.431 ' CG ' HD13 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.481 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.481 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.813 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.431 HD13 ' CG ' ' A' ' 104' ' ' PHE . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 33' ' ' PHE . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.411 ' O ' HG21 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.813 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 54' ' ' TYR . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.754 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.754 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.521 ' C ' ' H ' ' A' ' 145' ' ' ALA . 16.0 pttm -106.75 158.7 16.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.5 t70 56.41 -4.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 143' ' ' LYS . . . -60.16 -52.79 70.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.698 0.285 . . . . 0.0 111.125 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 145' ' ' ALA . 94.5 Cg_endo -84.31 14.0 2.56 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.73 2.287 . . . . 0.0 113.042 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -21.86 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.158 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.7 166.19 2.66 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.968 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.748 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.82 -16.35 80.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.747 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' O ' ' HB3' ' A' ' 7' ' ' TYR . 4.6 mt -50.87 -27.58 7.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.463 ' CE1' ' CD2' ' A' ' 100' ' ' LEU . 2.5 t80 -60.66 -69.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -173.68 105.5 0.3 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 7.69 2.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.765 2.31 . . . . 0.0 113.228 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 -37.01 6.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.399 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt -64.39 103.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 16' ' ' ARG . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.426 ' CG2' ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.443 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.443 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.588 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.588 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' CG2' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.605 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.406 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 77' ' ' PHE . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.422 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.64 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.49 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.463 ' CD2' ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 122' ' ' VAL . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.612 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.451 HG21 ' N ' ' A' ' 114' ' ' GLY . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG21 ' A' ' 113' ' ' ILE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.437 HG13 ' CZ ' ' A' ' 104' ' ' PHE . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 104' ' ' PHE . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.612 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.716 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp -48.95 150.7 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -126.5 -11.05 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.586 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 41.92 64.71 5.45 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.872 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.64 -178.92 3.71 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.688 2.259 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.0 mt 56.3 -174.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -66.25 89.41 0.13 Allowed 'General case' 0 C--O 1.249 1.079 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.788 0 O-C-N 123.5 0.5 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.99 -24.54 58.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.8 mt -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 -95.7 -55.57 2.97 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.547 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -170.05 -54.36 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.353 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 88.8 Cg_exo -47.56 148.68 5.32 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.204 1.936 . . . . 0.0 112.396 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 26.33 9.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.644 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.4 ' CD1' ' CD2' ' A' ' 8' ' ' LEU . 56.7 mt -94.37 -80.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.453 ' HA ' ' HA3' ' A' ' 114' ' ' GLY . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.41 ' CE2' HG23 ' A' ' 115' ' ' VAL . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.451 ' CE1' ' CG2' ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 35' ' ' PHE . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.448 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.529 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 ' CG ' ' A' ' 84' ' ' MET . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.455 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.455 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.438 ' CD1' ' CB ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.438 ' CB ' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.533 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.431 ' CZ ' ' CD ' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.443 ' SG ' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.466 ' CE1' ' HE3' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.466 ' HE3' ' CE1' ' A' ' 80' ' ' TYR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.555 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.555 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.528 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.427 HG12 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.467 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.646 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 113' ' ' ILE . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG23 ' CE2' ' A' ' 33' ' ' PHE . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' ' CG2' ' A' ' 113' ' ' ILE . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.437 ' C ' ' HG3' ' A' ' 126' ' ' ARG . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.437 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.646 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.433 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.755 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -70.47 179.37 2.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.5 t0 38.31 -162.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.021 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.491 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . . . -146.72 -68.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.328 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.491 ' CD ' ' CB ' ' A' ' 145' ' ' ALA . 56.0 Cg_endo -69.95 63.91 1.91 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.229 1.953 . . . . 0.0 112.148 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mp -56.11 111.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.064 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.64 11.21 3.77 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.794 0 O-C-N 123.571 0.544 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.852 0.358 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.92 -25.26 60.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.9 -27.51 5.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -77.24 -63.11 1.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -169.75 -57.22 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.11 112.16 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.362 2.041 . . . . 0.0 112.338 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.88 -16.08 3.74 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.384 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' LYS . 96.7 mt -61.72 83.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.421 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.424 HG11 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.424 ' CE1' HG11 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.466 ' OH ' ' CZ2' ' A' ' 86' ' ' TRP . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.41 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.535 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' CZ3' ' A' ' 86' ' ' TRP . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.494 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.494 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.655 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.652 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.545 ' HB3' ' HB1' ' A' ' 88' ' ' ALA . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.544 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.655 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.652 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.545 ' HB1' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.414 HD13 ' CD2' ' A' ' 104' ' ' PHE . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD2' HD13 ' A' ' 100' ' ' LEU . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.632 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.402 HD11 ' CG ' ' A' ' 104' ' ' PHE . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.436 ' HA2' ' CE1' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.632 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.577 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.581 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -90.49 -179.34 5.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -84.58 153.18 23.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.05 -60.84 1.39 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.58 162.95 38.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.508 2.139 . . . . 0.0 112.323 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.3 mt -157.82 31.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 9.4 tp10 -173.83 169.1 4.2 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.47 ' N ' ' HG3' ' A' ' 148' ' ' GLU . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.547 0.529 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 6' ' ' LYS . . . -79.03 -34.98 31.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.54 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.74 -26.73 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -87.83 -55.07 3.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.502 ' HB3' ' HD3' ' A' ' 9' ' ' PRO . 3.4 tm? -175.84 -45.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 25.0 Cg_exo -63.87 10.31 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.5 2.134 . . . . 0.0 113.692 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -143.79 33.61 1.74 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.132 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 13' ' ' LYS . 43.9 mt -94.74 100.22 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.431 ' CB ' ' HB3' ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.404 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.494 ' HB3' ' CD2' ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.435 ' CD1' ' HB2' ' A' ' 68' ' ' CYS . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HB2' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.442 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.461 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' CG ' ' O ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.493 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.493 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD12 HG23 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 p80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.809 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.435 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.452 ' HB ' ' CZ ' ' A' ' 67' ' ' PHE . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.418 ' CZ ' HG22 ' A' ' 47' ' ' THR . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.476 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.809 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' CB ' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.412 ' CG2' HD13 ' A' ' 8' ' ' LEU . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.408 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.404 ' CG1' ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.432 ' HG ' ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.432 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.47 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.466 HD11 HG22 ' A' ' 113' ' ' ILE . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.431 HG23 ' CE1' ' A' ' 104' ' ' PHE . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.5 ' O ' HG11 ' A' ' 132' ' ' VAL . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG11 ' O ' ' A' ' 129' ' ' ALA . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.752 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.565 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.752 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 141' ' ' PRO . 51.2 pttt -113.13 -168.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 -169.84 2.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.27 81.78 1.41 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.69 -168.11 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.514 2.143 . . . . 0.0 112.332 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mt -115.88 85.39 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.5 149.44 40.28 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.796 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.721 0.296 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.18 -37.99 23.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.547 ' H ' ' CD2' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.84 -35.64 23.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.439 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -90.17 -56.46 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 10' ' ' GLY . 3.0 tp -174.15 -51.05 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 35.6 Cg_exo -59.0 11.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.728 2.285 . . . . 0.0 114.318 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -117.24 37.81 3.2 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.121 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' O ' ' C ' ' A' ' 12' ' ' GLU . 16.7 mt -117.58 160.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' HB2' ' CD2' ' A' ' 87' ' ' LEU . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.453 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.422 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.436 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' O ' ' C ' ' A' ' 43' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HB3' ' CZ3' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.402 HD13 ' CZ3' ' A' ' 86' ' ' TRP . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . 0.466 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.597 ' O ' ' HB2' ' A' ' 86' ' ' TRP . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.544 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 80' ' ' TYR . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.422 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.519 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.597 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.729 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.427 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.416 HD13 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.421 ' CD1' HD11 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.683 ' HG ' ' HB1' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.409 ' HA ' ' HG ' ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.683 ' HB1' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.591 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.765 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.591 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.765 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -90.17 -177.56 5.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.54 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -51.19 107.08 0.74 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.74 -174.42 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.529 2.152 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -56.99 -169.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 155.56 31.77 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.772 0 O-C-N 123.548 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.443 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 2.4 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 87' ' ' LEU . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.758 ' C ' HD23 ' A' ' 26' ' ' LEU . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 66' ' ' VAL . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE2' ' HA3' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.489 ' HB2' HG22 ' A' ' 111' ' ' THR . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.05 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.957 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.05 HG21 HD11 ' A' ' 50' ' ' LEU . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.803 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.682 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.699 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 111' ' ' THR . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.568 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.499 HG21 HG13 ' A' ' 106' ' ' VAL . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 4' ' ' LEU . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.637 ' OD2' HG21 ' A' ' 123' ' ' VAL . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 4' ' ' LEU . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 4' ' ' LEU . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.58 HG22 ' HE1' ' A' ' 104' ' ' PHE . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.637 HG21 ' OD2' ' A' ' 116' ' ' ASP . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 113' ' ' ILE . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.703 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.789 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.789 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.492 HD23 ' HZ ' ' A' ' 33' ' ' PHE . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.759 ' OH ' HG23 ' A' ' 122' ' ' VAL . 5.8 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 23' ' ' VAL . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 87' ' ' LEU . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 14' ' ' LEU . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 64' ' ' GLU . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG1' HG23 ' A' ' 66' ' ' VAL . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.684 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HZ ' HD23 ' A' ' 4' ' ' LEU . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HD2' HD22 ' A' ' 112' ' ' LEU . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB1' ' HD1' ' A' ' 39' ' ' TRP . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.577 ' HD1' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.553 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.85 HD11 ' HD2' ' A' ' 85' ' ' PRO . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 29' ' ' LYS . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 50' ' ' LEU . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.937 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.85 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 21' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.937 HG11 ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 104' ' ' PHE . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 114' ' ' GLY . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD2' HG21 ' A' ' 123' ' ' VAL . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.759 HG23 ' OH ' ' A' ' 7' ' ' TYR . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 ' OD2' ' A' ' 116' ' ' ASP . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 124' ' ' THR . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.776 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.749 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.4 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.564 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 HD21 ' A' ' 87' ' ' LEU . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG11 ' A' ' 31' ' ' VAL . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 115' ' ' VAL . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG11 HD13 ' A' ' 26' ' ' LEU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.741 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 132' ' ' VAL . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 132' ' ' VAL . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.868 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.454 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE1' HG23 ' A' ' 66' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 50' ' ' LEU . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.714 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' N ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.465 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.695 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.78 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' CG ' HG12 ' A' ' 11' ' ' ILE . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 98' ' ' GLN . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 69' ' ' THR . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.741 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 106' ' ' VAL . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 101' ' ' SER . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.445 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.795 ' CD2' HD13 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.851 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.731 ' O ' HD12 ' A' ' 30' ' ' LEU . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.682 ' OD1' HG21 ' A' ' 123' ' ' VAL . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.682 HG21 ' OD1' ' A' ' 116' ' ' ASP . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.849 ' O ' HD13 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.795 HD13 ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.773 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.773 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 31' ' ' VAL . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.1 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 87' ' ' LEU . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 12' ' ' GLU . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.689 ' C ' HD23 ' A' ' 26' ' ' LEU . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.87 ' NZ ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG22 ' NZ ' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.617 ' CE1' HG22 ' A' ' 115' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD2' HG21 ' A' ' 106' ' ' VAL . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.57 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 29' ' ' LYS . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 50' ' ' LEU . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CZ ' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' HG11 ' A' ' 97' ' ' VAL . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' CG ' ' HB1' ' A' ' 37' ' ' ALA . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CH2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 14' ' ' LEU . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 69' ' ' THR . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' VAL . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CG ' HD12 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 35' ' ' PHE . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 131' ' ' LEU . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 125' ' ' THR . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 33' ' ' PHE . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.577 ' HA ' HG23 ' A' ' 113' ' ' ILE . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' NH2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD11 HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.894 ' CD2' HD13 ' A' ' 100' ' ' LEU . 2.6 t80 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD1' HD11 ' A' ' 26' ' ' LEU . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG2' HG22 ' A' ' 21' ' ' VAL . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.734 HG22 ' HG2' ' A' ' 16' ' ' ARG . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.773 ' C ' HD23 ' A' ' 26' ' ' LEU . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CD1' HG21 ' A' ' 123' ' ' VAL . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.954 HG11 HD11 ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 111' ' ' THR . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.625 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HD3' HG22 ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 46' ' ' PHE . 55.5 mm-40 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.026 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.583 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 9.9 p-80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.026 HG21 HD11 ' A' ' 50' ' ' LEU . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.547 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.569 ' HB3' HG13 ' A' ' 97' ' ' VAL . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.682 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.764 ' HE1' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.649 HD12 ' CG ' ' A' ' 64' ' ' GLU . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 17.4 mm100 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.894 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 4' ' ' LEU . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.649 ' OD2' HG22 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.649 HG22 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.683 ' HA ' HD13 ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB1' ' HZ3' ' A' ' 142' ' ' TRP . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 129' ' ' ALA . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 128' ' ' ARG . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 100' ' ' LEU . 3.2 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 87' ' ' LEU . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.724 ' CB ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 HD22 ' A' ' 87' ' ' LEU . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.683 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 25' ' ' SER . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 112' ' ' LEU . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.68 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.718 ' O ' HG22 ' A' ' 47' ' ' THR . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.812 HG23 ' HD3' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' HG23 ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.921 HG21 HD11 ' A' ' 50' ' ' LEU . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.496 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.426 ' HD2' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.542 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 84' ' ' MET . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 69' ' ' THR . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 125' ' ' THR . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.517 HG21 ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HA ' HD22 ' A' ' 4' ' ' LEU . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG13 ' HE2' ' A' ' 143' ' ' LYS . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 113' ' ' ILE . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.764 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.592 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.531 ' HE2' HG13 ' A' ' 123' ' ' VAL . 5.9 mttm . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.795 ' CD1' HD11 ' A' ' 26' ' ' LEU . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 87' ' ' LEU . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HD23 ' A' ' 26' ' ' LEU . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 115' ' ' VAL . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 66' ' ' VAL . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.823 ' HB3' HD22 ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.616 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' HD23 ' A' ' 112' ' ' LEU . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.898 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.451 HD11 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 50' ' ' LEU . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.637 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.859 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.404 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.45 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 84' ' ' MET . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.641 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 33.9 mm-40 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.859 HG11 ' O ' ' A' ' 69' ' ' THR . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 106' ' ' VAL . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.678 ' HE1' HG22 ' A' ' 122' ' ' VAL . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.723 HG13 HG21 ' A' ' 111' ' ' THR . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.723 HG21 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 125' ' ' THR . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.793 ' O ' HD12 ' A' ' 30' ' ' LEU . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 123' ' ' VAL . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.678 HG22 ' HE1' ' A' ' 104' ' ' PHE . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 141' ' ' PRO . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 113' ' ' ILE . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.677 ' NH1' HG21 ' A' ' 130' ' ' THR . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.677 HG21 ' NH1' ' A' ' 126' ' ' ARG . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.821 ' O ' HG12 ' A' ' 123' ' ' VAL . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.808 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' A' ' 122' ' ' VAL . 2.7 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.598 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.598 HG22 ' CG ' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' C ' HD23 ' A' ' 26' ' ' LEU . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 25' ' ' SER . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.706 ' CB ' HD22 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.577 ' CA ' HD12 ' A' ' 51' ' ' ILE . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.577 HD12 ' CA ' ' A' ' 48' ' ' PRO . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.6 ' CE1' HG23 ' A' ' 65' ' ' VAL . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' TYR . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.708 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.546 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.547 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD12 ' HG2' ' A' ' 64' ' ' GLU . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.708 HG11 ' O ' ' A' ' 69' ' ' THR . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 99' ' ' LYS . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 106' ' ' VAL . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 122' ' ' VAL . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 101' ' ' SER . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 35' ' ' PHE . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.706 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.708 HG22 ' CE1' ' A' ' 33' ' ' PHE . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.496 ' CG ' HG21 ' A' ' 123' ' ' VAL . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.54 HG22 ' HE1' ' A' ' 104' ' ' PHE . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 115' ' ' VAL . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 113' ' ' ILE . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.56 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.781 ' HB1' ' CE ' ' A' ' 133' ' ' LYS . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.781 ' CE ' ' HB1' ' A' ' 129' ' ' ALA . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.771 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.771 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 115' ' ' VAL . 12.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.61 ' OH ' HG23 ' A' ' 122' ' ' VAL . 8.5 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.426 HD13 ' OE1' ' A' ' 93' ' ' GLN . 14.9 mm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB2' HD22 ' A' ' 87' ' ' LEU . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.635 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.928 ' CG2' HD21 ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.641 ' C ' HD23 ' A' ' 26' ' ' LEU . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 25' ' ' SER . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.682 ' CE2' HG21 ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 112' ' ' LEU . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.74 ' HB1' ' OD1' ' A' ' 71' ' ' ASP . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.496 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 50' ' ' LEU . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 33' ' ' PHE . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CD2' ' HD3' ' A' ' 83' ' ' LYS . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.841 ' O ' HG11 ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.593 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.74 ' OD1' ' HB1' ' A' ' 37' ' ' ALA . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.673 ' HE1' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.568 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.928 HD21 ' CG2' ' A' ' 21' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OE1' HD13 ' A' ' 11' ' ' ILE . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.689 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 112' ' ' LEU . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG21 HD21 ' A' ' 4' ' ' LEU . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.61 HG23 ' OH ' ' A' ' 7' ' ' TYR . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.498 HD22 HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.734 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 3.3 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.667 HG13 ' HG3' ' A' ' 16' ' ' ARG . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 26' ' ' LEU . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.698 HD23 ' C ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.619 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.753 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' A' ' 106' ' ' VAL . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PRO . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.454 ' CD2' ' HG2' ' A' ' 59' ' ' GLU . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HG2' HD12 ' A' ' 87' ' ' LEU . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 50' ' ' LEU . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.706 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.488 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.593 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.658 ' HB3' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.636 HG21 ' OH ' ' A' ' 7' ' ' TYR . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.967 HD22 ' CZ ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.736 HG21 ' CD2' ' A' ' 35' ' ' PHE . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.64 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 112' ' ' LEU . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 122' ' ' VAL . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.708 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.64 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 20.9 m-30 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.715 HG23 ' OE1' ' A' ' 93' ' ' GLN . 3.5 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HD23 ' A' ' 87' ' ' LEU . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.697 HG11 HD21 ' A' ' 87' ' ' LEU . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.711 ' C ' HD23 ' A' ' 26' ' ' LEU . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 25' ' ' SER . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 112' ' ' LEU . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.576 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 51' ' ' ILE . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.034 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 47' ' ' THR . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.916 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASP . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' LEU . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.541 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.626 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.626 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG13 HE21 ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.794 HE21 HG13 ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 69' ' ' THR . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 106' ' ' VAL . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 122' ' ' VAL . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG21 ' OG ' ' A' ' 101' ' ' SER . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 122' ' ' VAL . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 113' ' ' ILE . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 130' ' ' THR . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.566 HG23 ' HG3' ' A' ' 126' ' ' ARG . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' A' ' 50' ' ' LEU . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.767 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.767 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.693 ' OD1' HG21 ' A' ' 23' ' ' VAL . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' CB ' HD22 ' A' ' 87' ' ' LEU . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.862 HG22 ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.579 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 25' ' ' SER . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 115' ' ' VAL . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD13 ' A' ' 26' ' ' LEU . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.82 ' HB2' HG22 ' A' ' 111' ' ' THR . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG21 ' CD1' ' A' ' 50' ' ' LEU . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.693 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.471 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' A' ' 14' ' ' LEU . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 69' ' ' THR . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 104' ' ' PHE . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.664 ' CZ ' HG11 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 111' ' ' THR . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.818 ' O ' HD12 ' A' ' 109' ' ' ILE . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 124' ' ' THR . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 123' ' ' VAL . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 115' ' ' VAL . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.516 HG22 ' OD2' ' A' ' 116' ' ' ASP . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.432 ' HA ' HG23 ' A' ' 113' ' ' ILE . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.455 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.719 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.681 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.719 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 115' ' ' VAL . 7.6 mt . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' OH ' HG11 ' A' ' 115' ' ' VAL . 3.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.474 HG23 ' OE1' ' A' ' 93' ' ' GLN . 20.0 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 87' ' ' LEU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 31' ' ' VAL . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.766 HD23 ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HD13 ' A' ' 26' ' ' LEU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.768 ' O ' HG22 ' A' ' 66' ' ' VAL . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.511 ' HB2' HG22 ' A' ' 113' ' ' ILE . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.404 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.518 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 15.8 p-80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.693 ' CG ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG21 HD11 ' A' ' 50' ' ' LEU . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 32' ' ' PHE . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.559 ' CG ' HG21 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.583 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 16' ' ' ARG . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.549 ' C ' HD23 ' A' ' 14' ' ' LEU . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' HG23 ' A' ' 11' ' ' ILE . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 111' ' ' THR . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 113' ' ' ILE . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 4' ' ' LEU . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.686 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.562 HD13 HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 138' ' ' GLU . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 136' ' ' GLU . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.785 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.59 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 2.8 ptmm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 31' ' ' VAL . 16.1 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.422 ' HB3' HD13 ' A' ' 100' ' ' LEU . 32.5 m-85 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HD3' HG23 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.838 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' C ' HD23 ' A' ' 87' ' ' LEU . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.764 HG11 ' HD3' ' A' ' 16' ' ' ARG . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 13' ' ' LYS . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.737 ' C ' HD23 ' A' ' 26' ' ' LEU . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.737 HD23 ' C ' ' A' ' 25' ' ' SER . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 115' ' ' VAL . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.428 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HA ' HD12 ' A' ' 51' ' ' ILE . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 48' ' ' PRO . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 87' ' ' LEU . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 50' ' ' LEU . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' CG ' HG12 ' A' ' 51' ' ' ILE . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 14' ' ' LEU . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 106' ' ' VAL . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HD2' HG21 ' A' ' 113' ' ' ILE . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 101' ' ' SER . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 HG13 ' A' ' 106' ' ' VAL . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.874 ' CD2' HD13 ' A' ' 131' ' ' LEU . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 122' ' ' VAL . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 115' ' ' VAL . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.644 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.644 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.874 HD13 ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.788 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 124' ' ' THR . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.788 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 115' ' ' VAL . 16.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 23' ' ' VAL . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.619 ' CB ' HD22 ' A' ' 87' ' ' LEU . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.631 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.919 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.717 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG12 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 31' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CE2' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.819 HD11 ' HB3' ' A' ' 84' ' ' MET . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.627 ' CG ' HG23 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.809 ' CG ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.734 HG11 ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.798 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.552 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.819 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.773 ' CH2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.919 HD21 ' CG2' ' A' ' 21' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 81' ' ' PHE . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.565 HG12 ' OE1' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' OE1' HG12 ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.798 HG11 ' O ' ' A' ' 69' ' ' THR . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.48 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 125' ' ' THR . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 4' ' ' LEU . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.516 ' HA ' HG23 ' A' ' 113' ' ' ILE . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.697 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 126' ' ' ARG . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' LEU . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.78 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.78 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 141' ' ' PRO . 16.0 pttm . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mt . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 100' ' ' LEU . 2.5 t80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.681 ' CA ' HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 15' ' ' ARG . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.681 ' C ' HD23 ' A' ' 26' ' ' LEU . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 25' ' ' SER . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD23 ' CE2' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CE2' HD23 ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 111' ' ' THR . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HB2' ' O ' ' A' ' 70' ' ' TRP . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' CG ' HD23 ' A' ' 131' ' ' LEU . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.708 ' CD ' HD12 ' A' ' 87' ' ' LEU . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.814 HG21 ' HG ' ' A' ' 50' ' ' LEU . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.8 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' GLU . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.833 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 HG21 ' A' ' 111' ' ' THR . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.532 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 104' ' ' PHE . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.918 ' CG1' HG22 ' A' ' 122' ' ' VAL . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.918 HG22 ' CG1' ' A' ' 115' ' ' VAL . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.614 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.566 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.739 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.624 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 93' ' ' GLN . 56.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 89' ' ' VAL . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.795 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 12' ' ' GLU . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 31' ' ' VAL . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HE1' ' A' ' 32' ' ' PHE . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 26' ' ' LEU . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.497 ' HE1' HD23 ' A' ' 30' ' ' LEU . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.99 ' CE1' HG23 ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB2' HG22 ' A' ' 111' ' ' THR . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.443 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' ARG . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.99 HG23 ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CG ' ' HA ' ' A' ' 46' ' ' PHE . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD22 HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 48' ' ' PRO . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.541 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.637 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' A' ' 47' ' ' THR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' A' ' 21' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 14' ' ' LEU . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.531 ' OE1' HG12 ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.691 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CD2' HD12 ' A' ' 113' ' ' ILE . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 113' ' ' ILE . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 112' ' ' LEU . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 124' ' ' THR . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 4' ' ' LEU . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CG2' ' A' ' 125' ' ' THR . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.488 ' HA ' HD13 ' A' ' 113' ' ' ILE . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.532 HG21 ' HG3' ' A' ' 93' ' ' GLN . 96.7 mt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 87' ' ' LEU . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.661 ' HD2' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.864 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.728 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 25' ' ' SER . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' CE ' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 ' HE2' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.76 ' HB3' HD13 ' A' ' 112' ' ' LEU . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.643 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.015 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.866 HD11 ' HG3' ' A' ' 84' ' ' MET . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.808 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.015 HG21 HD11 ' A' ' 50' ' ' LEU . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.821 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.866 ' HG3' HD11 ' A' ' 51' ' ' ILE . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.864 HD21 ' CG2' ' A' ' 21' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 11' ' ' ILE . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 69' ' ' THR . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.776 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' CD2' HD13 ' A' ' 131' ' ' LEU . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 124' ' ' THR . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.754 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.754 HG21 ' OD1' ' A' ' 116' ' ' ASP . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' CD2' ' A' ' 112' ' ' LEU . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.737 HD22 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 13' ' ' LYS . 43.9 mt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.87 ' HA ' HD23 ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 21' ' ' VAL . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.819 ' C ' HD23 ' A' ' 26' ' ' LEU . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' HD12 ' A' ' 112' ' ' LEU . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.739 ' CB ' HD22 ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 111' ' ' THR . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.909 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 51' ' ' ILE . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 18.8 p-80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.909 HG21 ' CD1' ' A' ' 50' ' ' LEU . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.844 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.494 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.461 ' CG ' HG21 ' A' ' 11' ' ' ILE . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.844 HG11 ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 106' ' ' VAL . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 101' ' ' SER . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 35' ' ' PHE . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.977 HG23 HG22 ' A' ' 125' ' ' THR . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 122' ' ' VAL . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.791 ' OD2' HG21 ' A' ' 123' ' ' VAL . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.907 HG13 HG12 ' A' ' 115' ' ' VAL . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.791 HG21 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.977 HG22 HG23 ' A' ' 113' ' ' ILE . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.429 ' HB3' HG12 ' A' ' 123' ' ' VAL . 51.2 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' GLU . 16.7 mt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 26' ' ' LEU . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' HG11 ' A' ' 21' ' ' VAL . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' A' ' 16' ' ' ARG . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 11' ' ' ILE . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.598 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 14' ' ' LEU . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG23 ' A' ' 132' ' ' VAL . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.426 ' CG ' HD12 ' A' ' 87' ' ' LEU . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 50' ' ' LEU . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.891 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.545 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.522 ' HB3' HD13 ' A' ' 11' ' ' ILE . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.78 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.864 ' OD1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.864 HG21 ' OD1' ' A' ' 116' ' ' ASP . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 113' ' ' ILE . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.793 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.793 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 7' ' ' TYR . . . -78.99 -49.29 6.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -52.86 -25.6 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HA3' ' A' ' 3' ' ' GLY . 3.7 m-85 -50.9 -33.7 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.913 HD22 ' HB1' ' A' ' 96' ' ' ALA . 1.4 mt -106.01 175.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.847 ' HD3' ' HB2' ' A' ' 96' ' ' ALA . 6.5 Cg_exo -74.32 7.28 2.65 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.955 2.436 . . . . 0.0 113.24 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.56 50.82 1.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.817 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.626 HD13 HD13 ' A' ' 8' ' ' LEU . 2.4 mp -60.04 134.52 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 87' ' ' LEU . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.758 ' C ' HD23 ' A' ' 26' ' ' LEU . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 66' ' ' VAL . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE2' ' HA3' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' HB2' HG22 ' A' ' 111' ' ' THR . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.05 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.957 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.05 HG21 HD11 ' A' ' 50' ' ' LEU . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.803 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.682 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.699 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.913 ' HB1' HD22 ' A' ' 8' ' ' LEU . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.617 HD22 HD21 ' A' ' 8' ' ' LEU . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 111' ' ' THR . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.568 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.499 HG21 HG13 ' A' ' 106' ' ' VAL . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 4' ' ' LEU . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.637 ' OD2' HG21 ' A' ' 123' ' ' VAL . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 4' ' ' LEU . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 4' ' ' LEU . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.58 HG22 ' HE1' ' A' ' 104' ' ' PHE . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.637 HG21 ' OD2' ' A' ' 116' ' ' ASP . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 113' ' ' ILE . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.703 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.789 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.789 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm -58.98 -162.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -47.24 169.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.16 100.5 21.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.94 12.77 2.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 112.916 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.67 51.48 2.0 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.1 8.86 1.62 Allowed 'General case' 0 C--O 1.25 1.08 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.516 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.35 31.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 4' ' ' LEU . 6.0 mp -49.89 -27.91 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.759 ' OH ' HG23 ' A' ' 122' ' ' VAL . 5.8 m-85 -54.1 -29.05 43.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 100' ' ' LEU . 5.1 mp -139.15 79.84 25.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.97 112.29 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.505 2.136 . . . . 0.0 112.087 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.81 -19.86 6.11 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 8' ' ' LEU . 36.5 mm -60.65 137.24 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 23' ' ' VAL . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 87' ' ' LEU . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 14' ' ' LEU . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 64' ' ' GLU . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG1' HG23 ' A' ' 66' ' ' VAL . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.684 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HZ ' HD23 ' A' ' 4' ' ' LEU . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HD2' HD22 ' A' ' 112' ' ' LEU . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB1' ' HD1' ' A' ' 39' ' ' TRP . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.577 ' HD1' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.85 HD11 ' HD2' ' A' ' 85' ' ' PRO . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 29' ' ' LYS . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 50' ' ' LEU . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.937 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.85 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 21' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.937 HG11 ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 8' ' ' LEU . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 114' ' ' GLY . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD2' HG21 ' A' ' 123' ' ' VAL . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.759 HG23 ' OH ' ' A' ' 7' ' ' TYR . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 ' OD2' ' A' ' 116' ' ' ASP . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 124' ' ' THR . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.776 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -93.09 168.17 11.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -60.11 -172.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.85 108.24 1.1 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.94 -167.85 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.304 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.8 mm? -59.06 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.997 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 164.32 4.54 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.251 -3.715 0 CA-C-N 118.288 0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.04 -28.72 64.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.574 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.96 -26.82 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -81.28 -55.07 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.9 mp -98.53 155.13 37.14 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.079 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 96' ' ' ALA . 50.8 Cg_exo -55.48 -169.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.549 2.166 . . . . 0.0 112.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 49.07 3.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.381 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.4 mt -51.75 158.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.564 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 HD21 ' A' ' 87' ' ' LEU . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG11 ' A' ' 31' ' ' VAL . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 115' ' ' VAL . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG11 HD13 ' A' ' 26' ' ' LEU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.741 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 132' ' ' VAL . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 132' ' ' VAL . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.868 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.454 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE1' HG23 ' A' ' 66' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 50' ' ' LEU . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.714 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' N ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.465 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.695 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.78 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' CG ' HG12 ' A' ' 11' ' ' ILE . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 98' ' ' GLN . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 69' ' ' THR . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.741 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 106' ' ' VAL . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 101' ' ' SER . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.445 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.795 ' CD2' HD13 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.851 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.731 ' O ' HD12 ' A' ' 30' ' ' LEU . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.682 ' OD1' HG21 ' A' ' 123' ' ' VAL . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.682 HG21 ' OD1' ' A' ' 116' ' ' ASP . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.849 ' O ' HD13 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.795 HD13 ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.773 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.773 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt -102.34 137.01 41.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.3 p30 36.47 -163.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.541 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.816 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -151.77 -66.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.213 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 58.9 Cg_endo -71.51 -165.89 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.387 2.058 . . . . 0.0 112.277 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tt 68.14 105.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.39 2.49 3.0 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.764 0 O-C-N 123.505 0.503 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.819 0.342 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.79 -24.71 76.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 31' ' ' VAL . 44.1 mt -66.09 -34.17 77.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.1 m-85 -48.01 -43.43 29.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.715 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -121.9 79.58 41.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.25 156.09 52.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.645 2.23 . . . . 0.0 112.306 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.78 69.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.708 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.617 HD12 ' CB ' ' A' ' 8' ' ' LEU . 11.6 mt -130.16 118.9 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 87' ' ' LEU . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 12' ' ' GLU . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.689 ' C ' HD23 ' A' ' 26' ' ' LEU . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.87 ' NZ ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG22 ' NZ ' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.617 ' CE1' HG22 ' A' ' 115' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD2' HG21 ' A' ' 106' ' ' VAL . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 29' ' ' LYS . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 50' ' ' LEU . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CZ ' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' HG11 ' A' ' 97' ' ' VAL . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' CG ' ' HB1' ' A' ' 37' ' ' ALA . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CH2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 14' ' ' LEU . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.715 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 69' ' ' THR . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' VAL . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CG ' HD12 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 35' ' ' PHE . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 131' ' ' LEU . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 125' ' ' THR . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 33' ' ' PHE . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.577 ' HA ' HG23 ' A' ' 113' ' ' ILE . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' NH2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt -68.21 -176.74 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 -21.8 13.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.219 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.41 154.6 79.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.49 13.45 2.75 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.831 2.354 . . . . 0.0 112.902 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.65 -177.69 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.69 102.92 0.02 OUTLIER 'General case' 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.774 0 O-C-N 123.517 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.831 0.348 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -58.99 -24.2 57.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD11 HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -80.44 -31.54 37.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.894 ' CD2' HD13 ' A' ' 100' ' ' LEU . 2.6 t80 -55.91 -76.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 8' ' ' LEU . 4.4 tt -152.93 101.76 2.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.48 124.41 10.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.428 2.085 . . . . 0.0 112.299 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 -26.86 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.635 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm -52.36 -37.46 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD1' HD11 ' A' ' 26' ' ' LEU . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG2' HG22 ' A' ' 21' ' ' VAL . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.734 HG22 ' HG2' ' A' ' 16' ' ' ARG . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.773 ' C ' HD23 ' A' ' 26' ' ' LEU . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CD1' HG21 ' A' ' 123' ' ' VAL . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.954 HG11 HD11 ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 111' ' ' THR . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.625 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HD3' HG22 ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 46' ' ' PHE . 55.5 mm-40 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.026 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.583 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 9.9 p-80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.583 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.026 HG21 HD11 ' A' ' 50' ' ' LEU . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.547 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.569 ' HB3' HG13 ' A' ' 97' ' ' VAL . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.682 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.764 ' HE1' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.649 HD12 ' CG ' ' A' ' 64' ' ' GLU . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 69.3 mm-40 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.894 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 4' ' ' LEU . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.649 ' OD2' HG22 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.649 HG22 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.683 ' HA ' HD13 ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB1' ' HZ3' ' A' ' 142' ' ' TRP . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 129' ' ' ALA . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 128' ' ' ARG . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -95.36 -168.29 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.7 -169.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.23 56.26 2.45 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.294 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.422 ' C ' HD23 ' A' ' 147' ' ' LEU . 58.0 Cg_endo -70.91 76.24 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 112.232 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 40.51 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.684 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 59.41 92.4 0.04 OUTLIER 'General case' 0 C--O 1.248 1.021 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.007 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.789 0 O-C-N 123.51 0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.772 0.32 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.95 -32.99 38.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.706 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -50.58 -26.02 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 100' ' ' LEU . 3.2 m-85 -65.09 -27.16 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.094 HD21 HD22 ' A' ' 100' ' ' LEU . 12.2 mt -114.13 167.56 9.36 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.768 ' CD ' ' HB2' ' A' ' 96' ' ' ALA . 52.2 Cg_exo -55.04 -166.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.643 2.229 . . . . 0.0 111.783 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.3 44.42 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.923 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt -56.43 94.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 87' ' ' LEU . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.724 ' CB ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 HD22 ' A' ' 87' ' ' LEU . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.683 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 25' ' ' SER . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 112' ' ' LEU . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.68 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.718 ' O ' HG22 ' A' ' 47' ' ' THR . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.812 HG23 ' HD3' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' HG23 ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.921 HG21 HD11 ' A' ' 50' ' ' LEU . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.496 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.426 ' HD2' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.542 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 84' ' ' MET . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.865 ' HB1' HD22 ' A' ' 8' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 69' ' ' THR . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.094 HD22 HD21 ' A' ' 8' ' ' LEU . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 125' ' ' THR . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.517 HG21 ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HA ' HD22 ' A' ' 4' ' ' LEU . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG13 ' HE2' ' A' ' 143' ' ' LYS . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 113' ' ' ILE . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.764 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.592 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.531 ' HE2' HG13 ' A' ' 123' ' ' VAL . 5.9 mttm -80.4 130.05 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -101.32 133.13 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.964 ' HB1' ' HD2' ' A' ' 146' ' ' PRO . . . 48.15 179.44 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.964 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 70.6 Cg_endo -76.29 112.64 3.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.219 1.946 . . . . 0.0 112.429 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD11 ' OE2' ' A' ' 148' ' ' GLU . 33.1 tp 62.19 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' OE2' HD11 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -175.6 167.29 3.22 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.911 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.809 0 O-C-N 123.502 0.501 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.43 97.08 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.524 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp -59.42 -30.33 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' O ' HD22 ' A' ' 8' ' ' LEU . 22.9 m-85 -53.94 -43.61 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -164.5 105.71 0.85 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.77 8.27 2.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.885 2.39 . . . . 0.0 113.25 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.76 -19.26 34.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.91 100.7 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.795 ' CD1' HD11 ' A' ' 26' ' ' LEU . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 87' ' ' LEU . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HD23 ' A' ' 26' ' ' LEU . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 115' ' ' VAL . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 66' ' ' VAL . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.823 ' HB3' HD22 ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.616 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' HD23 ' A' ' 112' ' ' LEU . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.898 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.451 HD11 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 50' ' ' LEU . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.637 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.859 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.404 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.45 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 84' ' ' MET . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.641 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 33.9 mm-40 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.859 HG11 ' O ' ' A' ' 69' ' ' THR . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 106' ' ' VAL . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.678 ' HE1' HG22 ' A' ' 122' ' ' VAL . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.723 HG13 HG21 ' A' ' 111' ' ' THR . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.723 HG21 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 125' ' ' THR . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.793 ' O ' HD12 ' A' ' 30' ' ' LEU . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 123' ' ' VAL . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.678 HG22 ' HE1' ' A' ' 104' ' ' PHE . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 141' ' ' PRO . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 113' ' ' ILE . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.677 ' NH1' HG21 ' A' ' 130' ' ' THR . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.677 HG21 ' NH1' ' A' ' 126' ' ' ARG . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.821 ' O ' HG12 ' A' ' 123' ' ' VAL . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.808 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt -57.26 175.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -109.15 167.76 9.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -73.73 -61.76 1.28 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 56.8 Cg_endo -70.94 167.42 26.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.535 2.157 . . . . 0.0 112.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -93.79 159.24 15.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.3 mt-10 -141.84 162.39 35.59 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.781 0 O-C-N 123.526 0.516 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.805 0.336 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.46 -37.92 79.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -52.2 -29.45 22.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' A' ' 122' ' ' VAL . 2.7 m-85 -75.31 -36.67 61.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.665 ' HG ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -128.41 76.04 78.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.29 163.71 37.7 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.823 2.349 . . . . 0.0 112.187 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.2 45.77 92.31 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 8' ' ' LEU . 17.0 mm -126.27 105.12 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.598 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG22 ' CG ' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' C ' HD23 ' A' ' 26' ' ' LEU . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 25' ' ' SER . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.706 ' CB ' HD22 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.577 ' CA ' HD12 ' A' ' 51' ' ' ILE . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.577 HD12 ' CA ' ' A' ' 48' ' ' PRO . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.6 ' CE1' HG23 ' A' ' 65' ' ' VAL . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' TYR . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.708 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.546 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.547 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD12 ' HG2' ' A' ' 64' ' ' GLU . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.708 HG11 ' O ' ' A' ' 69' ' ' THR . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HG ' ' A' ' 8' ' ' LEU . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 106' ' ' VAL . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 122' ' ' VAL . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 101' ' ' SER . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 35' ' ' PHE . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.706 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.708 HG22 ' CE1' ' A' ' 33' ' ' PHE . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.496 ' CG ' HG21 ' A' ' 123' ' ' VAL . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.54 HG22 ' HE1' ' A' ' 104' ' ' PHE . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 115' ' ' VAL . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 113' ' ' ILE . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.56 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.781 ' HB1' ' CE ' ' A' ' 133' ' ' LYS . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.781 ' CE ' ' HB1' ' A' ' 129' ' ' ALA . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.771 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.771 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -43.67 166.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.77 125.1 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.886 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -104.37 -65.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.886 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 97.1 Cg_endo -79.29 76.96 4.27 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.328 2.019 . . . . 0.0 112.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -95.99 140.61 30.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -81.95 -13.31 57.66 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.817 0 O-C-N 123.542 0.526 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.826 0.346 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 -24.55 58.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.563 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 115' ' ' VAL . 12.9 mt -54.28 -24.82 20.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.61 ' OH ' HG23 ' A' ' 122' ' ' VAL . 8.5 m-85 -64.1 -30.7 71.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD23 ' HB1' ' A' ' 96' ' ' ALA . 4.0 mp -123.11 169.32 10.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.696 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' A' ' 96' ' ' ALA . 12.5 Cg_exo -70.94 9.06 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.931 2.421 . . . . 0.0 113.472 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.13 82.12 1.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.673 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.595 HG13 HD22 ' A' ' 8' ' ' LEU . 14.9 mm -87.82 104.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB2' HD22 ' A' ' 87' ' ' LEU . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.635 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.928 ' CG2' HD21 ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.641 ' C ' HD23 ' A' ' 26' ' ' LEU . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 25' ' ' SER . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.682 ' CE2' HG21 ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 112' ' ' LEU . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.74 ' HB1' ' OD1' ' A' ' 71' ' ' ASP . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.496 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 50' ' ' LEU . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 33' ' ' PHE . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CD2' ' HD3' ' A' ' 83' ' ' LYS . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.841 ' O ' HG11 ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.593 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.74 ' OD1' ' HB1' ' A' ' 37' ' ' ALA . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.673 ' HE1' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.568 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.928 HD21 ' CG2' ' A' ' 21' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OE1' HD13 ' A' ' 11' ' ' ILE . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.723 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.689 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 112' ' ' LEU . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG21 HD21 ' A' ' 4' ' ' LEU . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.61 HG23 ' OH ' ' A' ' 7' ' ' TYR . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.498 HD22 HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.734 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 144' ' ' ASP . 3.3 ptpt -62.95 -176.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 143' ' ' LYS . 11.0 t0 49.16 159.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.511 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.55 64.45 6.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.009 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.96 12.99 2.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.742 2.295 . . . . 0.0 113.031 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -131.49 118.6 20.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 147' ' ' LEU . 2.9 mm-40 61.88 169.22 0.11 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.792 0 O-C-N 123.528 0.517 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.766 0.317 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.03 -35.65 79.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.608 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mt -49.94 -25.89 3.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -52.58 -68.92 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD13 ' HB2' ' A' ' 96' ' ' ALA . 0.9 OUTLIER -172.57 93.36 0.38 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.246 . . . . 0.0 111.388 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.66 111.37 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.381 2.054 . . . . 0.0 112.016 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.25 -35.31 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.342 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.78 84.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.667 HG13 ' HG3' ' A' ' 16' ' ' ARG . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 26' ' ' LEU . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.698 HD23 ' C ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.753 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' A' ' 106' ' ' VAL . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PRO . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' CD2' ' HG2' ' A' ' 59' ' ' GLU . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HG2' HD12 ' A' ' 87' ' ' LEU . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 50' ' ' LEU . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.706 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.488 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.593 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.658 ' HB3' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.636 HG21 ' OH ' ' A' ' 7' ' ' TYR . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.727 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.967 HD22 ' CZ ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.736 HG21 ' CD2' ' A' ' 35' ' ' PHE . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.64 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 112' ' ' LEU . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 122' ' ' VAL . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.708 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.432 HG13 ' HZ2' ' A' ' 143' ' ' LYS . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.64 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt -111.6 167.25 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -67.18 -47.31 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.151 0.5 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.04 102.21 16.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.169 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.25 169.11 19.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.438 2.092 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -148.1 17.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.443 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.89 98.99 0.03 OUTLIER 'General case' 0 C--O 1.248 1.016 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.939 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.807 0 O-C-N 123.539 0.524 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.07 -12.86 83.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.669 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -59.75 -48.15 82.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 20.9 m-30 -93.12 -6.33 48.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 11' ' ' ILE . 7.2 mt -129.09 73.63 81.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.667 0.27 . . . . 0.0 111.129 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.72 122.37 8.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.863 2.375 . . . . 0.0 112.301 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.71 -49.45 3.12 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.458 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.715 HG23 ' OE1' ' A' ' 93' ' ' GLN . 3.5 mp -45.0 110.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HD23 ' A' ' 87' ' ' LEU . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.697 HG11 HD21 ' A' ' 87' ' ' LEU . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.711 ' C ' HD23 ' A' ' 26' ' ' LEU . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 25' ' ' SER . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 112' ' ' LEU . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.576 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 51' ' ' ILE . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.034 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 47' ' ' THR . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.916 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASP . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' LEU . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.541 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.626 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.626 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG13 HE21 ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.794 HE21 HG13 ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 69' ' ' THR . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 106' ' ' VAL . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 122' ' ' VAL . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG21 ' OG ' ' A' ' 101' ' ' SER . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 122' ' ' VAL . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 113' ' ' ILE . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 130' ' ' THR . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.566 HG23 ' HG3' ' A' ' 126' ' ' ARG . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' A' ' 50' ' ' LEU . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.767 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.767 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -50.98 179.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -57.9 -21.57 43.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.35 107.67 0.91 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.22 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.57 102.84 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.48 2.12 . . . . 0.0 112.325 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.24 -82.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.67 179.27 9.26 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.799 0 O-C-N 123.547 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.857 0.36 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.35 87.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.731 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -70.58 -18.58 62.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.693 ' OD1' HG21 ' A' ' 23' ' ' VAL . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -56.78 -46.96 81.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 ' HB1' ' A' ' 96' ' ' ALA . 1.2 mt -136.35 79.62 42.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.95 120.89 7.28 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.54 2.16 . . . . 0.0 112.44 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.33 -9.31 4.39 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.005 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.42 -41.37 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' CB ' HD22 ' A' ' 87' ' ' LEU . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG22 ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.579 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 25' ' ' SER . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 115' ' ' VAL . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD13 ' A' ' 26' ' ' LEU . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.82 ' HB2' HG22 ' A' ' 111' ' ' THR . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.641 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG21 ' CD1' ' A' ' 50' ' ' LEU . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.693 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.471 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' A' ' 14' ' ' LEU . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.991 ' HB1' HD13 ' A' ' 8' ' ' LEU . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 69' ' ' THR . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.718 ' HB2' HD11 ' A' ' 8' ' ' LEU . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.664 ' CZ ' HG11 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 111' ' ' THR . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.818 ' O ' HD12 ' A' ' 109' ' ' ILE . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 124' ' ' THR . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 123' ' ' VAL . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 115' ' ' VAL . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 145' ' ' ALA . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.432 ' HA ' HG23 ' A' ' 113' ' ' ILE . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.455 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.719 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.681 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.719 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt -58.93 -179.39 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -49.1 125.74 11.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -139.6 89.68 11.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.663 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.0 Cg_endo -68.85 108.6 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.539 2.159 . . . . 0.0 112.245 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.663 HD22 ' O ' ' A' ' 146' ' ' PRO . 1.0 OUTLIER -138.63 -81.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -131.16 113.15 13.52 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.822 0 O-C-N 123.494 0.496 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.6 62.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 115' ' ' VAL . 7.6 mt -50.05 -26.61 4.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' OH ' HG11 ' A' ' 115' ' ' VAL . 3.1 m-85 -56.68 -48.0 78.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD22 ' HB2' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -166.66 129.82 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 8' ' ' LEU . 2.7 Cg_exo -76.42 7.48 3.39 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.658 2.239 . . . . 0.0 113.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 36.52 4.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.594 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.474 HG23 ' OE1' ' A' ' 93' ' ' GLN . 20.0 mm -118.0 150.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 87' ' ' LEU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 31' ' ' VAL . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.766 HD23 ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HD13 ' A' ' 26' ' ' LEU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.768 ' O ' HG22 ' A' ' 66' ' ' VAL . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.511 ' HB2' HG22 ' A' ' 113' ' ' ILE . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.404 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.518 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 15.8 p-80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' CG ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.695 HG21 HD11 ' A' ' 50' ' ' LEU . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 32' ' ' PHE . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.559 ' CG ' HG21 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.583 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 16' ' ' ARG . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.549 ' C ' HD23 ' A' ' 14' ' ' LEU . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' HG23 ' A' ' 11' ' ' ILE . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 1.028 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 111' ' ' THR . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 113' ' ' ILE . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 4' ' ' LEU . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' NE ' ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.686 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.562 HD13 HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 138' ' ' GLU . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 136' ' ' GLU . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.785 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.59 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 2.8 ptmm? -56.11 162.89 1.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.9 t0 38.43 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.167 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -150.55 -67.26 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 65.8 Cg_endo -73.3 -166.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.287 1.992 . . . . 0.0 112.185 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -129.55 126.1 37.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.857 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -135.39 -51.72 0.76 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.721 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.75 0.31 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.7 -23.34 72.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.624 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 31' ' ' VAL . 16.1 mt -52.81 -26.24 13.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.422 ' HB3' HD13 ' A' ' 100' ' ' LEU . 32.5 m-85 -85.76 -6.5 59.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD22 ' CD1' ' A' ' 11' ' ' ILE . 4.4 mt -116.67 88.85 26.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.06 112.35 3.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.928 2.419 . . . . 0.0 112.902 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.789 ' O ' HD13 ' A' ' 11' ' ' ILE . . . 65.13 86.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.452 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 10' ' ' GLY . 35.4 mm -133.03 127.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HD3' HG23 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.838 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' C ' HD23 ' A' ' 87' ' ' LEU . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.764 HG11 ' HD3' ' A' ' 16' ' ' ARG . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 13' ' ' LYS . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.737 ' C ' HD23 ' A' ' 26' ' ' LEU . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.737 HD23 ' C ' ' A' ' 25' ' ' SER . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 115' ' ' VAL . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.428 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HA ' HD12 ' A' ' 51' ' ' ILE . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 48' ' ' PRO . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 87' ' ' LEU . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 50' ' ' LEU . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' CG ' HG12 ' A' ' 51' ' ' ILE . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 14' ' ' LEU . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 106' ' ' VAL . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HD2' HG21 ' A' ' 113' ' ' ILE . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 101' ' ' SER . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 HG13 ' A' ' 106' ' ' VAL . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.874 ' CD2' HD13 ' A' ' 131' ' ' LEU . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 122' ' ' VAL . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 115' ' ' VAL . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.644 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.644 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.874 HD13 ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.788 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 124' ' ' THR . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.788 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.592 ' O ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -74.85 -169.08 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.592 ' O ' ' O ' ' A' ' 143' ' ' LYS . 30.9 p-10 16.79 120.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.834 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -147.3 -67.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.179 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.834 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 61.4 Cg_endo -72.63 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.266 1.977 . . . . 0.0 112.294 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -72.0 -78.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -148.42 22.06 1.05 Allowed 'General case' 0 C--O 1.249 1.061 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.786 0 O-C-N 123.553 0.533 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.854 0.359 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.97 -12.05 84.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.84 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 115' ' ' VAL . 16.1 mt -65.73 -30.21 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -69.81 -32.21 70.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.996 HD21 HD23 ' A' ' 100' ' ' LEU . 3.1 mt -126.19 76.23 72.43 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.78 112.9 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.604 2.202 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.98 74.43 0.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.818 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 8' ' ' LEU . 16.8 mm -133.53 153.61 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 23' ' ' VAL . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.619 ' CB ' HD22 ' A' ' 87' ' ' LEU . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.631 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.919 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.717 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG12 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 31' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CE2' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.819 HD11 ' HB3' ' A' ' 84' ' ' MET . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.627 ' CG ' HG23 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' CG ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.734 HG11 ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.798 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.552 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.819 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.773 ' CH2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.919 HD21 ' CG2' ' A' ' 21' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 81' ' ' PHE . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.565 HG12 ' OE1' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' OE1' HG12 ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.848 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.798 HG11 ' O ' ' A' ' 69' ' ' THR . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.996 HD23 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.48 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 125' ' ' THR . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 4' ' ' LEU . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.516 ' HA ' HG23 ' A' ' 113' ' ' ILE . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.697 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 126' ' ' ARG . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' LEU . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.78 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.78 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 145' ' ' ALA . 16.0 pttm -106.75 158.7 16.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.5 t70 56.41 -4.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -60.16 -52.79 70.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.698 0.285 . . . . 0.0 111.125 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 94.5 Cg_endo -84.31 14.0 2.56 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.73 2.287 . . . . 0.0 113.042 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -58.4 -21.86 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.158 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.7 166.19 2.66 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.968 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.748 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.82 -16.35 80.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.747 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mt -50.87 -27.58 7.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 100' ' ' LEU . 2.5 t80 -60.66 -69.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.76 HD22 ' HB2' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -173.68 105.5 0.3 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 7.69 2.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.765 2.31 . . . . 0.0 113.228 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 -37.01 6.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.399 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt -64.39 103.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.681 ' CA ' HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 15' ' ' ARG . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.681 ' C ' HD23 ' A' ' 26' ' ' LEU . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 25' ' ' SER . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD23 ' CE2' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CE2' HD23 ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 111' ' ' THR . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HB2' ' O ' ' A' ' 70' ' ' TRP . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' CG ' HD23 ' A' ' 131' ' ' LEU . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.708 ' CD ' HD12 ' A' ' 87' ' ' LEU . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.814 HG21 ' HG ' ' A' ' 50' ' ' LEU . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.8 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' GLU . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.833 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 HG21 ' A' ' 111' ' ' THR . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.532 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 104' ' ' PHE . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.918 ' CG1' HG22 ' A' ' 122' ' ' VAL . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.918 HG22 ' CG1' ' A' ' 115' ' ' VAL . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.614 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.566 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.739 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.624 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp -48.95 150.7 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -126.5 -11.05 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.586 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 41.92 64.71 5.45 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.872 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.64 -178.92 3.71 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.688 2.259 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.0 mt 56.3 -174.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -66.25 89.41 0.13 Allowed 'General case' 0 C--O 1.249 1.079 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.788 0 O-C-N 123.5 0.5 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.99 -24.54 58.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.8 mt -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 -95.7 -55.57 2.97 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -170.05 -54.36 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.353 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG2' HD13 ' A' ' 4' ' ' LEU . 88.8 Cg_exo -47.56 148.68 5.32 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.204 1.936 . . . . 0.0 112.396 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 26.33 9.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.644 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 93' ' ' GLN . 56.7 mt -94.37 -80.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 89' ' ' VAL . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.795 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 12' ' ' GLU . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 31' ' ' VAL . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HE1' ' A' ' 32' ' ' PHE . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 26' ' ' LEU . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.497 ' HE1' HD23 ' A' ' 30' ' ' LEU . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.99 ' CE1' HG23 ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB2' HG22 ' A' ' 111' ' ' THR . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.443 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' ARG . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.99 HG23 ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CG ' ' HA ' ' A' ' 46' ' ' PHE . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD22 HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 48' ' ' PRO . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.541 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.637 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' A' ' 47' ' ' THR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' A' ' 21' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 14' ' ' LEU . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.531 ' OE1' HG12 ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.691 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CD2' HD12 ' A' ' 113' ' ' ILE . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 113' ' ' ILE . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 112' ' ' LEU . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 124' ' ' THR . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 4' ' ' LEU . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CG2' ' A' ' 125' ' ' THR . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.488 ' HA ' HD13 ' A' ' 113' ' ' ILE . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -70.47 179.37 2.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 143' ' ' LYS . 4.5 t0 38.31 -162.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.021 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -146.72 -68.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.328 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 56.0 Cg_endo -69.95 63.91 1.91 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.229 1.953 . . . . 0.0 112.148 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 145' ' ' ALA . 4.1 mp -56.11 111.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.064 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.64 11.21 3.77 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.794 0 O-C-N 123.571 0.544 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.852 0.358 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.92 -25.26 60.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.9 -27.51 5.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 8' ' ' LEU . 41.6 m-85 -77.24 -63.11 1.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.926 HD11 ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -169.75 -57.22 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 92.2 Cg_exo -45.11 112.16 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.362 2.041 . . . . 0.0 112.338 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 136.88 -16.08 3.74 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.384 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.532 HG21 ' HG3' ' A' ' 93' ' ' GLN . 96.7 mt -61.72 83.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 87' ' ' LEU . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.661 ' HD2' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.864 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG21 ' HA2' ' A' ' 10' ' ' GLY . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.728 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 25' ' ' SER . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' CE ' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 ' HE2' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.76 ' HB3' HD13 ' A' ' 112' ' ' LEU . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.643 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.015 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.866 HD11 ' HG3' ' A' ' 84' ' ' MET . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.808 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.015 HG21 HD11 ' A' ' 50' ' ' LEU . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.821 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.866 ' HG3' HD11 ' A' ' 51' ' ' ILE . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD21 ' CG2' ' A' ' 21' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD23 ' A' ' 8' ' ' LEU . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 11' ' ' ILE . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.926 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 69' ' ' THR . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.776 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' CD2' HD13 ' A' ' 131' ' ' LEU . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 124' ' ' THR . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.754 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.754 HG21 ' OD1' ' A' ' 116' ' ' ASP . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' CD2' ' A' ' 112' ' ' LEU . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -90.49 -179.34 5.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -84.58 153.18 23.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -74.05 -60.84 1.39 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 63.5 Cg_endo -73.58 162.95 38.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.508 2.139 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 147' ' ' LEU . 12.3 mt -157.82 31.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 9.4 tp10 -173.83 169.1 4.2 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' N ' ' HG3' ' A' ' 148' ' ' GLU . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.547 0.529 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 6' ' ' LYS . . . -79.03 -34.98 31.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.54 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.737 HD22 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -49.74 -26.73 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -87.83 -55.07 3.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.869 HD11 ' CG2' ' A' ' 89' ' ' VAL . 3.4 tm? -175.84 -45.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 25.0 Cg_exo -63.87 10.31 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.5 2.134 . . . . 0.0 113.692 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -143.79 33.61 1.74 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.132 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.843 HD12 HD22 ' A' ' 8' ' ' LEU . 43.9 mt -94.74 100.22 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.87 ' HA ' HD23 ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 21' ' ' VAL . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 10' ' ' GLY . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.819 ' C ' HD23 ' A' ' 26' ' ' LEU . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' HD12 ' A' ' 112' ' ' LEU . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.739 ' CB ' HD22 ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 111' ' ' THR . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.909 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 51' ' ' ILE . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.534 ' CE1' ' HG3' ' A' ' 59' ' ' GLU . 18.8 p-80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.534 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.909 HG21 ' CD1' ' A' ' 50' ' ' LEU . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.844 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.494 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.869 ' CG2' HD11 ' A' ' 8' ' ' LEU . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.461 ' CG ' HG21 ' A' ' 11' ' ' ILE . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.844 HG11 ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 106' ' ' VAL . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 101' ' ' SER . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 35' ' ' PHE . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.977 HG23 HG22 ' A' ' 125' ' ' THR . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 122' ' ' VAL . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.791 ' OD2' HG21 ' A' ' 123' ' ' VAL . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.907 HG13 HG12 ' A' ' 115' ' ' VAL . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.791 HG21 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.977 HG22 HG23 ' A' ' 113' ' ' ILE . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.429 ' HB3' HG12 ' A' ' 123' ' ' VAL . 51.2 pttt -113.13 -168.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 -169.84 2.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.27 81.78 1.41 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.69 -168.11 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.514 2.143 . . . . 0.0 112.332 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mt -115.88 85.39 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.5 149.44 40.28 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.796 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.721 0.296 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.18 -37.99 23.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.84 -35.64 23.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.465 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -90.17 -56.46 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.847 HD12 HD12 ' A' ' 11' ' ' ILE . 3.0 tp -174.15 -51.05 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 35.6 Cg_exo -59.0 11.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.728 2.285 . . . . 0.0 114.318 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -117.24 37.81 3.2 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.121 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.847 HD12 HD12 ' A' ' 8' ' ' LEU . 16.7 mt -117.58 160.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 26' ' ' LEU . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' HG11 ' A' ' 21' ' ' VAL . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' A' ' 16' ' ' ARG . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 11' ' ' ILE . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.598 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 14' ' ' LEU . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG23 ' A' ' 132' ' ' VAL . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' CG ' HD12 ' A' ' 87' ' ' LEU . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 50' ' ' LEU . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.891 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.545 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 8' ' ' LEU . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.522 ' HB3' HD13 ' A' ' 11' ' ' ILE . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.56 ' CB ' HD13 ' A' ' 8' ' ' LEU . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.78 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.864 ' OD1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.864 HG21 ' OD1' ' A' ' 116' ' ' ASP . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 113' ' ' ILE . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.793 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.793 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -90.17 -177.56 5.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.54 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -51.19 107.08 0.74 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.74 -174.42 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.529 2.152 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.1 pt? -56.99 -169.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 155.56 31.77 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.772 0 O-C-N 123.548 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.443 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 2.4 mp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 87' ' ' LEU . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.758 ' C ' HD23 ' A' ' 26' ' ' LEU . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 66' ' ' VAL . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE2' ' HA3' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.489 ' HB2' HG22 ' A' ' 111' ' ' THR . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.05 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.957 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.05 HG21 HD11 ' A' ' 50' ' ' LEU . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.803 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.682 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.699 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.803 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 111' ' ' THR . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.568 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.499 HG21 HG13 ' A' ' 106' ' ' VAL . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 4' ' ' LEU . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.637 ' OD2' HG21 ' A' ' 123' ' ' VAL . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 4' ' ' LEU . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 4' ' ' LEU . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.58 HG22 ' HE1' ' A' ' 104' ' ' PHE . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.637 HG21 ' OD2' ' A' ' 116' ' ' ASP . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 113' ' ' ILE . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.703 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.789 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.789 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.492 HD23 ' HZ ' ' A' ' 33' ' ' PHE . 6.0 mp . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.759 ' OH ' HG23 ' A' ' 122' ' ' VAL . 5.8 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 23' ' ' VAL . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 87' ' ' LEU . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 14' ' ' LEU . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 64' ' ' GLU . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG1' HG23 ' A' ' 66' ' ' VAL . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.684 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HZ ' HD23 ' A' ' 4' ' ' LEU . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HD2' HD22 ' A' ' 112' ' ' LEU . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB1' ' HD1' ' A' ' 39' ' ' TRP . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.577 ' HD1' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.553 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.85 HD11 ' HD2' ' A' ' 85' ' ' PRO . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 29' ' ' LYS . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 50' ' ' LEU . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.937 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.85 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 21' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.937 HG11 ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.403 ' HG ' ' CE2' ' A' ' 104' ' ' PHE . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 114' ' ' GLY . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD2' HG21 ' A' ' 123' ' ' VAL . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.759 HG23 ' OH ' ' A' ' 7' ' ' TYR . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 ' OD2' ' A' ' 116' ' ' ASP . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 124' ' ' THR . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.776 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.749 HD21 ' HA ' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.4 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.564 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 HD21 ' A' ' 87' ' ' LEU . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG11 ' A' ' 31' ' ' VAL . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 115' ' ' VAL . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG11 HD13 ' A' ' 26' ' ' LEU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.741 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 132' ' ' VAL . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 132' ' ' VAL . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.868 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.454 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE1' HG23 ' A' ' 66' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 50' ' ' LEU . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.714 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' N ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.465 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.695 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.78 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' CG ' HG12 ' A' ' 11' ' ' ILE . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 98' ' ' GLN . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 69' ' ' THR . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.741 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 106' ' ' VAL . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 101' ' ' SER . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.445 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.795 ' CD2' HD13 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.851 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.731 ' O ' HD12 ' A' ' 30' ' ' LEU . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.682 ' OD1' HG21 ' A' ' 123' ' ' VAL . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.682 HG21 ' OD1' ' A' ' 116' ' ' ASP . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.849 ' O ' HD13 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.795 HD13 ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.773 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.773 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 31' ' ' VAL . 44.1 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.1 m-85 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 11.6 mt . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 87' ' ' LEU . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 12' ' ' GLU . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.689 ' C ' HD23 ' A' ' 26' ' ' LEU . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.709 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.87 ' NZ ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG22 ' NZ ' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.617 ' CE1' HG22 ' A' ' 115' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD2' HG21 ' A' ' 106' ' ' VAL . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.57 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 29' ' ' LYS . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 50' ' ' LEU . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CZ ' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' HG11 ' A' ' 97' ' ' VAL . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' CG ' ' HB1' ' A' ' 37' ' ' ALA . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CH2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 14' ' ' LEU . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 69' ' ' THR . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' VAL . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CG ' HD12 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 35' ' ' PHE . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 131' ' ' LEU . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 125' ' ' THR . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 33' ' ' PHE . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.577 ' HA ' HG23 ' A' ' 113' ' ' ILE . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.61 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' NH2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.954 HD11 HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.894 ' CD2' HD13 ' A' ' 100' ' ' LEU . 2.6 t80 . . . . . 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD1' HD11 ' A' ' 26' ' ' LEU . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG2' HG22 ' A' ' 21' ' ' VAL . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.734 HG22 ' HG2' ' A' ' 16' ' ' ARG . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.773 ' C ' HD23 ' A' ' 26' ' ' LEU . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CD1' HG21 ' A' ' 123' ' ' VAL . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.954 HG11 HD11 ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 111' ' ' THR . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.625 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.591 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HD3' HG22 ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm100 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.026 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' TYR . 2.2 p80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.649 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.026 HG21 HD11 ' A' ' 50' ' ' LEU . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.547 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.569 ' HB3' HG13 ' A' ' 97' ' ' VAL . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.682 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.764 ' HE1' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.649 HD12 ' CG ' ' A' ' 64' ' ' GLU . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 17.4 mm100 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.894 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 4' ' ' LEU . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.649 ' OD2' HG22 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.649 HG22 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.683 ' HA ' HD13 ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB1' ' HZ3' ' A' ' 142' ' ' TRP . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 129' ' ' ALA . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 128' ' ' ARG . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 100' ' ' LEU . 3.2 m-85 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 87' ' ' LEU . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.724 ' CB ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 HD22 ' A' ' 87' ' ' LEU . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.683 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 25' ' ' SER . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 112' ' ' LEU . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.68 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.718 ' O ' HG22 ' A' ' 47' ' ' THR . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.812 HG23 ' HD3' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' HG23 ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.921 HG21 HD11 ' A' ' 50' ' ' LEU . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.541 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.496 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.426 ' HD2' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.542 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 84' ' ' MET . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 69' ' ' THR . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 125' ' ' THR . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.517 HG21 ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HA ' HD22 ' A' ' 4' ' ' LEU . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.531 HG13 ' HE2' ' A' ' 143' ' ' LYS . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 113' ' ' ILE . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.764 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.592 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.531 ' HE2' HG13 ' A' ' 123' ' ' VAL . 5.9 mttm . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.795 ' CD1' HD11 ' A' ' 26' ' ' LEU . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 87' ' ' LEU . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HD23 ' A' ' 26' ' ' LEU . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 115' ' ' VAL . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 66' ' ' VAL . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.823 ' HB3' HD22 ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.616 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' HD23 ' A' ' 112' ' ' LEU . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.898 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.451 HD11 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 50' ' ' LEU . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.637 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.859 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.404 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.45 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 84' ' ' MET . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.641 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.2 mm100 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.859 HG11 ' O ' ' A' ' 69' ' ' THR . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 106' ' ' VAL . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.678 ' HE1' HG22 ' A' ' 122' ' ' VAL . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.723 HG13 HG21 ' A' ' 111' ' ' THR . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.723 HG21 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 125' ' ' THR . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.793 ' O ' HD12 ' A' ' 30' ' ' LEU . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 123' ' ' VAL . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.678 HG22 ' HE1' ' A' ' 104' ' ' PHE . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 141' ' ' PRO . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 113' ' ' ILE . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.677 ' NH1' HG21 ' A' ' 130' ' ' THR . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.677 HG21 ' NH1' ' A' ' 126' ' ' ARG . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.821 ' O ' HG12 ' A' ' 123' ' ' VAL . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.808 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.658 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' A' ' 122' ' ' VAL . 2.7 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 17.0 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.598 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.598 HG22 ' CG ' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' C ' HD23 ' A' ' 26' ' ' LEU . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 25' ' ' SER . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.706 ' CB ' HD22 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.577 ' CA ' HD12 ' A' ' 51' ' ' ILE . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.577 HD12 ' CA ' ' A' ' 48' ' ' PRO . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.6 ' CE1' HG23 ' A' ' 65' ' ' VAL . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' TYR . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.708 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.546 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.547 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD12 ' HG2' ' A' ' 64' ' ' GLU . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.708 HG11 ' O ' ' A' ' 69' ' ' THR . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' N ' ' HG3' ' A' ' 99' ' ' LYS . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 106' ' ' VAL . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 122' ' ' VAL . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 101' ' ' SER . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 35' ' ' PHE . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.706 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.708 HG22 ' CE1' ' A' ' 33' ' ' PHE . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.496 ' CG ' HG21 ' A' ' 123' ' ' VAL . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.54 HG22 ' HE1' ' A' ' 104' ' ' PHE . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 115' ' ' VAL . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 113' ' ' ILE . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.56 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.781 ' HB1' ' CE ' ' A' ' 133' ' ' LYS . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.781 ' CE ' ' HB1' ' A' ' 129' ' ' ALA . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.771 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.771 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 115' ' ' VAL . 12.9 mt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.61 ' OH ' HG23 ' A' ' 122' ' ' VAL . 8.5 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 HD13 ' OE1' ' A' ' 93' ' ' GLN . 14.9 mm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB2' HD22 ' A' ' 87' ' ' LEU . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.635 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.928 ' CG2' HD21 ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.641 ' C ' HD23 ' A' ' 26' ' ' LEU . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 25' ' ' SER . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.682 ' CE2' HG21 ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 112' ' ' LEU . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.74 ' HB1' ' OD1' ' A' ' 71' ' ' ASP . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.496 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 50' ' ' LEU . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 33' ' ' PHE . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CD2' ' HD3' ' A' ' 83' ' ' LYS . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.841 ' O ' HG11 ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.593 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.74 ' OD1' ' HB1' ' A' ' 37' ' ' ALA . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.673 ' HE1' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.568 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.928 HD21 ' CG2' ' A' ' 21' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OE1' HD13 ' A' ' 11' ' ' ILE . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.0 p30 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.689 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 112' ' ' LEU . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.704 HG21 HD21 ' A' ' 4' ' ' LEU . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.61 HG23 ' OH ' ' A' ' 7' ' ' TYR . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.498 HD22 HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.734 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 3.3 ptpt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.667 HG13 ' HG3' ' A' ' 16' ' ' ARG . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 26' ' ' LEU . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.698 HD23 ' C ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.619 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.753 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' A' ' 106' ' ' VAL . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PRO . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.454 ' CD2' ' HG2' ' A' ' 59' ' ' GLU . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HG2' HD12 ' A' ' 87' ' ' LEU . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 50' ' ' LEU . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.706 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.488 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.593 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.658 ' HB3' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.636 HG21 ' OH ' ' A' ' 7' ' ' TYR . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.689 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.967 HD22 ' CZ ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.736 HG21 ' CD2' ' A' ' 35' ' ' PHE . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.64 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 112' ' ' LEU . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 122' ' ' VAL . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.708 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.64 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 20.9 m-30 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.715 HG23 ' OE1' ' A' ' 93' ' ' GLN . 3.5 mp . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HD23 ' A' ' 87' ' ' LEU . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.697 HG11 HD21 ' A' ' 87' ' ' LEU . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.711 ' C ' HD23 ' A' ' 26' ' ' LEU . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 25' ' ' SER . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 112' ' ' LEU . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.576 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 51' ' ' ILE . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.034 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 47' ' ' THR . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.916 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASP . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' LEU . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.541 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.626 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.626 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.794 HG13 HE21 ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.794 HE21 HG13 ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 69' ' ' THR . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 106' ' ' VAL . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 122' ' ' VAL . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG21 ' OG ' ' A' ' 101' ' ' SER . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 122' ' ' VAL . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 113' ' ' ILE . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 130' ' ' THR . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.566 HG23 ' HG3' ' A' ' 126' ' ' ARG . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' A' ' 50' ' ' LEU . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.767 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.767 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.656 HD11 ' HB2' ' A' ' 117' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.693 ' OD1' HG21 ' A' ' 23' ' ' VAL . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.645 ' CB ' HD22 ' A' ' 87' ' ' LEU . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.862 HG22 ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.579 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 25' ' ' SER . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 115' ' ' VAL . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD13 ' A' ' 26' ' ' LEU . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.82 ' HB2' HG22 ' A' ' 111' ' ' THR . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG21 ' CD1' ' A' ' 50' ' ' LEU . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.693 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.471 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' A' ' 14' ' ' LEU . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 69' ' ' THR . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD21 ' HE2' ' A' ' 104' ' ' PHE . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.664 ' CZ ' HG11 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 111' ' ' THR . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.818 ' O ' HD12 ' A' ' 109' ' ' ILE . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 124' ' ' THR . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.664 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 123' ' ' VAL . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 115' ' ' VAL . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.516 HG22 ' OD2' ' A' ' 116' ' ' ASP . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.432 ' HA ' HG23 ' A' ' 113' ' ' ILE . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.455 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.719 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.681 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.719 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 115' ' ' VAL . 7.6 mt . . . . . 0 N--CA 1.462 0.138 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.41 ' OH ' HG11 ' A' ' 115' ' ' VAL . 3.1 m-85 . . . . . 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.474 HG23 ' OE1' ' A' ' 93' ' ' GLN . 20.0 mm . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 87' ' ' LEU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 31' ' ' VAL . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.766 HD23 ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HD13 ' A' ' 26' ' ' LEU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.768 ' O ' HG22 ' A' ' 66' ' ' VAL . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.511 ' HB2' HG22 ' A' ' 113' ' ' ILE . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.404 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.518 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.5 p80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.693 ' CG ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.695 HG21 HD11 ' A' ' 50' ' ' LEU . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 32' ' ' PHE . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.559 ' CG ' HG21 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.583 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 16' ' ' ARG . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.549 ' C ' HD23 ' A' ' 14' ' ' LEU . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' HG23 ' A' ' 11' ' ' ILE . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 111' ' ' THR . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 113' ' ' ILE . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 4' ' ' LEU . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.686 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.562 HD13 HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 138' ' ' GLU . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 136' ' ' GLU . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.785 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.59 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 2.8 ptmm? . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 31' ' ' VAL . 16.1 mt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.422 ' HB3' HD13 ' A' ' 100' ' ' LEU . 32.5 m-85 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.4 mm . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HD3' HG23 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.838 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' C ' HD23 ' A' ' 87' ' ' LEU . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.764 HG11 ' HD3' ' A' ' 16' ' ' ARG . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 13' ' ' LYS . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.737 ' C ' HD23 ' A' ' 26' ' ' LEU . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.737 HD23 ' C ' ' A' ' 25' ' ' SER . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 115' ' ' VAL . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.428 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HA ' HD12 ' A' ' 51' ' ' ILE . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 48' ' ' PRO . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 87' ' ' LEU . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 50' ' ' LEU . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.412 ' CG ' HG12 ' A' ' 51' ' ' ILE . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 14' ' ' LEU . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 106' ' ' VAL . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HD2' HG21 ' A' ' 113' ' ' ILE . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 101' ' ' SER . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 HG13 ' A' ' 106' ' ' VAL . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.874 ' CD2' HD13 ' A' ' 131' ' ' LEU . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 122' ' ' VAL . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 115' ' ' VAL . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.4 ' O ' ' HD3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.644 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.644 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.874 HD13 ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.788 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 124' ' ' THR . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.788 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 115' ' ' VAL . 16.1 mt . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 16.8 mm . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 23' ' ' VAL . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.619 ' CB ' HD22 ' A' ' 87' ' ' LEU . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.631 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.919 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.717 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG12 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 31' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CE2' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.819 HD11 ' HB3' ' A' ' 84' ' ' MET . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.627 ' CG ' HG23 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.411 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.809 ' CG ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.734 HG11 ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.798 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.552 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.819 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.773 ' CH2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.919 HD21 ' CG2' ' A' ' 21' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 81' ' ' PHE . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.565 HG12 ' OE1' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.565 ' OE1' HG12 ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.798 HG11 ' O ' ' A' ' 69' ' ' THR . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.682 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.48 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 125' ' ' THR . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 4' ' ' LEU . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.516 ' HA ' HG23 ' A' ' 113' ' ' ILE . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.697 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 126' ' ' ARG . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' LEU . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.78 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.78 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 141' ' ' PRO . 16.0 pttm . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mt . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 100' ' ' LEU . 2.5 t80 . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.681 ' CA ' HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 15' ' ' ARG . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.681 ' C ' HD23 ' A' ' 26' ' ' LEU . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 25' ' ' SER . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 HD23 ' CE2' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CE2' HD23 ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 111' ' ' THR . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HB2' ' O ' ' A' ' 70' ' ' TRP . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.482 ' CG ' HD23 ' A' ' 131' ' ' LEU . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.708 ' CD ' HD12 ' A' ' 87' ' ' LEU . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.814 HG21 ' HG ' ' A' ' 50' ' ' LEU . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.8 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' GLU . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.833 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 HG21 ' A' ' 111' ' ' THR . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.532 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 104' ' ' PHE . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.918 ' CG1' HG22 ' A' ' 122' ' ' VAL . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.918 HG22 ' CG1' ' A' ' 115' ' ' VAL . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.614 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.566 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.739 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.624 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.8 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 93' ' ' GLN . 56.7 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 89' ' ' VAL . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.795 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 12' ' ' GLU . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 31' ' ' VAL . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HE1' ' A' ' 32' ' ' PHE . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 26' ' ' LEU . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.497 ' HE1' HD23 ' A' ' 30' ' ' LEU . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.99 ' CE1' HG23 ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB2' HG22 ' A' ' 111' ' ' THR . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.443 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' ARG . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.99 HG23 ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CG ' ' HA ' ' A' ' 46' ' ' PHE . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD22 HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 48' ' ' PRO . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.541 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.637 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' A' ' 47' ' ' THR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' A' ' 21' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 14' ' ' LEU . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.531 ' OE1' HG12 ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.691 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CD2' HD12 ' A' ' 113' ' ' ILE . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 113' ' ' ILE . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 112' ' ' LEU . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 124' ' ' THR . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 4' ' ' LEU . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CG2' ' A' ' 125' ' ' THR . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.488 ' HA ' HD13 ' A' ' 113' ' ' ILE . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.532 HG21 ' HG3' ' A' ' 93' ' ' GLN . 96.7 mt . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 87' ' ' LEU . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.661 ' HD2' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.864 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.728 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 25' ' ' SER . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.4 ' CE ' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 ' HE2' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.76 ' HB3' HD13 ' A' ' 112' ' ' LEU . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.643 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.015 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.866 HD11 ' HG3' ' A' ' 84' ' ' MET . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.808 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.015 HG21 HD11 ' A' ' 50' ' ' LEU . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.821 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.866 ' HG3' HD11 ' A' ' 51' ' ' ILE . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.864 HD21 ' CG2' ' A' ' 21' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 11' ' ' ILE . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 69' ' ' THR . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.776 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.838 ' CD2' HD13 ' A' ' 131' ' ' LEU . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 124' ' ' THR . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.754 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.754 HG21 ' OD1' ' A' ' 116' ' ' ASP . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' CD2' ' A' ' 112' ' ' LEU . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.737 HD22 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 13' ' ' LYS . 43.9 mt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.87 ' HA ' HD23 ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 21' ' ' VAL . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.819 ' C ' HD23 ' A' ' 26' ' ' LEU . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' HD12 ' A' ' 112' ' ' LEU . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.739 ' CB ' HD22 ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 111' ' ' THR . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.909 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 51' ' ' ILE . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 p80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.909 HG21 ' CD1' ' A' ' 50' ' ' LEU . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.844 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.494 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.461 ' CG ' HG21 ' A' ' 11' ' ' ILE . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 100' ' ' LEU . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.844 HG11 ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 106' ' ' VAL . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 101' ' ' SER . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.447 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 35' ' ' PHE . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.977 HG23 HG22 ' A' ' 125' ' ' THR . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 122' ' ' VAL . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.791 ' OD2' HG21 ' A' ' 123' ' ' VAL . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.907 HG13 HG12 ' A' ' 115' ' ' VAL . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.791 HG21 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.977 HG22 HG23 ' A' ' 113' ' ' ILE . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.429 ' HB3' HG12 ' A' ' 123' ' ' VAL . 51.2 pttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.653 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.137 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' GLU . 16.7 mt . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 26' ' ' LEU . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' HG11 ' A' ' 21' ' ' VAL . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' A' ' 16' ' ' ARG . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 11' ' ' ILE . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.598 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 14' ' ' LEU . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG23 ' A' ' 132' ' ' VAL . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.426 ' CG ' HD12 ' A' ' 87' ' ' LEU . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 50' ' ' LEU . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.891 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.545 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.522 ' HB3' HD13 ' A' ' 11' ' ' ILE . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.78 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.864 ' OD1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.864 HG21 ' OD1' ' A' ' 116' ' ' ASP . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 113' ' ' ILE . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.793 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.793 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.782 0.325 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.429 ' HA3' ' CZ ' ' A' ' 7' ' ' TYR . . . -78.99 -49.29 6.47 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.484 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.711 HD13 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -52.86 -25.6 12.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.696 0.284 . . . . 0.0 111.183 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -87.06 -27.47 23.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.808 0.337 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -82.4 -47.71 11.97 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.89 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' CZ ' ' HA3' ' A' ' 3' ' ' GLY . 3.7 m-85 -50.9 -33.7 25.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.301 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.913 HD22 ' HB1' ' A' ' 96' ' ' ALA . 1.4 mt -106.01 175.66 2.01 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.847 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.847 ' HD3' ' HB2' ' A' ' 96' ' ' ALA . 6.5 Cg_exo -74.32 7.28 2.65 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.955 2.436 . . . . 0.0 113.24 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.56 50.82 1.93 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.817 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.626 HD13 HD13 ' A' ' 8' ' ' LEU . 2.4 mp -60.04 134.52 25.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.786 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.9 OUTLIER -106.27 -34.03 7.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.489 -179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -127.75 156.29 42.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.971 0.415 . . . . 0.0 111.326 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 87' ' ' LEU . 17.7 mt -118.46 165.11 14.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.567 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 16' ' ' ARG . 4.1 mmm180 -79.21 -0.52 32.39 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.638 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 5.7 tpt85 27.49 -100.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.678 0.391 . . . . 0.0 111.96 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.58 -96.04 0.17 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.126 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.15 -30.28 1.88 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.877 0.37 . . . . 0.0 111.159 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -157.24 -108.67 0.27 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.428 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -140.23 158.17 44.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.638 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 0.9 OUTLIER -143.77 141.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.013 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -61.07 153.13 26.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.64 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -71.59 -27.39 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.172 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.1 pttt -51.05 -27.28 7.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.326 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.758 ' C ' HD23 ' A' ' 26' ' ' LEU . 30.2 t -60.75 -13.85 17.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.463 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.94 53.13 0.96 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.518 . . . . 0.0 110.041 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.41 88.31 2.93 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.878 0.846 . . . . 0.0 111.245 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.92 56.13 1.1 Allowed Glycine 0 C--N 1.304 -1.225 0 CA-C-N 114.043 -1.435 . . . . 0.0 113.203 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.663 ' HE3' ' N ' ' A' ' 64' ' ' GLU . 3.8 ptmm? -149.38 173.74 13.21 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 57.0 tp -95.28 102.15 13.94 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.808 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.588 ' CG1' HG23 ' A' ' 66' ' ' VAL . 13.1 t -97.97 142.37 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.212 0.529 . . . . 0.0 111.732 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE2' ' HA3' ' A' ' 114' ' ' GLY . 31.6 m-85 -116.14 162.17 17.84 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.107 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -141.64 107.02 5.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.929 0.395 . . . . 0.0 111.449 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD2' ' HB2' ' A' ' 112' ' ' LEU . 17.0 t80 -93.78 120.06 33.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.903 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.489 ' HB2' HG22 ' A' ' 111' ' ' THR . 6.1 m-30 -95.36 125.85 40.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.694 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.9 t -174.44 177.24 2.23 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.001 0.429 . . . . 0.0 111.411 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -139.84 161.98 36.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.605 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.9 t -72.28 -27.73 62.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 111.49 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 39.0 p-90 -90.72 3.49 54.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.539 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.6 p -52.11 156.91 2.44 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-O 120.61 0.243 . . . . 0.0 111.029 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.7 Cg_exo -56.59 -51.76 8.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.574 2.183 . . . . 0.0 113.201 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.9 -70.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.189 1.926 . . . . 0.0 111.206 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 36.1 m 44.25 30.34 0.45 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.248 178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -156.18 87.89 1.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.13 -62.98 0.5 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.514 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -81.41 89.69 6.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.869 0.366 . . . . 0.0 110.875 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.5 m -173.29 -62.7 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.498 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 71.4 Cg_endo -73.51 -5.24 16.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.459 2.106 . . . . 0.0 112.59 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -77.34 -41.29 41.0 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.894 0.378 . . . . 0.0 110.092 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.05 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -52.37 -48.71 65.42 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.297 0.57 . . . . 0.0 110.941 179.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.7 mm -61.8 -44.81 99.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.442 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -62.5 -47.35 84.36 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.729 0.299 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -64.62 -43.52 93.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.222 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.957 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.6 m-85 -76.41 -46.72 25.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.938 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -61.97 -26.61 68.31 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.631 0.253 . . . . 0.0 111.66 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -81.12 -21.96 39.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.61 2.72 3.8 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.514 ' N ' ' O ' ' A' ' 54' ' ' TYR . 1.8 t60 -56.44 -26.17 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.69 0.281 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -51.04 65.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.374 . . . . 0.0 111.762 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.6 t -86.68 -31.15 21.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.366 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HD3' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -84.04 -30.79 25.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.386 -179.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.1 t30 46.96 60.16 3.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.358 . . . . 0.0 111.247 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.523 ' CD1' ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -122.0 171.74 8.73 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.063 0.459 . . . . 0.0 111.51 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.663 ' N ' ' HE3' ' A' ' 29' ' ' LYS . 15.0 tp10 -144.39 140.02 28.78 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.171 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.05 HG21 HD11 ' A' ' 50' ' ' LEU . 55.4 t -112.88 132.59 61.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.833 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 87' ' ' LEU . 21.4 t -107.29 146.48 13.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.273 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.55 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 10.1 t80 -106.31 124.06 49.02 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.024 0.44 . . . . 0.0 111.75 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.483 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 1.3 m -108.74 108.49 19.34 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.364 178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.803 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.5 t -61.71 163.9 6.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 111.516 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.429 ' CE3' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -144.41 38.09 1.25 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.323 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.682 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 2.2 m-20 -108.7 174.89 5.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.139 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.06 -29.48 11.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.504 179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -115.61 151.63 34.61 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.617 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 91' ' ' PHE . 78.7 mt-10 -71.11 -25.87 62.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.216 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -55.86 -30.51 61.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.427 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.15 -56.26 4.45 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.991 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . 0.0 OUTLIER -69.98 -30.11 67.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.252 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -57.27 -54.4 47.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.016 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.83 -14.69 78.23 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.477 ' CE2' ' CE1' ' A' ' 67' ' ' PHE . 42.4 t80 -77.76 -42.83 32.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.492 -0.854 . . . . 0.0 111.302 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 1.8 p90 -79.14 -12.91 60.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.684 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -23.28 4.55 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -109.0 -71.56 0.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.575 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.9 OUTLIER -34.21 122.42 0.52 Allowed Pre-proline 0 N--CA 1.468 0.443 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.465 -179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -83.59 -31.75 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.881 2.387 . . . . 0.0 113.168 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.662 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 2.7 p90 -45.13 163.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.198 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.699 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.3 mt -82.71 129.7 35.01 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.652 -178.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.96 138.8 54.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.175 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.9 t -64.27 131.13 94.94 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.721 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.35 151.38 80.63 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.311 2.007 . . . . 0.0 111.921 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 74' ' ' GLU . 15.7 t80 -48.5 -28.77 3.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.882 0.373 . . . . 0.0 110.877 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.99 -37.16 52.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.824 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.443 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 21.4 mm-40 -113.0 27.74 9.37 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.736 0.303 . . . . 0.0 111.186 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.6 p -58.99 -24.45 62.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.713 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -56.13 -35.84 67.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.999 0.428 . . . . 0.0 110.267 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.913 ' HB1' HD22 ' A' ' 8' ' ' LEU . . . -59.9 -42.42 93.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.728 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.803 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -57.65 -34.27 47.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.774 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -72.68 -43.12 63.52 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.006 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -80.99 -36.41 30.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.126 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.617 HD22 HD21 ' A' ' 8' ' ' LEU . 2.8 tp -50.77 -37.56 42.9 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.1 t -57.14 -44.25 83.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.975 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 -31.03 62.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -77.75 -30.48 51.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.006 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.8 ' CD1' HG21 ' A' ' 113' ' ' ILE . 23.6 m-85 -98.52 2.48 47.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.432 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.4 t30 53.1 34.05 16.42 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.722 0.296 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 111' ' ' THR . 36.3 t -56.57 103.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.232 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -60.5 -51.27 70.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.542 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 66.9 m -167.21 150.41 6.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.84 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.568 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -82.31 156.8 68.72 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.471 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -82.87 160.73 75.52 Favored 'Cis proline' 0 C--N 1.346 0.442 0 C-N-CA 123.773 -1.345 . . . . 0.0 112.182 0.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.499 HG21 HG13 ' A' ' 106' ' ' VAL . 2.4 t -154.6 176.16 12.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.734 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.703 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.25 128.13 14.44 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.601 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.8 HG21 ' CD1' ' A' ' 104' ' ' PHE . 16.6 mm -126.83 147.08 31.76 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.473 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA3' ' CE2' ' A' ' 32' ' ' PHE . . . -121.13 129.18 7.68 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.111 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.468 HG23 HD21 ' A' ' 4' ' ' LEU . 21.8 m -133.09 161.87 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.147 0.499 . . . . 0.0 110.936 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.637 ' OD2' HG21 ' A' ' 123' ' ' VAL . 4.6 m-20 -102.88 118.28 36.47 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.628 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.711 ' HA ' HD13 ' A' ' 4' ' ' LEU . . . -56.46 -41.2 76.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.43 -58.5 3.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.3 m -58.93 -44.1 91.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.08 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 4' ' ' LEU . . . 95.86 -61.19 1.4 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.551 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -59.32 160.58 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.806 0.336 . . . . 0.0 110.976 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.58 HG22 ' HE1' ' A' ' 104' ' ' PHE . 20.2 t -66.51 137.74 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.119 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.637 HG21 ' OD2' ' A' ' 116' ' ' ASP . 20.1 t -107.17 -28.4 2.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.692 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.68 130.42 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.599 ' HA ' HG23 ' A' ' 113' ' ' ILE . 63.2 p -107.09 -24.52 11.93 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 130' ' ' THR . 0.1 OUTLIER -88.04 49.81 1.87 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.96 0.41 . . . . 0.0 110.614 179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.703 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -81.51 -4.7 56.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.994 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.413 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 1.4 ptp180 -78.43 -41.7 32.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.758 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.03 -39.46 18.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.064 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 134' ' ' ASP . 73.7 p -65.57 -49.5 68.61 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.417 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.37 -33.94 45.43 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.684 -179.783 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.14 -38.21 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 121.088 0.471 . . . . 0.0 111.816 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -101.68 18.94 19.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -130.75 78.67 73.35 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.76 0.314 . . . . 0.0 110.396 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -86.33 17.64 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 122.859 2.372 . . . . 0.0 113.431 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -115.05 -27.16 7.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.804 0.335 . . . . 0.0 110.628 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.93 22.32 26.96 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.804 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.4 pt-20 -74.17 -14.64 60.98 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.535 0.198 . . . . 0.0 111.535 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.62 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -138.05 27.38 2.65 Favored 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.789 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 6.3 p90 -27.93 -47.56 0.2 Allowed Pre-proline 0 N--CA 1.466 0.36 0 N-CA-C 114.627 1.343 . . . . 0.0 114.627 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.598 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 34.7 Cg_endo -62.47 4.45 0.35 Allowed 'Trans proline' 0 CA--C 1.533 0.449 0 CA-C-N 120.692 1.283 . . . . 0.0 111.163 177.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.789 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 7.97 64.32 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.185 0.994 . . . . 0.0 113.031 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 141' ' ' PRO . 21.7 pttm -58.98 -162.12 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.558 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -47.24 169.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.802 0.334 . . . . 0.0 111.125 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.16 100.5 21.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -83.94 12.77 2.9 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.655 2.236 . . . . 0.0 112.916 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 mt -90.67 51.48 2.0 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.922 0.391 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 60.1 8.86 1.62 Allowed 'General case' 0 C--O 1.25 1.08 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.516 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.808 0.337 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.35 31.42 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.534 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 4' ' ' LEU . 6.0 mp -49.89 -27.91 5.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.258 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -71.9 -39.16 69.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.687 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.89 -47.27 12.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.249 0.547 . . . . 0.0 110.17 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.759 ' OH ' HG23 ' A' ' 122' ' ' VAL . 5.8 m-85 -54.1 -29.05 43.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.13 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.915 HD21 HD22 ' A' ' 100' ' ' LEU . 5.1 mp -139.15 79.84 25.15 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.926 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -61.97 112.29 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.505 2.136 . . . . 0.0 112.087 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.81 -19.86 6.11 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.801 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 8' ' ' LEU . 36.5 mm -60.65 137.24 23.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.824 0.345 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -131.49 -52.93 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.941 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.71 166.1 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.967 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.591 ' CD1' HG22 ' A' ' 23' ' ' VAL . 2.5 mp -128.88 165.55 20.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.937 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.34 99.8 11.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 121.71 0.767 . . . . 0.0 111.011 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.606 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -86.84 162.18 17.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.383 179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.431 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -47.77 -76.94 0.12 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.765 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.77 -45.07 14.41 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.946 0.403 . . . . 0.0 111.557 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.51 -126.31 0.9 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.425 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -96.99 150.06 21.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.846 0.355 . . . . 0.0 110.814 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG11 HD21 ' A' ' 87' ' ' LEU . 1.9 t -145.06 150.92 15.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.88 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -83.1 153.07 25.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.372 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.591 HG22 ' CD1' ' A' ' 14' ' ' LEU . 77.6 t -71.73 -32.7 46.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.83 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -26.93 10.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.379 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.5 p -60.36 -16.89 39.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.572 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.463 ' O ' ' C ' ' A' ' 27' ' ' ALA . 6.3 mt -98.13 -39.0 9.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -10.64 90.25 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.474 1.11 . . . . 0.0 113.743 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.59 56.2 1.11 Allowed Glycine 0 C--N 1.304 -1.201 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.845 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 64' ' ' GLU . 9.2 ptpt -159.18 160.48 35.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.694 0.283 . . . . 0.0 110.969 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.684 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 17.1 tp -74.96 105.12 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.288 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' CG1' HG23 ' A' ' 66' ' ' VAL . 10.0 t -104.11 113.09 40.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.037 -179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.684 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 28.4 m-85 -85.81 162.37 18.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.815 178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.492 ' HZ ' HD23 ' A' ' 4' ' ' LEU . 29.1 m-85 -140.41 106.67 5.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.97 0.414 . . . . 0.0 111.813 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.58 ' HD2' HD22 ' A' ' 112' ' ' LEU . 25.5 t80 -92.82 111.64 23.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.744 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 6.4 m-85 -92.74 126.32 37.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.045 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 p -174.62 177.44 2.11 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.884 0.373 . . . . 0.0 111.32 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.577 ' HB1' ' HD1' ' A' ' 39' ' ' TRP . . . -139.3 165.27 27.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -88.26 22.67 2.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.565 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.577 ' HD1' ' HB1' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -128.72 -32.46 2.13 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -179.393 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.441 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.8 p -45.71 164.22 0.2 Allowed Pre-proline 0 CA--C 1.531 0.22 0 CA-C-O 120.728 0.299 . . . . 0.0 111.635 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.6 Cg_exo -64.57 -55.55 0.54 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.177 1.918 . . . . 0.0 112.428 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.6 Cg_exo -63.2 -79.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 121.923 1.749 . . . . 0.0 112.575 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.535 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 0.46 74.13 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.508 0.67 . . . . 0.0 112.352 -179.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 42' ' ' PRO . 14.7 ptt180 -161.18 -43.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.669 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.93 -46.47 4.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.268 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.52 107.59 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.879 0.371 . . . . 0.0 110.694 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.36 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.47 0.91 7.42 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.413 2.075 . . . . 0.0 113.113 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.03 -35.7 56.73 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.082 0.468 . . . . 0.0 110.038 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -70.25 -49.59 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.221 179.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.85 HD11 ' HD2' ' A' ' 85' ' ' PRO . 34.8 mm -56.22 -45.99 81.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.487 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.3 tm-20 -68.43 -51.12 47.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.463 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 74.8 t80 -61.11 -30.89 70.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 58' ' ' HIS . 27.3 t80 -82.74 -62.6 1.56 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.599 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -55.74 -26.5 45.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -71.66 -30.53 65.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.03 3.04 2.63 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 17.2 p-80 -50.73 -26.4 5.53 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.631 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 22.8 mt-10 -80.06 -29.97 39.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.757 0.313 . . . . 0.0 111.479 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -93.55 -43.7 8.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.227 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.516 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 46.3 mtmt -82.29 -27.14 32.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.3 t30 48.35 64.93 1.47 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.885 0.374 . . . . 0.0 111.685 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 21.3 m-85 -130.41 170.54 14.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.286 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 29' ' ' LYS . 19.0 tp10 -130.96 164.27 25.71 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.426 0.631 . . . . 0.0 110.206 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 50' ' ' LEU . 51.5 t -136.12 129.61 47.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.967 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 31.5 t -107.84 140.8 24.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.27 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.555 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.54 108.93 20.99 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.575 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -81.93 127.89 33.5 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.937 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -98.98 159.44 14.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.22 0.533 . . . . 0.0 111.946 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -141.41 37.37 1.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.119 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -80.11 169.27 18.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.62 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -107.2 -32.67 7.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.217 179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -122.87 160.59 25.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.531 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -73.08 -25.98 61.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.278 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.52 -43.02 89.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.418 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.445 ' HA3' ' CZ2' ' A' ' 39' ' ' TRP . . . -68.54 -56.1 10.61 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.877 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.68 -28.95 23.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.731 0.301 . . . . 0.0 111.257 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.47 -53.55 10.38 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.109 0.481 . . . . 0.0 111.643 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.14 -14.34 31.99 Favored Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 109.956 -1.258 . . . . 0.0 109.956 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.502 ' CE1' ' CZ ' ' A' ' 67' ' ' PHE . 9.9 t80 -98.69 -29.92 12.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.815 -0.693 . . . . 0.0 111.825 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.3 -22.12 45.06 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.123 -0.231 . . . . 0.0 111.383 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -47.23 -40.17 15.78 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 0.0 111.579 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 84' ' ' MET . 4.3 pttm -93.65 -146.24 0.24 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.741 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.565 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER 36.44 110.35 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.379 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.85 ' HD2' HD11 ' A' ' 51' ' ' ILE . 66.6 Cg_endo -73.07 -32.7 8.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.549 2.166 . . . . 0.0 112.529 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 2.0 p90 -47.51 162.89 0.06 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.639 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.639 HD21 HG11 ' A' ' 21' ' ' VAL . 1.3 mt -82.97 146.64 28.67 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.729 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 133.51 33.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.219 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.61 119.38 50.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.702 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.1 155.51 55.59 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.338 2.026 . . . . 0.0 111.991 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -49.29 -27.75 4.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.17 51.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.855 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 40.0 mm-40 -117.24 26.8 9.51 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.688 0.28 . . . . 0.0 111.225 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 79.3 p -60.34 -27.43 67.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.685 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -54.34 -33.99 60.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.974 0.416 . . . . 0.0 110.462 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -63.26 -40.12 96.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.773 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.937 HG11 ' O ' ' A' ' 69' ' ' THR . 91.7 t -57.9 -34.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.546 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -72.27 -44.32 62.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.059 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -79.45 -35.95 39.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.063 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.915 HD22 HD21 ' A' ' 8' ' ' LEU . 13.2 tp -52.01 -45.1 64.42 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.852 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 p -56.36 -34.04 66.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.995 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -56.44 -29.72 61.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.885 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -78.8 -29.66 44.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.403 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.3 m-85 -101.24 2.06 39.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.432 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 52.87 37.71 24.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 111.119 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 32.6 t -54.32 103.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -58.34 -53.22 60.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 67.8 m -165.17 150.42 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.51 158.21 69.02 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.373 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -85.64 158.04 60.16 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.564 -1.432 . . . . 0.0 112.539 0.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.401 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.8 OUTLIER -148.51 167.02 26.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.64 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.5 tp -147.24 127.17 13.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.536 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.451 HG22 ' N ' ' A' ' 114' ' ' GLY . 14.8 mt -136.32 155.04 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.81 0.338 . . . . 0.0 111.53 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -116.78 136.78 13.01 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.47 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 18.1 m -133.18 163.09 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.028 0.442 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' OD2' HG21 ' A' ' 123' ' ' VAL . 15.5 m-20 -103.19 116.27 32.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.85 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.07 -52.06 61.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.119 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -63.54 -58.86 5.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.9 t -59.03 -44.03 91.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.936 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.91 66.91 1.79 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.634 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -178.93 141.38 0.18 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.784 0.326 . . . . 0.0 110.823 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.759 HG23 ' OH ' ' A' ' 7' ' ' TYR . 20.6 t -59.94 117.57 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.065 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG21 ' OD2' ' A' ' 116' ' ' ASP . 12.9 t -101.57 -18.45 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.511 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.421 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -138.51 167.91 20.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.794 0.331 . . . . 0.0 110.751 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 124' ' ' THR . 42.4 p -157.6 41.55 0.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.37 48.48 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.37 6.17 12.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.263 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.575 ' HG3' ' N ' ' A' ' 129' ' ' ALA . 6.2 ptp85 -78.98 -50.86 10.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.048 0.451 . . . . 0.0 110.132 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.575 ' N ' ' HG3' ' A' ' 128' ' ' ARG . . . -85.59 -36.53 20.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.298 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 80.8 p -70.79 -48.97 51.42 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.26 -35.21 49.3 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.349 -179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.5 p -89.22 -50.01 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.418 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 33.5 mmtm -81.4 18.31 1.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.441 ' CB ' ' O ' ' A' ' 130' ' ' THR . 48.5 t0 -113.5 78.1 3.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.768 0.318 . . . . 0.0 110.506 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.63 4.69 6.82 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.674 2.25 . . . . 0.0 113.342 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -114.77 -26.57 7.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.766 0.317 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.81 23.35 37.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.732 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 3.9 pt-20 -76.48 -14.6 60.03 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.601 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -137.02 25.83 2.99 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 110.487 -0.19 . . . . 0.0 110.487 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.776 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.9 p90 -31.96 -45.81 0.38 Allowed Pre-proline 0 N--CA 1.465 0.312 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 31.4 Cg_endo -61.71 3.64 0.37 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 CA-C-N 120.405 1.18 . . . . 0.0 111.373 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.776 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.0 65.03 0.0 OUTLIER 'General case' 0 C--N 1.352 0.711 0 C-N-CA 124.153 0.981 . . . . 0.0 112.545 -179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -93.09 168.17 11.3 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.925 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 35.7 p-10 -60.11 -172.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -54.85 108.24 1.1 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.127 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.94 -167.85 0.21 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.455 2.103 . . . . 0.0 112.304 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 147' ' ' LEU . 3.8 mm? -59.06 -79.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.997 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.47 164.32 4.54 Favored 'General case' 0 C--O 1.249 1.073 0 CA-C-O 118.27 -0.872 . . . . 0.0 110.87 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.251 -3.715 0 CA-C-N 118.288 0.495 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.864 0.364 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.04 -28.72 64.19 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.574 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.96 -26.82 4.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 0.0 111.023 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -62.65 -24.69 67.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.27 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.46 -28.02 63.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.962 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -81.28 -55.07 4.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.98 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 8' ' ' LEU . 3.9 mp -98.53 155.13 37.14 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.079 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 96' ' ' ALA . 50.8 Cg_exo -55.48 -169.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.549 2.166 . . . . 0.0 112.066 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.94 49.07 3.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.381 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 12' ' ' GLU . 11.4 mt -51.75 158.07 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.77 0.319 . . . . 0.0 111.036 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.65 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.4 mt-10 -99.98 -59.35 1.73 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.399 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -130.06 166.08 20.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.962 0.41 . . . . 0.0 111.285 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.5 mt -123.05 165.4 16.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.911 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -88.09 98.15 11.38 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.726 0.774 . . . . 0.0 110.788 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.564 ' HB2' HD23 ' A' ' 87' ' ' LEU . 2.7 tpp85 -77.83 -88.04 0.05 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.803 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.14 -124.22 2.17 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.523 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -43.96 -31.25 0.85 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.353 . . . . 0.0 111.537 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.63 -159.2 7.84 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.485 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -96.94 157.8 15.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.789 0.328 . . . . 0.0 110.982 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG11 HD21 ' A' ' 87' ' ' LEU . 2.0 t -133.3 156.78 42.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -85.24 153.11 22.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.582 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.8 t -68.71 -27.19 35.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.137 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.91 -26.91 6.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.504 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.1 p -60.38 -16.71 38.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.343 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG11 ' A' ' 31' ' ' VAL . 6.9 mt -97.95 40.73 1.16 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.991 0.424 . . . . 0.0 110.533 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.77 86.13 2.24 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.852 0.834 . . . . 0.0 111.115 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.51 52.59 1.42 Allowed Glycine 0 C--N 1.304 -1.22 0 CA-C-N 114.226 -1.352 . . . . 0.0 113.021 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.53 143.65 11.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.76 0.314 . . . . 0.0 110.457 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.731 HD12 ' O ' ' A' ' 115' ' ' VAL . 41.6 tp -69.29 111.11 4.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.818 0.342 . . . . 0.0 110.771 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG11 HD13 ' A' ' 26' ' ' LEU . 2.4 t -100.83 110.67 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.467 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.482 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 9.6 m-85 -88.98 153.48 20.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.553 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 5.2 m-85 -125.2 106.14 9.66 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.086 0.47 . . . . 0.0 110.603 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -100.18 123.69 44.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.628 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.741 ' HZ ' HD11 ' A' ' 100' ' ' LEU . 6.0 m-85 -106.38 137.86 43.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.176 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.0 t -174.23 179.77 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.956 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.64 166.96 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.803 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.38 5.81 43.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.529 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 50.0 p-90 -120.5 -4.79 9.82 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.2 p -55.54 152.29 18.24 Favored Pre-proline 0 CA--C 1.533 0.296 0 CA-C-O 120.704 0.287 . . . . 0.0 111.286 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.1 Cg_exo -55.78 -50.23 13.18 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.758 2.306 . . . . 0.0 113.424 -178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.32 -69.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.238 1.959 . . . . 0.0 110.992 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 40.6 m 43.92 31.02 0.45 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.376 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -168.76 98.99 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.14 -46.92 0.74 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.59 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CE1' HG22 ' A' ' 132' ' ' VAL . 8.1 t80 -107.38 -27.34 10.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.742 0.306 . . . . 0.0 111.1 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -55.26 42.93 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.035 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -81.22 6.53 5.53 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.664 2.243 . . . . 0.0 112.881 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.436 ' NE2' HG13 ' A' ' 132' ' ' VAL . 1.5 tp60 -77.61 -35.79 52.4 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.868 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -56.57 -49.13 75.77 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.249 0.547 . . . . 0.0 110.667 179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 32.4 mm -61.85 -45.87 97.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.487 -0.778 . . . . 0.0 110.787 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 1.8 tp10 -56.98 -51.17 70.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.247 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -64.93 -36.54 84.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.136 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 7.6 t80 -59.26 -57.24 13.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.018 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.454 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.3 t0 -55.55 -26.36 42.89 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 8.8 mmmt -55.78 -55.73 28.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -139.06 4.33 2.25 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -49.33 -25.61 2.55 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.435 -178.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -78.23 -29.84 48.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.833 0.349 . . . . 0.0 110.819 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 m -91.72 -54.73 3.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.0 mtpt -66.43 -14.14 61.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.373 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 42.44 61.86 1.89 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.065 0.46 . . . . 0.0 111.824 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 58' ' ' HIS . 39.9 p90 -121.79 170.54 9.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.322 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' OE1' HG23 ' A' ' 66' ' ' VAL . 7.5 tm-20 -134.5 138.56 44.79 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.211 0.529 . . . . 0.0 110.643 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.868 HG21 HD11 ' A' ' 50' ' ' LEU . 86.1 t -118.51 109.64 27.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.968 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 87' ' ' LEU . 71.0 t -93.37 147.2 5.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.672 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HB3' ' NE1' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -121.75 126.09 48.08 Favored 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.269 -0.572 . . . . 0.0 111.697 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 35' ' ' PHE . 4.0 m -97.76 105.07 17.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.604 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.714 ' O ' HG11 ' A' ' 97' ' ' VAL . 12.2 t -57.64 164.57 1.97 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.741 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.89 40.28 1.06 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -110.49 159.4 17.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.956 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -87.61 -30.89 20.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.743 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.93 133.43 35.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.781 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.461 ' HG3' ' CE2' ' A' ' 91' ' ' PHE . 1.2 mp0 -73.09 -55.95 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.951 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -59.81 -28.24 67.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.137 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -70.42 -56.23 7.89 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.62 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.12 -35.39 76.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 0.0 111.047 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.647 ' O ' ' HB3' ' A' ' 82' ' ' ALA . . . -78.34 -53.0 7.77 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.064 -0.517 . . . . 0.0 112.172 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -54.89 -13.92 4.98 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' N ' ' C ' ' A' ' 78' ' ' ALA . 0.3 OUTLIER -108.23 -61.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.027 -0.587 . . . . 0.0 112.11 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.53 ' CG ' ' CZ ' ' A' ' 67' ' ' PHE . 78.7 m-85 -79.21 -38.45 35.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 78' ' ' ALA . . . -46.0 -27.31 0.89 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -57.06 -27.5 61.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.758 0.313 . . . . 0.0 111.135 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.465 ' HG2' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -66.62 142.52 97.64 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.001 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.43 -38.94 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.757 2.305 . . . . 0.0 112.821 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.695 ' NE1' ' HB3' ' A' ' 67' ' ' PHE . 1.3 p90 -48.12 167.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.954 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.78 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.2 mt -84.65 127.71 34.22 Favored 'General case' 0 N--CA 1.435 -1.191 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.785 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.1 135.7 52.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.018 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.9 t -60.24 119.08 39.22 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.842 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.58 153.56 74.26 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.665 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.461 ' CE2' ' HG3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -48.78 -28.71 3.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 110.804 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.06 -37.04 52.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.812 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' CG ' HG12 ' A' ' 11' ' ' ILE . 2.2 mm-40 -112.77 36.97 3.24 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.614 0.245 . . . . 0.0 111.232 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 m -61.6 -29.14 69.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.765 0.316 . . . . 0.0 110.556 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 98' ' ' GLN . 75.7 mm-40 -54.65 -29.92 53.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.084 0.469 . . . . 0.0 110.348 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.07 -38.15 87.58 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.057 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.714 HG11 ' O ' ' A' ' 69' ' ' THR . 80.5 t -59.53 -37.09 68.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.843 -178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.433 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 5.2 pt20 -79.86 -35.87 37.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.899 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 20.5 mmmt -82.07 -32.11 30.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.952 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.741 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -80.66 -51.88 8.2 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.1 0.476 . . . . 0.0 110.039 179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.48 ' HB2' HG21 ' A' ' 106' ' ' VAL . 53.6 p -54.95 -32.62 61.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.997 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -28.61 62.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.136 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -71.24 -28.57 64.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.055 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.851 ' CZ ' HG21 ' A' ' 113' ' ' ILE . 35.0 m-85 -94.48 7.51 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.381 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.7 t30 51.96 37.13 20.25 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.744 0.307 . . . . 0.0 111.252 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 101' ' ' SER . 35.0 t -54.44 96.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.077 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -67.17 -47.89 69.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.966 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.5 m -153.78 151.33 29.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.048 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.445 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -89.16 159.3 45.29 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.043 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 69.8 Cg_endo -90.62 151.13 22.09 Favored 'Cis proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.802 0.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.51 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.4 t -128.05 172.61 10.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.795 ' CD2' HD13 ' A' ' 131' ' ' LEU . 0.6 OUTLIER -147.39 120.86 9.06 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.807 0.337 . . . . 0.0 110.916 179.255 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.851 HG21 ' CZ ' ' A' ' 104' ' ' PHE . 6.0 mm -123.14 145.33 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.666 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -123.4 135.16 9.75 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.536 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.731 ' O ' HD12 ' A' ' 30' ' ' LEU . 17.2 m -133.23 163.09 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.682 ' OD1' HG21 ' A' ' 123' ' ' VAL . 5.1 m-20 -101.85 117.84 35.68 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.558 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD21 ' A' ' 4' ' ' LEU . . . -59.01 -51.99 67.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.185 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -71.5 -52.42 18.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.997 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -59.21 -43.98 92.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.39 -54.1 4.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.57 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -59.74 151.98 23.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 0.0 110.989 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.0 t -59.83 133.15 25.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.055 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.682 HG21 ' OD1' ' A' ' 116' ' ' ASP . 23.3 t -105.26 -32.17 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.514 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -157.27 169.28 25.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.385 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.849 ' O ' HD13 ' A' ' 113' ' ' ILE . 16.9 p -145.75 -54.85 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.441 ' HD3' ' C ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -80.96 49.37 1.22 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.116 0.484 . . . . 0.0 111.031 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.43 -8.31 54.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.964 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.424 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -58.64 -36.21 73.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 0.0 111.091 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . . . -84.58 -57.44 3.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.171 0.51 . . . . 0.0 112.066 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 43.7 p -48.74 -50.29 34.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.795 HD13 ' CD2' ' A' ' 112' ' ' LEU . 8.6 tt -52.52 -33.17 43.99 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.748 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.486 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -89.78 -38.54 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 121.077 0.465 . . . . 0.0 111.682 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -101.29 21.58 13.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.676 -177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' CB ' ' O ' ' A' ' 130' ' ' THR . 20.7 t0 -131.87 73.9 77.96 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 120.902 0.382 . . . . 0.0 110.488 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -86.24 19.63 1.36 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.928 2.419 . . . . 0.0 113.151 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.414 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 17.3 mt-10 -112.84 -28.3 7.8 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 120.884 0.373 . . . . 0.0 110.377 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 58.84 27.14 61.45 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.581 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.414 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 2.6 mt-10 -78.51 -26.71 45.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.747 0.308 . . . . 0.0 111.366 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.664 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.87 34.69 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.875 -179.403 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.773 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 18.8 p90 -36.23 -43.11 0.82 Allowed Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.7 Cg_endo -64.88 3.97 0.79 Allowed 'Trans proline' 0 CA--C 1.533 0.453 0 CA-C-N 120.588 1.246 . . . . 0.0 111.127 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.773 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 6.41 64.87 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.025 0.93 . . . . 0.0 112.624 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.5 ptpt -102.34 137.01 41.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.206 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.3 p30 36.47 -163.05 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.89 -0.595 . . . . 0.0 112.541 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.816 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -151.77 -66.9 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.213 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 58.9 Cg_endo -71.51 -165.89 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.387 2.058 . . . . 0.0 112.277 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tt 68.14 105.29 0.05 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -135.39 2.49 3.0 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.853 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.764 0 O-C-N 123.505 0.503 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.819 0.342 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.79 -24.71 76.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.572 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 31' ' ' VAL . 44.1 mt -66.09 -34.17 77.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 110.669 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -61.21 -24.95 66.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -47.16 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.036 0.446 . . . . 0.0 110.321 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' HB3' HD13 ' A' ' 100' ' ' LEU . 18.1 m-85 -48.01 -43.43 29.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.267 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.715 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.7 OUTLIER -121.9 79.58 41.4 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.25 156.09 52.85 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.645 2.23 . . . . 0.0 112.306 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.78 69.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.708 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.617 HD12 ' CB ' ' A' ' 8' ' ' LEU . 11.6 mt -130.16 118.9 45.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 0.0 111.165 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.84 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -110.55 -31.56 7.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.927 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mttt -134.79 140.47 45.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.971 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 87' ' ' LEU . 56.7 mt -100.89 165.37 11.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.95 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.45 98.38 10.05 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.856 0.836 . . . . 0.0 111.111 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.545 ' HB2' ' HB ' ' A' ' 21' ' ' VAL . 13.4 tpt180 -100.47 157.93 16.28 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.916 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -34.14 -84.38 0.01 OUTLIER Glycine 0 CA--C 1.52 0.405 0 CA-C-N 116.372 -0.376 . . . . 0.0 113.894 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.97 -67.35 0.2 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.983 0.421 . . . . 0.0 111.799 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.97 -79.05 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.047 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -139.25 150.26 45.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.827 0.346 . . . . 0.0 110.658 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.564 ' CG1' HD21 ' A' ' 87' ' ' LEU . 0.9 OUTLIER -125.12 132.74 70.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.847 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -63.75 152.96 37.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.238 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.84 HG23 ' O ' ' A' ' 12' ' ' GLU . 83.9 t -68.77 -28.96 41.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.873 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.8 tttm -51.85 -27.04 11.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.46 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.689 ' C ' HD23 ' A' ' 26' ' ' LEU . 2.6 m -60.71 -6.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.709 HD22 ' HZ2' ' A' ' 29' ' ' LYS . 2.0 mt -110.5 47.98 0.94 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.063 0.458 . . . . 0.0 110.376 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.55 87.56 2.56 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.78 0.8 . . . . 0.0 111.077 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 37.03 4.62 Favored Glycine 0 C--N 1.305 -1.175 0 CA-C-N 114.211 -1.358 . . . . 0.0 113.261 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.87 ' NZ ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -139.71 168.22 20.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.565 0.221 . . . . 0.0 110.756 179.586 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' A' ' 32' ' ' PHE . 5.5 tp -94.84 136.32 35.29 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.697 0.284 . . . . 0.0 110.708 -179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG22 ' NZ ' ' A' ' 29' ' ' LYS . 2.5 t -115.42 117.1 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.043 0.449 . . . . 0.0 111.756 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' A' ' 30' ' ' LEU . 13.0 m-85 -97.34 147.69 23.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.006 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.617 ' CE1' HG22 ' A' ' 115' ' ' VAL . 1.3 m-85 -137.01 106.79 6.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.065 0.46 . . . . 0.0 111.344 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' CD1' ' A' ' 46' ' ' PHE . 54.7 t80 -96.42 110.42 22.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.665 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.629 ' CD2' HG21 ' A' ' 106' ' ' VAL . 6.3 m-30 -86.94 128.94 35.06 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.776 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 8.1 t -174.41 171.76 3.32 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.785 0.326 . . . . 0.0 110.879 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -132.73 157.67 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.067 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.445 ' CB ' ' CD1' ' A' ' 80' ' ' TYR . 52.3 p -81.78 -2.88 52.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.932 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.9 p-90 -128.88 6.15 5.49 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 4.2 p -69.33 167.53 21.27 Favored Pre-proline 0 C--N 1.331 -0.218 0 C-N-CA 120.992 -0.283 . . . . 0.0 110.846 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 15.1 Cg_exo -64.86 -55.96 0.45 Allowed 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 121.967 1.778 . . . . 0.0 112.539 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 17.3 Cg_exo -65.17 -78.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.002 1.801 . . . . 0.0 112.891 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.525 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.7 OUTLIER 0.89 73.18 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.305 0.642 . . . . 0.0 112.716 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' PRO . 10.4 mtm180 -164.45 29.31 0.07 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.02 34.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.672 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CD1' ' CE1' ' A' ' 34' ' ' TYR . 2.9 t80 -153.65 23.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.79 0.328 . . . . 0.0 111.06 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -95.16 -62.92 0.14 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.224 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 47' ' ' THR . 73.1 Cg_endo -76.47 5.45 4.7 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.4 2.067 . . . . 0.0 113.164 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -77.47 -42.15 36.95 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.829 0.347 . . . . 0.0 110.108 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -57.23 -49.12 77.04 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 111.039 179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.6 mt -55.87 -44.62 78.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.888 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.13 -36.64 75.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.805 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.57 -37.34 65.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.808 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.543 ' O ' ' HB2' ' A' ' 58' ' ' HIS . 11.3 t80 -68.06 -52.27 37.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -55.53 -26.33 42.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.082 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -64.59 0.89 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -147.17 3.11 0.78 Allowed 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.543 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 0.3 OUTLIER -50.7 -26.7 5.83 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 118.365 0.53 . . . . 0.0 110.971 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -71.45 -30.85 66.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.623 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.9 m -83.41 -51.71 7.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 12.9 ptpt -74.69 -6.54 49.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.178 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 42.9 73.71 0.13 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 61' ' ' LYS . 23.0 m-30 -121.56 170.82 9.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.879 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 29' ' ' LYS . 12.6 tp10 -137.23 138.35 40.04 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.285 0.564 . . . . 0.0 111.221 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 50' ' ' LEU . 59.3 t -110.42 124.24 67.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.426 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.5 t -97.43 140.9 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.507 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CZ ' ' HD2' ' A' ' 83' ' ' LYS . 9.7 t80 -98.52 99.75 10.93 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.344 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 15.5 m -98.09 102.57 14.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.099 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.507 ' O ' HG11 ' A' ' 97' ' ' VAL . 14.6 t -67.1 167.59 11.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.471 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -145.22 37.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.94 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' CG ' ' HB1' ' A' ' 37' ' ' ALA . 1.3 m-20 -99.62 172.72 7.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -108.09 -29.0 9.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.655 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.28 152.51 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 50.4 mt-10 -73.06 -25.77 61.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.288 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -55.81 -43.07 76.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.365 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.3 -56.08 15.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.542 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -54.79 -26.84 37.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.82 0.343 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.96 -53.5 7.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.996 0.427 . . . . 0.0 111.757 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.68 -14.47 36.44 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' CB ' ' A' ' 38' ' ' SER . 0.9 OUTLIER -97.12 -3.95 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.625 -0.787 . . . . 0.0 111.627 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -48.88 -25.78 2.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.475 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.42 -17.84 15.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.656 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' CZ ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -50.67 -178.89 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.927 0.394 . . . . 0.0 111.514 -179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.48 ' CB ' ' CE2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -59.98 139.89 90.57 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.474 179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 17' ' ' GLY . 92.9 Cg_endo -92.17 -10.92 2.18 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.999 2.466 . . . . 0.0 115.169 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.565 ' CH2' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -34.96 -83.33 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -177.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 14' ' ' LEU . 13.6 mt -140.56 131.43 25.96 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 118.861 0.755 . . . . 0.0 109.813 178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.82 134.94 20.39 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.905 0.383 . . . . 0.0 111.998 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.7 t -72.23 121.33 84.43 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.453 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.41 152.79 80.14 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.175 1.917 . . . . 0.0 111.812 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 77.2 t80 -47.81 -29.85 3.53 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.103 0.477 . . . . 0.0 110.753 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.59 -37.09 65.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.065 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -113.71 36.49 3.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-O 120.654 0.264 . . . . 0.0 111.592 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 m -62.05 -25.23 67.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.755 0.312 . . . . 0.0 110.534 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.83 -32.23 52.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.052 0.453 . . . . 0.0 110.484 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.715 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.74 -41.38 86.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.535 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 69' ' ' THR . 96.5 t -59.79 -33.25 51.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.445 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -72.07 -44.71 62.88 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.824 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -81.11 -38.83 26.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.048 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.411 ' HB3' ' O ' ' A' ' 96' ' ' ALA . 26.0 tp -68.93 -27.97 66.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.789 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 106' ' ' VAL . 14.2 m -74.87 -40.08 61.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.805 0.336 . . . . 0.0 110.703 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.77 -30.19 71.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.992 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.32 -38.61 77.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.973 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' CG ' HD12 ' A' ' 113' ' ' ILE . 29.2 m-85 -94.88 16.52 15.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.123 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 43.41 43.37 4.31 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 35' ' ' PHE . 28.0 t -56.65 96.77 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.928 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -60.76 -37.09 80.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.6 p -172.93 151.24 2.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.01 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 70' ' ' TRP . 0.0 OUTLIER -85.47 159.38 55.97 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.882 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.439 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 69.0 Cg_endo -90.7 152.99 24.16 Favored 'Cis proline' 0 C--N 1.347 0.498 0 C-N-CA 123.747 -1.356 . . . . 0.0 112.831 0.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.75 164.22 29.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.403 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.814 HD21 HD13 ' A' ' 131' ' ' LEU . 4.8 tp -147.34 125.94 12.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.614 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.577 HG23 ' HA ' ' A' ' 125' ' ' THR . 26.8 mt -136.36 155.42 34.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.699 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.442 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -126.21 141.32 12.74 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.238 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.617 HG22 ' CE1' ' A' ' 33' ' ' PHE . 16.6 m -133.31 163.07 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.062 0.458 . . . . 0.0 111.024 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.53 121.33 38.23 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.647 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.677 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -71.42 -37.53 71.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -57.3 -63.0 1.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -74.53 -31.1 62.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.93 27.68 62.08 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.542 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -125.05 158.52 33.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.86 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.1 t -65.89 126.76 25.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.035 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.4 -35.14 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.399 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 125' ' ' THR . 0.1 OUTLIER -136.51 168.27 19.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.353 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.577 ' HA ' HG23 ' A' ' 113' ' ' ILE . 43.5 p -157.01 41.27 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.074 0.464 . . . . 0.0 110.841 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.95 43.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.212 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.61 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -75.49 -3.03 31.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.124 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.537 ' NH2' HG21 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.16 -37.9 66.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.912 0.387 . . . . 0.0 110.58 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 -48.94 9.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.012 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 134' ' ' ASP . 72.3 p -58.45 -46.08 87.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.814 HD13 HD21 ' A' ' 112' ' ' LEU . 0.7 OUTLIER -52.78 -35.44 56.55 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.268 -0.573 . . . . 0.0 110.402 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.537 HG21 ' NH2' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.13 -38.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.916 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -104.9 22.52 15.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.862 -176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 130' ' ' THR . 3.2 t0 -147.34 60.43 5.57 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.811 0.339 . . . . 0.0 110.88 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 66.3 Cg_endo -90.16 23.84 0.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.825 2.35 . . . . 0.0 112.68 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -109.32 -36.75 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.833 0.349 . . . . 0.0 110.713 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.17 31.58 10.64 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.517 -0.849 . . . . 0.0 111.856 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -77.09 -44.18 31.54 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.708 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mt-30 -137.78 37.62 2.4 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 121.212 -0.195 . . . . 0.0 111.418 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.743 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.8 p90 -39.53 -40.7 1.52 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.626 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 41.4 Cg_endo -67.88 5.57 1.04 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 CA-C-N 120.751 1.304 . . . . 0.0 111.007 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.743 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 5.36 65.52 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.705 -179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 141' ' ' PRO . 44.4 mttt -68.21 -176.74 0.76 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.93 -21.8 13.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.219 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.41 154.6 79.91 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.15 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -85.49 13.45 2.75 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.831 2.354 . . . . 0.0 112.902 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.65 -177.69 3.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.847 0.356 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 60.69 102.92 0.02 OUTLIER 'General case' 0 C--O 1.249 1.027 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.94 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.774 0 O-C-N 123.517 0.51 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.831 0.348 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.416 ' O ' ' CG ' ' A' ' 6' ' ' LYS . . . -58.99 -24.2 57.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.655 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.954 HD11 HG11 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -80.44 -31.54 37.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -84.63 -23.33 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.41 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -53.99 -29.87 44.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.025 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.894 ' CD2' HD13 ' A' ' 100' ' ' LEU . 2.6 t80 -55.91 -76.72 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.869 0.366 . . . . 0.0 110.508 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 8' ' ' LEU . 4.4 tt -152.93 101.76 2.67 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.764 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -48.48 124.41 10.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.428 2.085 . . . . 0.0 112.299 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 -26.86 0.32 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.635 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' HA ' ' HG3' ' A' ' 93' ' ' GLN . 24.8 mm -52.36 -37.46 23.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.877 0.37 . . . . 0.0 110.942 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.698 ' O ' HG23 ' A' ' 23' ' ' VAL . 1.8 mt-10 62.96 -79.09 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.697 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.4 mtpp -131.82 166.46 21.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.153 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.652 ' CD1' HD11 ' A' ' 26' ' ' LEU . 26.1 mt -100.7 165.58 11.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.004 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.9 mtp180 -98.61 102.02 13.63 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.739 0.78 . . . . 0.0 110.944 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG2' HG22 ' A' ' 21' ' ' VAL . 26.7 mmm-85 -90.06 -176.05 4.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 114.358 -1.292 . . . . 0.0 110.664 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -74.72 -89.46 0.2 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.106 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -48.07 -36.77 13.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 111.309 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.05 -129.45 1.1 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.606 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.22 152.61 50.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.734 HG22 ' HG2' ' A' ' 16' ' ' ARG . 17.3 m -126.98 140.81 48.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -60.97 153.05 26.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.181 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -55.98 -27.44 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.121 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -51.33 -27.37 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.117 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.773 ' C ' HD23 ' A' ' 26' ' ' LEU . 59.1 m -60.79 -17.39 48.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.96 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.773 HD23 ' C ' ' A' ' 25' ' ' SER . 0.5 OUTLIER -117.83 52.02 1.02 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.172 0.51 . . . . 0.0 109.722 179.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.48 89.82 3.15 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 121.832 0.825 . . . . 0.0 111.106 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.97 54.42 1.2 Allowed Glycine 0 C--N 1.302 -1.343 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.976 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.4 OUTLIER -152.25 161.31 42.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.61 0.243 . . . . 0.0 110.359 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.555 ' CD1' HG21 ' A' ' 123' ' ' VAL . 25.9 tp -81.21 95.83 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.75 0.309 . . . . 0.0 110.264 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.954 HG11 HD11 ' A' ' 4' ' ' LEU . 4.1 t -85.67 144.93 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.235 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 112' ' ' LEU . 3.6 m-85 -116.2 161.08 19.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.994 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.585 ' CZ ' HD13 ' A' ' 4' ' ' LEU . 16.6 m-85 -133.8 105.15 6.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.671 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.463 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 25.7 t80 -95.91 108.96 21.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.183 -179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.755 ' HB2' HG22 ' A' ' 111' ' ' THR . 62.5 m-85 -95.15 125.23 39.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 20.1 p -174.29 171.99 3.34 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-O 120.947 0.404 . . . . 0.0 111.002 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.682 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -146.54 140.4 26.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.823 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 33.8 p -58.84 -19.54 42.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.272 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.625 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 7.6 p-90 -96.97 13.95 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -70.7 158.27 88.31 Favored Pre-proline 0 CA--C 1.532 0.278 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.591 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 16.4 Cg_exo -64.74 -56.92 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.335 2.023 . . . . 0.0 113.149 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.8 Cg_exo -66.48 -75.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 121.748 1.632 . . . . 0.0 112.032 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' PRO . 58.9 m 31.79 79.11 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 120.952 0.406 . . . . 0.0 111.797 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.2 ttm-85 174.56 39.0 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.17 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.69 65.0 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.95 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 18.1 t80 -179.95 -31.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.626 0.25 . . . . 0.0 111.435 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.69 HG22 ' HD3' ' A' ' 48' ' ' PRO . 7.3 t -65.82 -32.73 6.21 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.69 ' HD3' HG22 ' A' ' 47' ' ' THR . 85.8 Cg_endo -85.8 -3.62 9.02 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.914 1.742 . . . . 0.0 112.807 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' A' ' 46' ' ' PHE . 13.7 mm100 -77.6 -35.96 52.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.886 0.374 . . . . 0.0 110.269 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.026 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -66.95 -49.32 65.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.057 179.564 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.49 -45.31 90.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.352 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -67.62 -51.04 54.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.881 0.372 . . . . 0.0 110.787 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CZ ' ' NZ ' ' A' ' 61' ' ' LYS . 25.4 t80 -62.88 -32.75 74.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.661 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.467 ' O ' ' N ' ' A' ' 58' ' ' HIS . 14.7 t80 -81.24 -58.88 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.471 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.57 -26.14 41.99 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -81.76 -29.63 32.74 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.503 ' HB3' ' CE ' ' A' ' 61' ' ' LYS . 6.3 m-85 -134.76 2.56 3.17 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 54' ' ' TYR . 2.2 p80 -52.42 -33.33 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 111.234 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.2 mt-10 -80.1 -29.71 39.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.093 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.1 p -80.19 -62.66 1.61 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.701 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' CE ' ' HB3' ' A' ' 57' ' ' PHE . 7.7 ptpt -77.26 -6.82 54.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 -179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 42.52 75.3 0.09 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-O 121.146 0.498 . . . . 0.0 111.699 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.432 ' CE2' HG23 ' A' ' 65' ' ' VAL . 1.7 p90 -132.49 170.53 15.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.981 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.649 ' CG ' HD12 ' A' ' 87' ' ' LEU . 3.6 tp10 -138.14 136.22 36.49 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 110.621 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.026 HG21 HD11 ' A' ' 50' ' ' LEU . 66.0 t -112.01 125.69 69.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.987 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.2 t -103.87 142.1 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.514 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.547 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -104.75 116.43 32.01 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.995 0.426 . . . . 0.0 111.719 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.569 ' HB3' HG13 ' A' ' 97' ' ' VAL . 2.5 m -96.05 101.33 12.98 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.881 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.4 t -60.18 154.4 19.78 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.3 0.571 . . . . 0.0 111.618 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.682 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 3.9 m95 -141.74 36.1 1.61 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.432 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 39' ' ' TRP . 5.4 m-20 -97.76 175.06 6.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.205 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.28 -31.26 9.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.582 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -113.89 164.41 13.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.761 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -73.12 -32.7 65.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.999 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -58.07 -43.06 86.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.418 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -68.82 -33.04 74.58 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.837 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -83.72 -37.26 22.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.66 0.266 . . . . 0.0 111.247 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -76.34 -53.61 7.94 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.87 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.27 -14.28 18.6 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -96.13 -51.03 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.875 -0.662 . . . . 0.0 111.862 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -79.08 -12.6 60.01 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.71 -9.92 59.2 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -117.86 8.18 12.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.764 ' HE1' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -112.67 144.66 31.42 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.809 0.337 . . . . 0.0 111.536 -179.615 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -84.5 -45.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.832 2.355 . . . . 0.0 112.858 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.547 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 4.2 p90 -44.0 162.33 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.649 HD12 ' CG ' ' A' ' 64' ' ' GLU . 1.6 mt -83.53 154.53 23.79 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 120.162 -0.615 . . . . 0.0 111.633 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.764 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -142.85 157.75 44.3 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.357 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 70.0 t -85.57 133.53 41.83 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -62.06 145.42 96.58 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.201 1.934 . . . . 0.0 111.738 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -47.87 -29.84 3.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.982 0.42 . . . . 0.0 110.696 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.01 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.052 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.418 ' HG3' ' HA ' ' A' ' 11' ' ' ILE . 17.4 mm100 -108.57 27.93 8.89 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.678 0.275 . . . . 0.0 111.398 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.7 p -63.86 -27.54 69.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.893 0.378 . . . . 0.0 110.441 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.41 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -54.15 -30.82 50.67 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.165 0.507 . . . . 0.0 110.34 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' A' ' 7' ' ' TYR . . . -72.2 -39.49 68.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.128 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.881 HG11 ' O ' ' A' ' 69' ' ' THR . 95.8 t -58.03 -35.05 50.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.313 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 3.7 pt20 -72.95 -41.01 64.88 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.9 mmmp? -82.07 -36.09 28.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.894 HD13 ' CD2' ' A' ' 7' ' ' TYR . 7.5 tp -51.57 -39.07 57.18 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.6 p -57.09 -49.68 75.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.048 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 -29.13 65.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.881 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.13 -28.4 42.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.615 ' CE2' HD11 ' A' ' 100' ' ' LEU . 16.7 m-85 -100.96 10.36 41.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.366 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.2 t30 52.93 73.69 0.34 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.855 0.36 . . . . 0.0 111.301 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.96 105.45 18.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.097 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -57.77 -45.31 86.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.747 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.3 p -176.78 150.61 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.833 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.562 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.5 156.66 70.79 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.472 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.17 163.43 89.16 Favored 'Cis proline' 0 C--N 1.346 0.435 0 C-N-CA 123.681 -1.383 . . . . 0.0 112.139 0.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.755 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.7 t -155.4 176.29 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.95 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.1 OUTLIER -146.93 120.73 9.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.994 179.047 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.683 HD13 ' HA ' ' A' ' 125' ' ' THR . 2.5 mm -122.57 119.36 57.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.911 0.386 . . . . 0.0 110.972 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -96.66 136.82 13.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.438 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.444 HG21 HD22 ' A' ' 4' ' ' LEU . 9.8 m -133.32 155.29 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.649 ' OD2' HG22 ' A' ' 123' ' ' VAL . 0.9 OUTLIER -105.07 110.29 22.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.586 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.6 -51.98 67.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.228 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -58.52 -63.03 1.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.24 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.05 -44.02 91.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.178 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.46 -57.44 0.52 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.742 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.27 179.39 0.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 111.072 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.6 t -79.93 153.94 4.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.08 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.649 HG22 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -108.28 -37.28 3.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -154.52 152.43 30.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.634 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.683 ' HA ' HD13 ' A' ' 113' ' ' ILE . 67.4 p -130.42 45.2 2.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.951 0.405 . . . . 0.0 111.399 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.65 58.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.471 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.616 ' HB1' ' HZ3' ' A' ' 142' ' ' TRP . . . -96.32 23.16 6.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.967 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 129' ' ' ALA . 4.6 ppt_? -82.61 -46.7 12.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.799 0.333 . . . . 0.0 110.423 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 128' ' ' ARG . . . -84.74 -42.78 14.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.793 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 69.4 p -67.25 -42.88 83.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.543 ' CD1' HD22 ' A' ' 50' ' ' LEU . 1.0 OUTLIER -52.07 -36.54 50.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.946 0.403 . . . . 0.0 110.264 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -89.34 -49.66 13.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.923 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -83.89 19.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 130' ' ' THR . 11.1 t70 -123.48 71.23 47.12 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 120.844 0.354 . . . . 0.0 110.789 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.46 12.88 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.766 2.311 . . . . 0.0 112.821 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.01 -24.57 14.58 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.098 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.86 25.24 29.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.778 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -84.34 -28.99 26.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.957 0.408 . . . . 0.0 111.231 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.606 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -128.08 31.27 5.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.082 -179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.3 p90 -32.47 -46.31 0.44 Allowed Pre-proline 0 N--CA 1.465 0.323 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.568 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 28.7 Cg_endo -61.03 2.95 0.35 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 CA-C-N 120.353 1.162 . . . . 0.0 111.583 177.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.7 64.4 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.049 0.94 . . . . 0.0 112.787 -179.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.5 OUTLIER -95.36 -168.29 1.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.656 179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -56.7 -169.3 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.905 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.23 56.26 2.45 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.294 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.422 ' C ' HD23 ' A' ' 147' ' ' LEU . 58.0 Cg_endo -70.91 76.24 1.61 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.432 2.088 . . . . 0.0 112.232 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.1 OUTLIER 40.51 -93.69 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.684 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 59.41 92.4 0.04 OUTLIER 'General case' 0 C--O 1.248 1.021 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.007 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.789 0 O-C-N 123.51 0.506 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.772 0.32 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.95 -32.99 38.18 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.706 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 117' ' ' ALA . 0.5 OUTLIER -50.58 -26.02 4.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.79 0.329 . . . . 0.0 110.874 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -59.23 -29.39 67.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.898 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -32.16 66.74 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.896 0.379 . . . . 0.0 110.67 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.408 ' HB3' HD13 ' A' ' 100' ' ' LEU . 3.2 m-85 -65.09 -27.16 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.889 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.094 HD21 HD22 ' A' ' 100' ' ' LEU . 12.2 mt -114.13 167.56 9.36 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.939 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.768 ' CD ' ' HB2' ' A' ' 96' ' ' ALA . 52.2 Cg_exo -55.04 -166.53 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.643 2.229 . . . . 0.0 111.783 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.3 44.42 2.66 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.923 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.479 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 10.8 mt -56.43 94.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.93 0.395 . . . . 0.0 110.564 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' O ' HG23 ' A' ' 23' ' ' VAL . 51.9 mm-40 -59.02 -46.89 87.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.78 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -133.32 165.98 23.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 111.449 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 87' ' ' LEU . 72.5 mt -107.53 165.24 11.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.82 103.16 11.16 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.384 0.611 . . . . 0.0 110.987 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.724 ' CB ' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -105.51 -176.6 3.12 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.697 179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.42 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . -51.79 -87.96 0.01 OUTLIER Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.963 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -41.99 -33.93 0.63 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.85 0.357 . . . . 0.0 111.786 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.71 -142.19 7.35 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.419 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -105.1 151.05 24.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.806 0.336 . . . . 0.0 111.218 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.631 HG22 HD22 ' A' ' 87' ' ' LEU . 28.5 m -128.86 163.1 34.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -74.59 139.13 43.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.994 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.8 t -56.02 -27.74 23.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.141 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.55 -27.51 11.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.2 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.683 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 m -60.7 -17.0 45.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.683 HD23 ' C ' ' A' ' 25' ' ' SER . 1.8 mt -112.98 48.34 1.03 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.0 0.428 . . . . 0.0 110.352 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.72 88.41 2.74 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.848 0.832 . . . . 0.0 111.154 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.64 52.36 1.43 Allowed Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.927 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -152.67 174.72 13.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.724 0.297 . . . . 0.0 110.804 179.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 22.1 tp -97.52 118.98 35.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.522 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 64' ' ' GLU . 1.9 t -113.68 125.95 71.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.443 . . . . 0.0 111.437 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.538 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 34.4 m-85 -94.56 162.43 13.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 17.3 m-85 -131.79 106.4 8.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.048 0.451 . . . . 0.0 111.056 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 112' ' ' LEU . 35.7 t80 -96.38 108.96 21.56 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.636 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 7.8 m-85 -99.2 125.82 44.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.65 175.11 2.53 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.815 0.341 . . . . 0.0 111.131 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.68 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -130.67 136.82 49.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.783 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.41 ' HB2' ' CG ' ' A' ' 80' ' ' TYR . 11.6 t -53.16 -23.77 9.07 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.778 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.68 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 61.7 p-90 -82.05 1.21 36.84 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.7 148.25 41.25 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-O 120.709 0.29 . . . . 0.0 110.814 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 13.9 Cg_exo -67.65 -53.98 0.4 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 122.709 2.273 . . . . 0.0 114.275 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 50.0 Cg_exo -55.49 -65.54 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.087 1.858 . . . . 0.0 112.691 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.718 ' O ' HG22 ' A' ' 47' ' ' THR . 4.9 p -36.21 -33.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.146 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.02 -27.94 1.49 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.182 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.01 1.27 7.24 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.06 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -87.72 -38.54 15.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.952 0.376 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.812 HG23 ' HD3' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -43.16 -51.37 13.74 Favored Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.967 -179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.812 ' HD3' HG23 ' A' ' 47' ' ' THR . 57.9 Cg_endo -71.11 -1.86 10.21 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.223 1.948 . . . . 0.0 113.542 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -77.46 -35.44 53.83 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.891 0.376 . . . . 0.0 110.283 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.921 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.28 -49.0 75.75 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.312 0.577 . . . . 0.0 110.73 179.573 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' CD1' ' CZ3' ' A' ' 86' ' ' TRP . 2.3 mp -56.82 -33.88 42.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.262 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -68.6 -51.44 42.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.356 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -72.35 -29.95 64.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 0.0 110.393 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.495 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 10.6 t80 -78.03 -52.75 8.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.273 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -60.89 -26.55 67.51 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -93.68 -10.91 32.85 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -138.17 2.91 2.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' TYR . 42.9 p-80 -59.27 -29.48 67.61 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.488 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -70.53 -50.09 41.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.781 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 5.4 p -81.4 -36.23 29.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.379 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 10.3 mmpt? -81.1 -36.33 30.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.222 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 47.18 77.45 0.09 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.966 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.45 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -139.88 170.76 15.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.241 -179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.679 ' O ' HG13 ' A' ' 31' ' ' VAL . 1.4 tp10 -133.19 126.8 32.42 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.887 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.921 HG21 HD11 ' A' ' 50' ' ' LEU . 42.3 t -103.43 137.08 33.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.172 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 26.8 t -110.95 142.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.02 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.541 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.6 OUTLIER -98.08 135.61 39.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.289 0.566 . . . . 0.0 111.677 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 51.9 m -117.52 116.51 27.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.362 178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.796 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -84.28 156.65 21.85 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.275 0.559 . . . . 0.0 111.766 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.496 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 8.8 m95 -141.27 36.42 1.7 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -107.49 162.76 13.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.42 -17.82 15.08 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.014 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -105.1 115.1 29.7 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.844 0.354 . . . . 0.0 110.95 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -52.98 -51.74 60.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.245 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -55.81 -24.02 33.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.082 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.1 -56.0 4.57 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.399 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -35.66 79.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.407 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -68.57 -53.8 20.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 111.9 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.58 -14.4 9.36 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 178.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' HB2' ' A' ' 38' ' ' SER . 0.4 OUTLIER -103.5 -31.14 10.11 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.916 -0.642 . . . . 0.0 111.987 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.426 ' HD2' ' HE1' ' A' ' 84' ' ' MET . 0.0 OUTLIER -79.44 -12.58 59.89 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.88 -40.32 9.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.773 0.321 . . . . 0.0 111.486 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 84' ' ' MET . 7.9 ptpt -80.55 -119.96 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.768 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.516 ' HE3' ' HB2' ' A' ' 88' ' ' ALA . 4.6 ptm 33.78 104.47 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 51' ' ' ILE . 43.6 Cg_endo -67.48 -32.3 32.07 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.35 2.033 . . . . 0.0 111.676 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.542 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.8 p90 -55.38 162.19 1.62 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.417 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -83.91 157.18 22.04 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.255 -179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' A' ' 84' ' ' MET . . . -142.47 160.1 40.93 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.564 -178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.4 t -85.14 124.36 72.23 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.322 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.84 147.17 82.68 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.236 1.957 . . . . 0.0 111.786 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -47.94 -29.99 3.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.003 0.43 . . . . 0.0 110.601 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.92 -37.21 63.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.865 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.479 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 6.3 mm100 -115.32 24.44 11.63 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.652 0.263 . . . . 0.0 111.344 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.7 p -55.39 -24.79 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.885 0.374 . . . . 0.0 110.476 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -55.09 -30.04 58.85 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.265 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.865 ' HB1' HD22 ' A' ' 8' ' ' LEU . . . -56.13 -42.54 77.07 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.796 HG11 ' O ' ' A' ' 69' ' ' THR . 96.0 t -59.15 -33.13 49.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.472 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -71.83 -45.03 62.85 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.939 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -81.47 -38.92 25.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.789 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.094 HD22 HD21 ' A' ' 8' ' ' LEU . 27.4 tp -68.86 -27.91 66.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.014 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.4 p -67.74 -49.64 61.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.808 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -32.58 65.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -58.51 -30.48 67.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.039 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 113' ' ' ILE . 40.4 m-85 -99.76 5.65 45.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.41 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 53.14 37.81 25.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.787 0.327 . . . . 0.0 111.273 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 26.2 t -57.22 100.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.043 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.79 -47.4 77.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.855 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 69.0 m -165.45 150.35 8.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.009 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -81.92 158.5 67.53 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.327 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 2.5 Cg_endo -85.41 150.22 50.14 Favored 'Cis proline' 0 C--N 1.346 0.419 0 C-N-CA 123.971 -1.262 . . . . 0.0 112.319 0.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.77 166.5 22.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.576 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.613 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 4.2 tp -147.28 127.27 13.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.653 179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 125' ' ' THR . 33.0 mm -128.1 156.33 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.294 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -123.92 131.0 7.83 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.517 HG21 ' CZ ' ' A' ' 33' ' ' PHE . 10.5 m -133.28 156.12 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.765 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -96.58 121.2 38.15 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.638 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.461 ' HA ' HD22 ' A' ' 4' ' ' LEU . . . -60.49 -52.04 66.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.157 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.66 -55.89 28.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -61.97 -28.78 69.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.987 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 61.66 27.11 67.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.518 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -139.69 160.6 39.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 0.0 110.852 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.75 126.35 26.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.15 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.531 HG13 ' HE2' ' A' ' 143' ' ' LYS . 21.4 t -104.76 -32.52 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.326 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.78 148.69 27.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.327 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 113' ' ' ILE . 74.4 p -126.97 26.46 6.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.771 0.32 . . . . 0.0 111.496 -179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.437 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -135.02 46.17 2.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.001 0.429 . . . . 0.0 110.178 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.613 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -78.76 -3.72 45.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.715 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -85.61 -38.91 17.9 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.02 -39.99 17.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.818 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.451 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 71.9 p -66.68 -47.36 72.67 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.7 -35.61 55.86 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.556 -0.457 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -39.54 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.111 0.481 . . . . 0.0 111.695 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -99.51 23.59 9.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.531 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.451 ' CB ' ' O ' ' A' ' 130' ' ' THR . 4.7 t0 -145.17 74.9 14.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.304 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.22 17.49 1.71 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.878 2.385 . . . . 0.0 113.483 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -112.67 -25.66 9.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.805 0.336 . . . . 0.0 110.366 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.54 23.74 21.34 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.747 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 2.0 pt-20 -78.86 -14.47 59.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.553 0.216 . . . . 0.0 111.567 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.615 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -136.97 29.36 2.82 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.764 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.1 p90 -33.74 -44.71 0.52 Allowed Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.592 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 40.7 Cg_endo -66.23 4.93 0.78 Allowed 'Trans proline' 0 CA--C 1.533 0.434 0 CA-C-N 120.863 1.344 . . . . 0.0 110.957 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.764 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.7 OUTLIER 6.95 65.37 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.01 0.924 . . . . 0.0 112.634 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.531 ' HE2' HG13 ' A' ' 123' ' ' VAL . 5.9 mttm -80.4 130.05 34.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.074 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -101.32 133.13 46.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.85 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.964 ' HB1' ' HD2' ' A' ' 146' ' ' PRO . . . 48.15 179.44 0.01 OUTLIER Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.964 ' HD2' ' HB1' ' A' ' 145' ' ' ALA . 70.6 Cg_endo -76.29 112.64 3.52 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.219 1.946 . . . . 0.0 112.429 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD11 ' OE2' ' A' ' 148' ' ' GLU . 33.1 tp 62.19 -83.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.04 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' OE2' HD11 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -175.6 167.29 3.22 Favored 'General case' 0 C--O 1.249 1.072 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.911 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.809 0 O-C-N 123.502 0.501 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.837 0.351 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.45 -41.43 97.08 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.524 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.8 mp -59.42 -30.33 68.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.939 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.99 -28.52 64.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -82.1 -47.27 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.193 0.521 . . . . 0.0 110.437 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' O ' HD22 ' A' ' 8' ' ' LEU . 22.9 m-85 -53.94 -43.61 69.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.112 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -164.5 105.71 0.85 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.773 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.77 8.27 2.04 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.885 2.39 . . . . 0.0 113.25 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.76 -19.26 34.98 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.629 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 6.8 mt -79.91 100.7 4.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.79 0.328 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -115.9 -3.75 12.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.666 -179.742 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 165.19 30.91 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.047 0.451 . . . . 0.0 111.043 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.795 ' CD1' HD11 ' A' ' 26' ' ' LEU . 9.4 mt -118.13 165.58 13.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.93 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -102.02 101.87 12.31 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.644 0.735 . . . . 0.0 110.696 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.74 -164.28 1.07 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.595 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 -96.18 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -44.17 -34.22 1.78 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 111.54 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.75 -144.91 5.45 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.491 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -96.8 158.05 15.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.352 . . . . 0.0 110.95 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.533 HG21 HD21 ' A' ' 87' ' ' LEU . 33.0 m -125.49 163.12 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.266 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -67.09 132.43 47.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.377 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -57.67 -27.32 29.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.734 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.15 -27.37 8.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.005 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.782 ' C ' HD23 ' A' ' 26' ' ' LEU . 42.6 t -60.29 -19.08 53.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.959 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD11 ' CD1' ' A' ' 14' ' ' LEU . 0.7 OUTLIER -116.7 50.82 1.03 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.067 0.461 . . . . 0.0 110.027 179.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.8 92.55 4.09 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.819 0.819 . . . . 0.0 110.866 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.09 44.69 2.55 Favored Glycine 0 C--N 1.302 -1.341 0 CA-C-N 114.049 -1.432 . . . . 0.0 112.752 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 164.07 30.53 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.793 HD12 ' O ' ' A' ' 115' ' ' VAL . 57.8 tp -88.79 95.82 10.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.822 0.344 . . . . 0.0 110.176 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG1' HG23 ' A' ' 66' ' ' VAL . 3.5 t -89.1 128.39 41.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.204 0.526 . . . . 0.0 111.834 -179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.611 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 3.2 m-30 -106.62 158.59 16.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.084 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.446 ' CE2' HG22 ' A' ' 115' ' ' VAL . 2.3 m-85 -141.31 106.42 4.98 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.905 0.383 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.823 ' HB3' HD22 ' A' ' 112' ' ' LEU . 4.9 p90 -93.75 125.82 38.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.66 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 101' ' ' SER . 12.6 m-85 -96.36 128.48 43.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.411 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 5.7 p -174.35 172.48 3.2 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.749 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -135.81 143.14 45.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.994 0.426 . . . . 0.0 110.902 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.68 -29.99 62.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.776 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -114.16 33.89 5.0 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.498 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 2.2 p -81.99 173.45 7.61 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.499 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.616 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.9 Cg_exo -67.23 -58.96 0.12 Allowed 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.023 1.816 . . . . 0.0 112.787 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 11.5 Cg_exo -70.68 -74.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.072 1.848 . . . . 0.0 113.431 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 14.16 77.94 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 121.226 0.536 . . . . 0.0 112.335 -178.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.04 30.42 3.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.573 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 149.11 -147.59 18.15 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.215 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.595 ' CE1' HD23 ' A' ' 112' ' ' LEU . 0.2 OUTLIER 76.17 -54.09 0.6 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.63 0.252 . . . . 0.0 111.503 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD3' ' A' ' 48' ' ' PRO . 1.4 p -48.46 -43.92 62.91 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.432 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' OG1' ' A' ' 47' ' ' THR . 85.3 Cg_endo -83.2 -8.03 10.88 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.089 1.859 . . . . 0.0 112.636 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -77.67 -40.33 41.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 110.248 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.898 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -59.54 -49.16 78.86 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.205 0.526 . . . . 0.0 111.003 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.451 HD11 ' CE3' ' A' ' 86' ' ' TRP . 1.1 mp -59.91 -34.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.773 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.36 -51.03 32.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.795 0.331 . . . . 0.0 110.762 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -71.07 -27.79 63.88 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.675 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 58' ' ' HIS . 22.8 t80 -83.67 -50.08 8.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.61 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -55.87 -26.7 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 mmmm -87.39 -12.82 45.12 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.42 ' CE1' ' HB3' ' A' ' 60' ' ' SER . 1.1 t80 -136.82 2.95 2.67 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 54' ' ' TYR . 28.0 p-80 -54.87 -36.17 64.82 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.25 -50.93 68.22 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 57' ' ' PHE . 35.2 t -73.31 -47.28 43.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.099 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE2' ' A' ' 140' ' ' PHE . 24.6 mtpt -81.28 -30.92 33.87 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER 46.34 71.81 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.806 0.336 . . . . 0.0 111.629 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CG ' ' HB3' ' A' ' 30' ' ' LEU . 21.0 m-85 -131.53 170.98 13.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.598 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -135.83 139.59 43.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.265 0.555 . . . . 0.0 110.735 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 50' ' ' LEU . 86.0 t -110.3 116.27 51.91 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.614 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 87' ' ' LEU . 22.0 t -90.63 147.32 5.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.75 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.637 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.4 OUTLIER -90.37 126.39 35.86 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.033 0.444 . . . . 0.0 111.564 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -112.81 111.75 22.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.477 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.859 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.4 t -77.95 165.08 24.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.287 0.565 . . . . 0.0 111.859 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.404 ' HB3' HD12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -150.35 40.55 0.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.506 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.749 ' OD2' ' HB1' ' A' ' 37' ' ' ALA . 4.1 m-20 -107.6 176.95 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.021 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -105.39 -29.41 10.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.792 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -103.03 150.87 23.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.45 ' HG2' ' CD2' ' A' ' 91' ' ' PHE . 20.5 mt-10 -73.03 -41.09 64.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.85 -24.1 48.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.289 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -72.39 -56.24 6.32 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.702 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.81 -41.6 87.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.883 0.373 . . . . 0.0 111.091 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' C ' ' N ' ' A' ' 80' ' ' TYR . . . -56.97 -53.5 57.36 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.69 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.65 -14.42 9.55 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.403 ' N ' ' C ' ' A' ' 78' ' ' ALA . 1.3 t80 -97.26 -36.83 10.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.745 -0.728 . . . . 0.0 111.342 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.39 -13.01 59.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.322 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.06 61.96 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.806 0.336 . . . . 0.0 111.438 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 84' ' ' MET . 0.6 OUTLIER -96.86 -158.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.647 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.478 ' HG3' ' CZ2' ' A' ' 86' ' ' TRP . 11.9 mmt 43.0 101.75 0.03 OUTLIER Pre-proline 0 CA--C 1.536 0.44 0 CA-C-O 120.82 0.343 . . . . 0.0 111.79 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 84' ' ' MET . 19.1 Cg_endo -60.48 -14.43 30.46 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.797 2.331 . . . . 0.0 113.873 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.641 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.7 OUTLIER -54.11 159.52 1.82 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.988 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 66' ' ' VAL . 4.1 mt -84.6 141.01 30.97 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.2 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.637 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -127.42 155.98 42.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.883 0.373 . . . . 0.0 111.627 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 48.7 t -78.23 130.62 71.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.853 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.83 149.97 78.43 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.377 2.051 . . . . 0.0 111.731 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -47.98 -29.89 3.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.936 0.398 . . . . 0.0 110.651 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.12 59.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.767 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.405 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 8.2 mm100 -111.08 22.8 14.87 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.657 0.265 . . . . 0.0 111.095 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -63.09 -29.47 70.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.77 0.319 . . . . 0.0 110.532 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -55.2 -34.12 63.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.4 96.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.557 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.859 HG11 ' O ' ' A' ' 69' ' ' THR . 95.7 t -57.76 -33.85 46.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.445 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -65.28 -55.59 17.5 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.319 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -81.64 -32.43 31.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.348 -178.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD11 ' CE2' ' A' ' 104' ' ' PHE . 12.9 tp -69.82 -27.74 65.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.759 0.314 . . . . 0.0 110.628 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 106' ' ' VAL . 67.5 p -63.71 -50.11 70.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.847 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -36.15 79.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.096 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 m170 -67.49 -27.25 66.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.08 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.678 ' HE1' HG22 ' A' ' 122' ' ' VAL . 6.9 m-85 -93.09 18.16 9.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.37 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.6 t30 54.12 66.61 1.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.901 0.381 . . . . 0.0 111.328 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.723 HG13 HG21 ' A' ' 111' ' ' THR . 25.0 t -108.27 96.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.978 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -57.27 -43.0 82.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 26.9 p -176.18 151.09 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.999 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.37 155.4 69.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.051 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.0 Cg_endo -74.91 142.49 74.9 Favored 'Cis proline' 0 C--N 1.349 0.557 0 C-N-CA 123.436 -1.485 . . . . 0.0 112.497 0.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.723 HG21 HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -130.34 170.99 13.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.859 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -146.98 120.96 9.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.344 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.623 HG23 HG22 ' A' ' 125' ' ' THR . 18.0 mm -124.35 147.09 28.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 0.0 111.283 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.611 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -127.15 133.47 7.98 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.884 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.793 ' O ' HD12 ' A' ' 30' ' ' LEU . 16.1 m -133.29 163.14 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.981 0.42 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.56 ' OD2' HG22 ' A' ' 123' ' ' VAL . 2.1 p30 -106.78 110.47 22.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.746 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.06 92.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.265 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -56.07 -63.0 1.32 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -66.11 -43.94 85.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.023 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.61 38.93 7.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -144.56 161.69 38.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.726 0.298 . . . . 0.0 110.906 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.678 HG22 ' HE1' ' A' ' 104' ' ' PHE . 13.6 t -71.69 131.81 34.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.821 HG12 ' O ' ' A' ' 141' ' ' PRO . 2.7 t -109.08 -39.02 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.243 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.03 146.01 29.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.623 HG22 HG23 ' A' ' 113' ' ' ILE . 37.4 p -143.34 45.82 1.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.765 0.317 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.677 ' NH1' HG21 ' A' ' 130' ' ' THR . 1.7 ppt_? -177.82 63.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.909 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.859 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -87.0 -3.03 59.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.936 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.47 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.24 -54.98 17.3 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.877 179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.29 -50.62 7.2 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.677 HG21 ' NH1' ' A' ' 126' ' ' ARG . 61.9 p -57.35 -52.24 66.16 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.65 ' HB2' ' HB1' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -52.51 -32.86 42.38 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.39 -0.524 . . . . 0.0 111.337 -179.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -39.98 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 CA-C-O 121.185 0.517 . . . . 0.0 111.446 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -95.37 18.74 11.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.138 -177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 135' ' ' PRO . 8.6 t0 -137.68 56.13 10.85 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.342 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 134' ' ' ASP . 68.1 Cg_endo -86.35 20.01 1.3 Allowed 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 122.785 2.323 . . . . 0.0 112.633 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.57 -36.37 9.19 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.79 0.329 . . . . 0.0 110.288 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.1 31.34 14.71 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.322 -0.942 . . . . 0.0 111.284 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -73.63 -45.68 51.41 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.627 -0.287 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.695 ' O ' ' N ' ' A' ' 142' ' ' TRP . 2.1 mt-30 -145.97 24.15 1.34 Allowed 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.808 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 t80 -26.11 -53.09 0.19 Allowed Pre-proline 0 N--CA 1.474 0.774 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.821 ' O ' HG12 ' A' ' 123' ' ' VAL . 18.0 Cg_endo -60.19 5.44 0.13 Allowed 'Trans proline' 0 CA--C 1.535 0.56 0 CA-C-N 119.871 0.99 . . . . 0.0 111.383 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.808 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 5.72 65.31 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.182 0.993 . . . . 0.0 112.626 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.444 ' N ' ' O ' ' A' ' 141' ' ' PRO . 3.5 mtmt -57.26 175.74 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.051 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -109.15 167.76 9.87 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.738 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -73.73 -61.76 1.28 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.738 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 56.8 Cg_endo -70.94 167.42 26.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.535 2.157 . . . . 0.0 112.274 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 148' ' ' GLU . 0.5 OUTLIER -93.79 159.24 15.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.845 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.425 ' H ' HD23 ' A' ' 147' ' ' LEU . 3.3 mt-10 -141.84 162.39 35.59 Favored 'General case' 0 C--O 1.25 1.104 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.781 0 O-C-N 123.526 0.516 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.805 0.336 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.46 -37.92 79.35 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.538 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.792 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -52.2 -29.45 22.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.864 0.364 . . . . 0.0 111.144 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -67.67 -46.96 70.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttp -78.71 -36.88 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' OH ' HG23 ' A' ' 122' ' ' VAL . 2.7 m-85 -75.31 -36.67 61.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.665 ' HG ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -128.41 76.04 78.67 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.805 179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.29 163.71 37.7 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.823 2.349 . . . . 0.0 112.187 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.2 45.77 92.31 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.66 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.566 HG13 HD22 ' A' ' 8' ' ' LEU . 17.0 mm -126.27 105.12 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.81 0.338 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.7 mm-40 -94.1 -50.36 5.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -141.83 166.07 25.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.788 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.601 HD13 HD22 ' A' ' 87' ' ' LEU . 4.9 mt -109.04 165.26 11.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -78.84 -4.68 50.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.598 ' CG ' HG22 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 18.81 54.79 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 51.79 -106.34 0.32 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.104 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.56 -68.16 0.19 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.043 0.449 . . . . 0.0 111.12 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -117.46 -162.26 12.45 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.271 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 17.9 pt-20 -114.59 151.37 33.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.757 0.313 . . . . 0.0 111.617 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.598 HG22 ' CG ' ' A' ' 16' ' ' ARG . 6.9 m -128.12 146.23 34.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.962 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.96 135.45 52.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.134 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.3 t -55.83 -28.03 23.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.732 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.8 -27.32 11.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.083 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' C ' HD23 ' A' ' 26' ' ' LEU . 9.8 t -60.4 -16.75 38.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.406 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.609 HD23 ' C ' ' A' ' 25' ' ' SER . 3.3 mt -108.76 47.03 0.93 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.123 0.487 . . . . 0.0 110.067 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -107.07 88.54 2.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 121.82 0.819 . . . . 0.0 111.077 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.94 54.26 1.22 Allowed Glycine 0 C--N 1.303 -1.303 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.099 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.34 -174.26 4.54 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.468 ' HB3' ' CG ' ' A' ' 63' ' ' PHE . 16.3 tp -106.93 96.23 6.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.818 0.342 . . . . 0.0 110.109 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 ' O ' ' CE1' ' A' ' 33' ' ' PHE . 4.6 t -85.69 112.67 22.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' ' HA3' ' A' ' 114' ' ' GLY . 4.2 m-30 -94.1 155.89 16.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.651 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.708 ' CE1' HG22 ' A' ' 115' ' ' VAL . 0.3 OUTLIER -139.43 106.14 5.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.398 179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.706 ' CB ' HD22 ' A' ' 112' ' ' LEU . 5.8 p90 -93.41 114.96 27.5 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.977 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.1 m-85 -90.0 129.63 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.025 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.4 t -174.57 162.29 3.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.802 0.334 . . . . 0.0 111.046 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -128.36 168.29 15.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.641 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.21 12.27 31.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.803 0.335 . . . . 0.0 110.646 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 50.2 p-90 -120.62 -26.46 5.31 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.415 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.5 p -51.47 149.82 7.33 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.741 0.305 . . . . 0.0 110.96 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -56.74 -52.07 7.67 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.341 2.027 . . . . 0.0 112.385 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 61.3 Cg_endo -73.86 -107.09 0.01 OUTLIER 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.179 1.919 . . . . 0.0 111.788 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.8 OUTLIER 33.08 86.07 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 120.963 0.411 . . . . 0.0 111.86 179.352 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 176.28 -36.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.9 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.2 -70.1 1.32 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.803 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 49' ' ' GLN . 17.4 t80 -62.44 -88.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.936 -0.155 . . . . 0.0 111.139 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.544 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER 14.08 -76.51 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.577 ' CA ' HD12 ' A' ' 51' ' ' ILE . 88.4 Cg_endo -75.8 12.51 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.448 2.099 . . . . 0.0 114.071 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 46' ' ' PHE . 10.5 tp60 -77.22 -29.76 54.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.929 0.395 . . . . 0.0 110.992 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -74.06 -25.29 59.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.212 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.577 HD12 ' CA ' ' A' ' 48' ' ' PRO . 13.3 mt -50.77 -42.35 22.74 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.796 0.331 . . . . 0.0 110.66 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -62.78 -51.07 68.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.778 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -65.8 -32.03 73.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.496 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.6 ' CE1' HG23 ' A' ' 65' ' ' VAL . 70.2 t80 -75.13 -56.53 4.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.3 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -56.04 -26.52 49.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.916 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -90.16 -12.9 36.84 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' C ' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -133.77 2.88 3.47 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.462 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 24.9 p-80 -57.35 -49.93 74.59 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.751 0.31 . . . . 0.0 111.46 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.457 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 0.2 OUTLIER -62.29 -50.94 69.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.791 -179.475 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 75.1 m -55.81 -72.66 0.07 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.686 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.478 ' HB3' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -69.24 -10.85 59.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.945 -179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 14.6 t30 48.77 68.9 0.63 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.756 0.312 . . . . 0.0 111.521 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 61' ' ' LYS . 22.9 m-30 -121.79 170.89 9.31 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.792 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.0 tp10 -141.69 139.72 33.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 121.212 0.53 . . . . 0.0 110.461 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' CE1' ' A' ' 54' ' ' TYR . 59.6 t -112.51 123.79 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 32.2 t -101.7 140.7 19.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.574 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' CD2' ' HE3' ' A' ' 83' ' ' LYS . 2.1 t80 -84.47 132.33 34.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.153 0.502 . . . . 0.0 111.649 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 6.4 m -120.01 107.46 13.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.281 178.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.708 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.79 158.92 30.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.289 0.566 . . . . 0.0 111.709 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.444 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.3 m95 -142.81 36.09 1.42 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.745 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -96.87 176.68 5.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.3 pm0 -108.52 -28.91 9.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.848 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -117.25 159.2 23.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 91' ' ' PHE . 13.9 mt-10 -73.07 -25.8 61.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.143 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -55.8 -43.04 76.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.289 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -63.78 -56.19 20.4 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.472 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -51.89 -26.73 10.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.756 0.313 . . . . 0.0 111.167 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.33 -54.28 6.66 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.052 0.453 . . . . 0.0 111.633 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.15 -14.8 69.01 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 7.9 t80 -85.49 -5.98 59.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.511 -0.845 . . . . 0.0 111.54 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -52.93 -23.74 7.81 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.49 -24.73 5.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.707 0.289 . . . . 0.0 111.654 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.502 ' HE3' ' CD2' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -54.56 -170.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.432 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.546 ' HG3' HD11 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -69.54 116.16 40.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.322 179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 86' ' ' TRP . 72.7 Cg_endo -79.62 -8.59 14.76 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.695 2.263 . . . . 0.0 114.896 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.547 ' HD1' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -30.57 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD12 ' HG2' ' A' ' 64' ' ' GLU . 6.5 mt -139.49 138.14 36.12 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.09 152.17 35.72 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.7 t -89.14 120.9 69.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.314 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -57.55 150.37 60.95 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.201 1.934 . . . . 0.0 111.939 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.433 ' CZ ' ' HG2' ' A' ' 74' ' ' GLU . 0.2 OUTLIER -47.86 -29.17 3.05 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 0.0 110.918 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.89 -37.19 51.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.923 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 -115.64 21.92 13.55 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 111.587 0.217 . . . . 0.0 111.587 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.9 p -56.35 -23.93 40.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.633 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -56.11 -30.77 62.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.44 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -59.81 -43.5 94.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.708 HG11 ' O ' ' A' ' 69' ' ' THR . 99.0 t -57.59 -32.62 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.343 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -55.27 22.23 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.001 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -81.42 -34.76 31.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.142 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.665 HD22 ' HG ' ' A' ' 8' ' ' LEU . 25.3 tp -69.67 -27.89 65.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.779 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.557 ' O ' HG23 ' A' ' 106' ' ' VAL . 64.4 p -71.44 -48.93 46.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.825 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.59 -31.16 71.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.934 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -59.64 -29.49 68.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.998 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.54 ' HE1' HG22 ' A' ' 122' ' ' VAL . 21.8 m-85 -90.69 10.88 24.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.33 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 52.48 34.31 15.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.747 0.308 . . . . 0.0 111.182 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 101' ' ' SER . 22.0 t -58.86 109.28 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.087 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -57.95 -53.97 52.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.733 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.4 m -166.53 150.44 7.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.35 157.85 67.3 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.306 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.3 Cg_exo -79.11 162.66 86.56 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.837 -1.318 . . . . 0.0 112.118 0.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.789 HG22 ' HB2' ' A' ' 35' ' ' PHE . 4.2 t -151.59 -179.87 7.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.12 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.706 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -147.39 122.96 10.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.014 179.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG21 ' CD2' ' A' ' 104' ' ' PHE . 22.8 mm -123.01 151.45 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.737 0.303 . . . . 0.0 111.523 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -138.02 133.26 6.25 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.35 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.708 HG22 ' CE1' ' A' ' 33' ' ' PHE . 15.2 m -133.1 163.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 121.049 0.452 . . . . 0.0 110.845 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.496 ' CG ' HG21 ' A' ' 123' ' ' VAL . 26.2 m-20 -102.15 115.08 29.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.825 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.605 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -74.63 -34.72 62.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.55 -63.1 1.31 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.262 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 37.3 p -88.36 -44.05 11.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.109 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.88 -166.54 12.16 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.461 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 58.73 163.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.819 0.342 . . . . 0.0 110.882 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.54 HG22 ' HE1' ' A' ' 104' ' ' PHE . 10.9 t -72.35 147.97 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.13 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.519 HG23 ' HA ' ' A' ' 115' ' ' VAL . 25.0 t -114.86 -38.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.867 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.12 148.51 23.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.786 0.327 . . . . 0.0 110.415 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.416 ' O ' HD13 ' A' ' 113' ' ' ILE . 66.8 p -123.88 -52.16 1.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.78 45.42 0.51 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 0.0 111.278 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.56 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.2 -23.1 64.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.289 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.491 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.2 OUTLIER -55.04 -39.66 69.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.803 0.335 . . . . 0.0 110.487 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.781 ' HB1' ' CE ' ' A' ' 133' ' ' LYS . . . -85.0 -58.12 2.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.957 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.56 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.94 -48.14 64.41 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.735 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.446 HD21 ' HA ' ' A' ' 50' ' ' LEU . 4.2 tt -52.44 -33.65 45.12 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.005 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.65 -38.64 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-O 121.052 0.454 . . . . 0.0 111.716 179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.781 ' CE ' ' HB1' ' A' ' 129' ' ' ALA . 5.6 mtmp? -98.39 19.01 15.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.87 -177.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 130' ' ' THR . 4.6 m-20 -128.31 72.03 79.91 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.5 12.81 2.61 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.731 2.287 . . . . 0.0 113.098 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.419 ' HB2' ' HG3' ' A' ' 138' ' ' GLU . 0.2 OUTLIER -102.88 -24.54 13.68 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.832 0.349 . . . . 0.0 110.231 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 51.22 26.36 13.08 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.666 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 136' ' ' GLU . 74.5 mt-10 -84.26 -26.27 28.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.06 0.457 . . . . 0.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.647 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.4 mt-30 -127.45 32.43 5.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.548 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.771 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 16.7 p90 -35.56 -42.99 0.66 Allowed Pre-proline 0 C--N 1.33 -0.275 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 36.8 Cg_endo -64.64 4.12 0.71 Allowed 'Trans proline' 0 CA--C 1.533 0.425 0 CA-C-N 120.556 1.234 . . . . 0.0 111.178 177.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.771 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 6.95 68.99 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.967 0.907 . . . . 0.0 112.41 -179.622 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -43.67 166.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.417 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.77 125.1 22.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.049 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.886 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -104.37 -65.0 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.886 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 97.1 Cg_endo -79.29 76.96 4.27 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.328 2.019 . . . . 0.0 112.394 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 147' ' ' LEU . 1.0 OUTLIER -95.99 140.61 30.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.893 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -81.95 -13.31 57.66 Favored 'General case' 0 C--O 1.25 1.103 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.817 0 O-C-N 123.542 0.526 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.826 0.346 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -59.03 -24.55 58.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.563 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 HG21 ' A' ' 115' ' ' VAL . 12.9 mt -54.28 -24.82 20.39 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.745 0.307 . . . . 0.0 110.997 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.11 -41.75 88.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.909 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.78 -28.13 55.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.61 ' OH ' HG23 ' A' ' 122' ' ' VAL . 8.5 m-85 -64.1 -30.7 71.75 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.849 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD23 ' HB1' ' A' ' 96' ' ' ALA . 4.0 mp -123.11 169.32 10.22 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.696 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.611 ' CD ' ' HB2' ' A' ' 96' ' ' ALA . 12.5 Cg_exo -70.94 9.06 0.86 Allowed 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.931 2.421 . . . . 0.0 113.472 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.13 82.12 1.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.673 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.595 HG13 HD22 ' A' ' 8' ' ' LEU . 14.9 mm -87.82 104.37 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.3 tp10 -62.78 -64.72 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.174 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -143.21 166.18 25.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.984 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.734 ' HB2' HD22 ' A' ' 87' ' ' LEU . 11.1 mt -108.6 165.29 11.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.847 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -103.92 102.61 12.4 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.59 0.709 . . . . 0.0 110.569 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.635 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt-85 -90.92 44.5 1.2 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.632 -1.167 . . . . 0.0 111.125 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.36 111.16 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.343 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.3 t70 68.23 -53.94 0.53 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.813 0.34 . . . . 0.0 111.801 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -112.16 145.39 17.94 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.306 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -97.04 151.85 19.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.856 0.36 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.928 ' CG2' HD21 ' A' ' 87' ' ' LEU . 30.4 m -122.86 133.01 70.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.9 mp0 -60.3 144.98 49.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -56.06 -28.04 24.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.067 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.9 -27.66 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.287 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.641 ' C ' HD23 ' A' ' 26' ' ' LEU . 41.8 t -60.57 -17.86 49.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.239 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 25' ' ' SER . 3.2 mt -109.58 47.74 0.92 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.199 0.524 . . . . 0.0 110.185 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -100.91 84.42 2.69 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 121.988 0.899 . . . . 0.0 111.178 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.71 53.15 1.33 Allowed Glycine 0 C--N 1.304 -1.231 0 CA-C-N 113.952 -1.476 . . . . 0.0 113.155 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.59 170.9 15.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.673 0.273 . . . . 0.0 110.626 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 63' ' ' PHE . 29.3 tp -97.48 94.11 6.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.791 0.329 . . . . 0.0 110.359 179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.64 117.32 30.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.964 0.412 . . . . 0.0 111.321 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -89.68 151.24 21.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.533 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.682 ' CE2' HG21 ' A' ' 66' ' ' VAL . 46.6 m-85 -141.84 106.87 4.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.797 0.332 . . . . 0.0 111.156 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.502 ' HB3' HD13 ' A' ' 112' ' ' LEU . 22.4 p90 -101.94 123.92 46.69 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.952 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.48 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 1.2 m-30 -95.23 129.92 42.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.724 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -174.18 165.83 4.13 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.044 0.45 . . . . 0.0 111.307 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.74 ' HB1' ' OD1' ' A' ' 71' ' ' ASP . . . -131.35 169.03 16.56 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.247 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 31.5 p -80.73 -38.76 28.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.626 0.25 . . . . 0.0 111.426 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -89.77 2.5 54.8 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 15.1 p -52.22 154.94 3.74 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 120.635 0.255 . . . . 0.0 110.991 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.496 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 31.5 Cg_exo -56.65 -51.11 9.82 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.561 2.174 . . . . 0.0 113.17 -178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 6.1 Cg_exo -73.76 -69.75 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.253 1.968 . . . . 0.0 111.346 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 40' ' ' CYS . 60.6 m 43.26 35.2 0.81 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.119 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.0 ttp85 -71.01 59.78 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.422 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 38.84 38.97 0.79 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.836 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.657 ' O ' HG23 ' A' ' 47' ' ' THR . 2.7 t80 -80.75 101.12 9.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.92 0.36 . . . . 0.0 110.548 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER 176.87 -58.17 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.673 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 9.2 Cg_endo -52.36 -15.66 4.13 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.802 2.335 . . . . 0.0 113.082 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.43 -40.97 56.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.66 ' HG ' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.95 -49.06 79.29 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.005 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' A' ' 55' ' ' ASP . 1.0 OUTLIER -60.44 -33.92 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.687 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -71.6 -51.19 24.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.784 0.326 . . . . 0.0 110.581 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -67.09 -31.5 72.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.029 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.539 ' O ' ' N ' ' A' ' 58' ' ' HIS . 9.8 t80 -81.0 -57.39 3.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.496 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' CB ' ' O ' ' A' ' 51' ' ' ILE . 23.9 t70 -57.48 -26.6 61.52 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -91.29 -14.85 30.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -135.77 3.34 2.97 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' TYR . 40.0 p-80 -50.85 -23.89 3.13 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.83 -47.84 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.6 t -82.6 -36.19 26.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.744 0.307 . . . . 0.0 111.508 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.1 -36.34 23.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.534 -179.444 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 41.07 66.27 0.68 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE1' ' CD1' ' A' ' 54' ' ' TYR . 6.0 p90 -125.29 170.77 10.98 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.906 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.652 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -128.54 124.64 36.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.052 0.454 . . . . 0.0 110.846 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.66 HG11 ' HG ' ' A' ' 50' ' ' LEU . 14.1 t -101.1 119.11 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.695 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 33' ' ' PHE . 31.5 t -90.82 147.29 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.918 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.471 ' CD2' ' HD3' ' A' ' 83' ' ' LYS . 2.6 t80 -96.83 96.95 8.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.896 0.379 . . . . 0.0 111.001 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.3 m -93.57 110.69 22.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.974 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.841 ' O ' HG11 ' A' ' 97' ' ' VAL . 11.1 t -74.72 164.53 26.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.638 -179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.593 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.42 38.79 1.05 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.666 179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.74 ' OD1' ' HB1' ' A' ' 37' ' ' ALA . 21.6 m-20 -99.19 121.3 40.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.975 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.6 -28.0 69.05 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.583 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -119.84 168.25 11.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -73.01 -25.89 61.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.222 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -55.72 -43.03 76.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.269 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.0 -55.95 18.95 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.511 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -54.12 -26.84 29.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.831 0.348 . . . . 0.0 111.134 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.87 -53.61 6.9 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.578 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.14 -14.59 40.28 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.432 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.8 OUTLIER -95.96 -3.49 45.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.555 -0.823 . . . . 0.0 111.568 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -26.34 2.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.68 -9.88 31.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.487 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HD3' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -48.96 -176.31 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.232 0.539 . . . . 0.0 112.034 -179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.673 ' HE1' ' HA ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -75.22 142.2 75.07 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.246 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -89.43 -12.56 3.11 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.925 2.417 . . . . 0.0 114.605 -178.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.568 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -32.91 -84.93 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.928 HD21 ' CG2' ' A' ' 21' ' ' VAL . 7.2 mt -139.8 137.75 35.26 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 118.635 0.652 . . . . 0.0 109.451 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -148.25 159.97 43.43 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.6 t -97.26 122.4 56.06 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.272 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -55.14 147.12 55.75 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.153 1.902 . . . . 0.0 111.668 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -47.79 -29.09 2.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.917 0.389 . . . . 0.0 110.742 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.2 -37.15 61.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.972 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.426 ' OE1' HD13 ' A' ' 11' ' ' ILE . 2.1 mt-30 -112.74 22.52 14.43 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.619 0.247 . . . . 0.0 111.409 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.0 p -59.92 -27.75 67.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.805 0.336 . . . . 0.0 110.368 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.74 -41.6 67.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.176 0.512 . . . . 0.0 110.654 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.723 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -52.7 -39.99 62.52 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.059 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.841 HG11 ' O ' ' A' ' 69' ' ' THR . 94.3 t -57.45 -34.49 46.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.265 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -67.29 -55.33 14.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.216 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HG3' ' N ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -74.85 -32.9 62.03 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.797 -1.092 . . . . 0.0 111.892 -179.032 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 15.5 tp -55.56 -32.59 63.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.895 0.379 . . . . 0.0 110.282 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.6 p -68.79 -33.23 73.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.987 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -30.23 64.84 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.016 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -80.02 -31.07 39.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.036 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.512 ' CE1' HG21 ' A' ' 113' ' ' ILE . 26.0 m-85 -92.9 11.17 28.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.321 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.0 p30 44.39 37.79 2.21 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 120.852 0.358 . . . . 0.0 111.511 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 35' ' ' PHE . 21.6 t -58.43 101.96 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.052 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -55.64 -50.15 70.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.739 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 58.7 m -167.87 150.76 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.556 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.41 157.23 73.02 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.206 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 71.6 Cg_endo -76.0 157.58 98.35 Favored 'Cis proline' 0 C--N 1.347 0.469 0 C-N-CA 123.438 -1.484 . . . . 0.0 112.582 0.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.444 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.0 OUTLIER -141.99 167.81 21.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.421 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.689 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 3.6 tp -147.25 128.5 14.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.422 -0.353 . . . . 0.0 110.532 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.585 ' N ' HD12 ' A' ' 112' ' ' LEU . 10.9 mm -131.57 149.98 33.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.914 0.388 . . . . 0.0 111.496 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -127.42 129.24 6.39 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.975 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.704 HG21 HD21 ' A' ' 4' ' ' LEU . 24.6 m -133.14 163.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-O 121.148 0.499 . . . . 0.0 111.061 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -104.68 114.73 29.13 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.651 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.7 -34.87 73.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.155 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.26 -63.05 1.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.076 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -68.17 -44.02 76.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.32 -47.89 1.16 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.543 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -59.32 173.22 0.52 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.61 HG23 ' OH ' ' A' ' 7' ' ' TYR . 22.1 t -80.99 135.58 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.144 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 16.1 t -104.79 -26.07 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.517 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.17 158.18 27.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.282 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.531 ' O ' HD13 ' A' ' 113' ' ' ILE . 45.2 p -130.08 -53.19 1.12 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.6 48.09 0.19 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.056 0.455 . . . . 0.0 110.666 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -72.5 -6.55 44.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.874 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.474 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.7 tmm_? -77.28 -36.3 54.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.821 0.343 . . . . 0.0 110.252 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 -46.33 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.127 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 134' ' ' ASP . 75.8 p -58.43 -53.06 62.56 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.498 HD22 HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.64 -32.4 41.73 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.576 -0.449 . . . . 0.0 111.459 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.81 -39.68 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.265 0.555 . . . . 0.0 111.265 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -97.33 21.7 9.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.914 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.428 ' N ' ' O ' ' A' ' 130' ' ' THR . 8.4 t70 -147.58 60.69 5.64 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.199 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -83.76 17.85 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.821 2.347 . . . . 0.0 112.983 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -101.79 -30.96 10.99 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 110.256 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.25 31.35 42.56 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.623 -0.798 . . . . 0.0 111.683 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -77.61 -36.37 51.85 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.768 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 3.2 mm-40 -143.27 39.29 1.43 Allowed 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.274 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.734 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.4 p90 -40.13 -40.87 1.99 Allowed Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.1 Cg_endo -70.47 7.46 1.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 CA-C-N 120.545 1.23 . . . . 0.0 110.663 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.768 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.9 OUTLIER 6.86 66.01 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.151 0.98 . . . . 0.0 112.386 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.512 ' O ' ' O ' ' A' ' 144' ' ' ASP . 3.3 ptpt -62.95 -176.07 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.399 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.512 ' O ' ' O ' ' A' ' 143' ' ' LYS . 11.0 t0 49.16 159.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.511 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.55 64.45 6.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.009 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -82.96 12.99 2.76 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.742 2.295 . . . . 0.0 113.031 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.581 HD12 ' HG2' ' A' ' 148' ' ' GLU . 0.1 OUTLIER -131.49 118.6 20.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.826 0.346 . . . . 0.0 110.842 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.581 ' HG2' HD12 ' A' ' 147' ' ' LEU . 2.9 mm-40 61.88 169.22 0.11 Allowed 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.89 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.792 0 O-C-N 123.528 0.517 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.766 0.317 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.03 -35.65 79.11 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.608 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.708 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mt -49.94 -25.89 3.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.881 0.372 . . . . 0.0 110.628 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.47 -30.68 63.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.639 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -25.24 12.55 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.868 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.967 ' CZ ' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -52.58 -68.92 0.13 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.678 179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.727 HD13 ' HB2' ' A' ' 96' ' ' ALA . 0.9 OUTLIER -172.57 93.36 0.38 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.616 0.246 . . . . 0.0 111.388 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -56.66 111.37 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.381 2.054 . . . . 0.0 112.016 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.25 -35.31 1.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.342 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.6 mt -67.78 84.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.842 0.353 . . . . 0.0 110.462 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.762 ' O ' HG23 ' A' ' 23' ' ' VAL . 18.5 mt-10 -83.91 -18.98 35.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.834 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -129.7 163.52 25.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 87' ' ' LEU . 0.4 OUTLIER -116.62 165.39 13.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.643 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 16' ' ' ARG . 17.6 ttp180 -73.05 -7.87 53.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.917 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.667 ' HG3' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER 23.87 47.12 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.049 0.54 . . . . 0.0 112.332 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 15' ' ' ARG . . . 48.65 -115.43 2.56 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.462 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -51.13 -58.62 5.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.859 0.361 . . . . 0.0 111.59 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 15' ' ' ARG . . . -106.85 -151.44 18.2 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.512 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HA ' ' HB2' ' A' ' 16' ' ' ARG . 0.3 OUTLIER -142.05 151.49 42.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.143 -179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.667 HG13 ' HG3' ' A' ' 16' ' ' ARG . 29.2 m -142.57 163.14 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.337 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 153.0 43.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.9 t -73.52 -27.32 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.644 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.99 -27.11 7.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.987 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.698 ' C ' HD23 ' A' ' 26' ' ' LEU . 35.4 t -60.32 -17.25 41.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.948 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.698 HD23 ' C ' ' A' ' 25' ' ' SER . 0.8 OUTLIER -114.66 50.58 0.95 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.148 0.499 . . . . 0.0 109.686 179.159 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 89.98 3.3 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 121.978 0.894 . . . . 0.0 111.118 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.93 52.09 1.43 Allowed Glycine 0 C--N 1.302 -1.309 0 CA-C-N 113.885 -1.507 . . . . 0.0 112.816 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.29 160.92 40.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.686 0.279 . . . . 0.0 110.61 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 32' ' ' PHE . 25.3 tp -78.15 93.45 4.56 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 ' CG1' ' CZ ' ' A' ' 33' ' ' PHE . 11.3 t -90.39 120.05 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 0.0 111.968 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.619 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 15.6 m-85 -97.15 158.99 15.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.241 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.493 ' CD2' ' HB ' ' A' ' 66' ' ' VAL . 19.9 m-85 -148.6 106.87 3.74 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.743 0.275 . . . . 0.0 111.743 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.753 ' CE2' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -96.78 132.59 42.33 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.305 0.574 . . . . 0.0 111.123 178.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.736 ' CD2' HG21 ' A' ' 106' ' ' VAL . 3.7 m-30 -102.52 131.01 49.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.636 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 p -174.57 178.63 1.9 Allowed 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.97 0.414 . . . . 0.0 111.325 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.05 146.01 34.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.756 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 84.0 p -50.96 -23.18 2.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.123 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -85.31 -6.03 59.27 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 129.35 88.64 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.86 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 40.1 Cg_exo -56.58 -46.19 31.73 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.643 2.229 . . . . 0.0 113.288 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 99.0 Cg_endo -78.75 11.23 2.58 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.468 2.112 . . . . 0.0 113.42 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 23.5 m -55.94 -23.51 32.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.789 0.328 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -77.37 -26.7 52.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.774 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -101.98 23.84 33.27 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.597 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -165.27 101.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.85 0.357 . . . . 0.0 110.793 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -175.37 -60.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 52' ' ' GLU . 84.4 Cg_endo -80.8 7.74 4.7 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.643 2.228 . . . . 0.0 113.157 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -77.22 -35.35 55.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.061 0.457 . . . . 0.0 110.239 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.025 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -71.2 -49.27 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.504 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 48' ' ' PRO . 2.8 mp -51.56 -47.84 36.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.826 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -66.75 -51.04 60.46 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.912 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -59.96 -29.66 68.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 16.6 t80 -86.25 -61.07 1.83 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.346 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -55.97 -26.32 47.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -94.22 -19.19 20.96 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -139.65 2.82 2.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -178.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.454 ' CD2' ' HG2' ' A' ' 59' ' ' GLU . 31.9 p-80 -55.4 -44.19 75.93 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.151 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' HG2' ' CD2' ' A' ' 58' ' ' HIS . 3.7 mt-10 -79.98 -30.51 39.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 110.875 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -58.88 -74.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.217 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 14.8 ptpt -84.07 4.51 29.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.704 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 24.7 t30 49.44 79.3 0.08 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.739 0.304 . . . . 0.0 111.542 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 54' ' ' TYR . 15.9 p90 -139.58 170.32 16.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.883 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.497 ' HG2' HD12 ' A' ' 87' ' ' LEU . 7.7 tp10 -148.3 141.97 25.55 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.261 0.553 . . . . 0.0 110.444 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.025 HG21 HD11 ' A' ' 50' ' ' LEU . 51.3 t -112.58 136.92 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.975 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 36.8 t -115.26 145.78 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.941 179.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 3.7 t80 -101.24 139.03 37.48 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.7 m -127.44 105.37 8.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.843 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.706 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.5 t -73.45 164.41 26.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.553 0.692 . . . . 0.0 112.547 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 4.1 m95 -141.28 35.01 1.69 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.585 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.68 157.9 16.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.103 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -94.18 -32.75 13.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -101.71 139.98 36.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.597 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 91' ' ' PHE . 23.4 mt-10 -73.05 -37.54 66.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.215 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.96 -25.94 45.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.299 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.14 -56.2 4.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.762 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' C ' ' CD1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -63.32 -42.11 98.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.911 0.386 . . . . 0.0 111.339 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -53.83 41.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.01 -14.07 44.15 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -97.65 -37.7 9.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.743 -0.728 . . . . 0.0 112.163 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' CZ ' ' CD1' ' A' ' 67' ' ' PHE . 4.2 m-85 -79.26 -12.75 59.95 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.82 -40.41 66.38 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -106.08 70.42 0.85 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.488 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 1.8 ptm -145.19 123.64 6.6 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.431 ' HD2' ' CE3' ' A' ' 86' ' ' TRP . 94.5 Cg_endo -83.26 -24.43 3.1 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.613 2.208 . . . . 0.0 112.698 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.593 ' NE1' ' HB2' ' A' ' 67' ' ' PHE . 20.6 p90 -72.99 162.09 29.91 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.836 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.658 ' HB3' HD22 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -83.83 142.99 30.22 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.27 -179.591 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -135.4 153.31 51.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.403 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.636 HG21 ' OH ' ' A' ' 7' ' ' TYR . 39.9 t -80.36 122.67 82.92 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.822 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.42 ' HA ' ' NH1' ' A' ' 15' ' ' ARG . 27.7 Cg_endo -62.43 152.43 77.16 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.225 1.95 . . . . 0.0 111.927 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.422 ' CE1' ' HG2' ' A' ' 74' ' ' GLU . 22.4 t80 -48.0 -29.18 3.24 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.933 0.397 . . . . 0.0 110.991 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.96 -37.08 51.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.861 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.4 ' HB2' ' CG1' ' A' ' 89' ' ' VAL . 15.5 mm-40 -114.61 29.22 8.17 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.736 0.303 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.7 p -61.65 -28.27 69.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.679 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 9.1 tt0 -53.92 -29.53 42.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.044 0.449 . . . . 0.0 110.458 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.727 ' HB2' HD13 ' A' ' 8' ' ' LEU . . . -70.62 -34.37 72.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.353 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.706 HG11 ' O ' ' A' ' 69' ' ' THR . 70.4 t -62.02 -34.35 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.108 -178.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.427 ' CG ' ' O ' ' A' ' 95' ' ' GLU . 7.2 pt20 -74.2 -40.02 62.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.134 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 1.4 mmmp? -81.93 -36.55 27.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.135 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.967 HD22 ' CZ ' ' A' ' 7' ' ' TYR . 37.8 tp -53.03 -47.2 68.54 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.8 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.8 p -60.31 -42.04 94.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.038 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.9 tttp -52.84 -27.9 20.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.4 -28.95 61.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.117 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -97.32 7.58 46.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.412 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 51.2 37.99 19.93 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.745 0.307 . . . . 0.0 111.201 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.736 HG21 ' CD2' ' A' ' 35' ' ' PHE . 27.3 t -55.25 107.01 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.223 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -58.5 -54.53 45.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.714 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 74.1 m -166.03 150.09 7.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.29 159.05 65.68 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.385 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.437 ' HG3' ' HG2' ' A' ' 42' ' ' PRO . 78.2 Cg_endo -86.28 160.82 55.94 Favored 'Cis proline' 0 C--N 1.348 0.51 0 C-N-CA 123.516 -1.452 . . . . 0.0 112.598 0.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -152.07 168.11 26.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.651 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.64 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.13 120.93 9.26 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.191 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.456 ' N ' HD12 ' A' ' 112' ' ' LEU . 25.1 mt -119.84 154.47 22.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.895 0.379 . . . . 0.0 111.817 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 113' ' ' ILE . . . -128.79 124.59 4.67 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.2 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.618 HG12 ' HA ' ' A' ' 122' ' ' VAL . 23.2 m -133.16 163.16 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-O 121.146 0.498 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.9 120.76 40.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.395 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.708 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -39.5 94.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.298 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -54.91 -62.95 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.287 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.4 t -76.14 -44.06 40.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.14 -43.47 1.78 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.52 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -58.77 142.27 50.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.848 0.356 . . . . 0.0 110.972 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.618 ' HA ' HG12 ' A' ' 115' ' ' VAL . 21.4 t -59.28 136.17 23.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.432 HG13 ' HZ2' ' A' ' 143' ' ' LYS . 21.6 t -103.49 -32.47 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.269 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.49 146.61 24.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.583 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 33.4 p -130.37 49.4 2.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.018 0.437 . . . . 0.0 111.075 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.21 51.06 0.13 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.981 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.64 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -87.54 9.08 22.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.271 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -74.58 -54.99 6.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.047 0.451 . . . . 0.0 110.245 179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.88 -36.67 21.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.526 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 64.9 p -68.63 -47.44 66.61 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.544 HD21 HD22 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -52.42 -34.79 49.97 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.302 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.87 -49.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.026 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 23.0 mtmt -82.23 16.64 1.92 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 130' ' ' THR . 5.6 t0 -138.03 62.04 30.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.891 0.377 . . . . 0.0 110.576 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -86.17 20.15 1.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.93 2.42 . . . . 0.0 112.882 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -105.38 -28.52 10.82 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.941 0.401 . . . . 0.0 110.128 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.08 56.92 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.926 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -84.39 -29.49 26.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.657 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.5 mm-40 -139.97 34.6 1.95 Allowed 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 121.293 -0.163 . . . . 0.0 111.112 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.747 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 7.9 p90 -33.88 -44.46 0.52 Allowed Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.611 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 43.3 Cg_endo -66.52 6.71 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.49 0 CA-C-N 120.541 1.229 . . . . 0.0 111.152 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.747 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.33 64.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.258 1.023 . . . . 0.0 112.769 -179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.485 ' N ' ' O ' ' A' ' 141' ' ' PRO . 8.3 ptmt -111.6 167.25 10.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.883 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -67.18 -47.31 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.151 0.5 . . . . 0.0 111.082 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.04 102.21 16.09 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.169 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.25 169.11 19.01 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.438 2.092 . . . . 0.0 112.298 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.787 HD22 ' O ' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -148.1 17.02 1.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.443 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 60.89 98.99 0.03 OUTLIER 'General case' 0 C--O 1.248 1.016 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.939 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.807 0 O-C-N 123.539 0.524 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.07 -12.86 83.63 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.669 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 4' ' ' LEU . 0.1 OUTLIER -59.75 -48.15 82.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.0 110.935 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -59.08 -34.84 72.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.06 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -51.94 -47.62 64.63 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.773 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 20.9 m-30 -93.12 -6.33 48.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.473 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 HD22 HG21 ' A' ' 11' ' ' ILE . 7.2 mt -129.09 73.63 81.61 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 120.667 0.27 . . . . 0.0 111.129 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.72 122.37 8.79 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.863 2.375 . . . . 0.0 112.301 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.71 -49.45 3.12 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.458 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.715 HG23 ' OE1' ' A' ' 93' ' ' GLN . 3.5 mp -45.0 110.49 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.82 0.343 . . . . 0.0 111.534 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.672 ' O ' HG23 ' A' ' 23' ' ' VAL . 4.5 mt-10 -128.11 1.44 5.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.547 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.446 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -140.24 160.86 39.02 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.869 0.366 . . . . 0.0 110.877 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.71 HD12 HD13 ' A' ' 87' ' ' LEU . 37.4 mt -135.15 165.54 25.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.079 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HD3' ' HB3' ' A' ' 90' ' ' PRO . 3.4 mtm180 -91.2 100.54 13.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.734 0.778 . . . . 0.0 110.982 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.654 ' HB2' HD23 ' A' ' 87' ' ' LEU . 16.8 tpt85 -88.66 155.42 19.61 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.35 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' ' HG3' ' A' ' 16' ' ' ARG . . . -46.99 -71.65 0.51 Allowed Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.652 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -46.69 -37.92 9.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.875 0.369 . . . . 0.0 111.294 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.92 -109.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -108.22 151.13 26.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.771 0.319 . . . . 0.0 110.879 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.697 HG11 HD21 ' A' ' 87' ' ' LEU . 1.1 t -145.07 158.48 13.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' N ' ' CG1' ' A' ' 21' ' ' VAL . 12.7 mm-40 -88.05 153.07 21.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.526 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.4 t -68.38 -27.16 35.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.143 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 -27.11 6.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.346 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.711 ' C ' HD23 ' A' ' 26' ' ' LEU . 19.6 m -60.44 -16.72 38.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.12 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 25' ' ' SER . 1.4 mt -113.89 50.52 0.92 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.167 0.508 . . . . 0.0 109.869 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.39 89.57 3.27 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.962 0.887 . . . . 0.0 111.079 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.98 56.01 1.1 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.968 -1.469 . . . . 0.0 113.0 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.76 162.3 41.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.7 tp -80.0 93.96 5.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 t -85.62 121.94 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.16 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.562 ' CD1' HD12 ' A' ' 112' ' ' LEU . 8.9 m-85 -99.17 160.35 14.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.876 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -133.74 105.29 6.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 110.05 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.523 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 43.2 t80 -94.27 108.96 20.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.77 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 5.3 m-85 -95.27 119.23 33.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -174.32 165.63 4.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.861 0.362 . . . . 0.0 110.967 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . . . -125.3 148.75 48.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.692 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.55 -5.05 37.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.801 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.8 p-90 -130.34 17.52 5.44 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 1.9 p -73.3 168.91 20.73 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 120.976 -0.289 . . . . 0.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.576 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 12.7 Cg_exo -66.41 -57.0 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.087 1.858 . . . . 0.0 112.767 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 16.6 Cg_exo -66.16 -75.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 121.91 1.74 . . . . 0.0 113.156 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.543 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.5 OUTLIER 3.07 73.84 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.483 0.659 . . . . 0.0 112.473 -178.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.41 27.35 6.58 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.525 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 46' ' ' PHE . . . 155.42 -153.14 24.55 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.281 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CB ' ' O ' ' A' ' 45' ' ' GLY . 5.6 t80 82.95 -33.46 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 122.509 0.324 . . . . 0.0 111.675 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.805 ' O ' HD12 ' A' ' 51' ' ' ILE . 85.7 m -49.05 -48.95 71.69 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.825 -0.17 . . . . 0.0 111.429 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 47' ' ' THR . 60.4 Cg_endo -72.74 -9.06 23.39 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.238 1.959 . . . . 0.0 113.1 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -77.38 -38.09 50.71 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.912 0.387 . . . . 0.0 110.181 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.034 HD11 HG21 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -69.82 -49.86 48.47 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.166 179.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.805 HD12 ' O ' ' A' ' 47' ' ' THR . 3.0 mp -62.98 -45.87 97.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.848 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -64.06 -38.26 90.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.87 0.367 . . . . 0.0 110.514 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -70.89 -44.02 67.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.55 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.916 ' CZ ' HG23 ' A' ' 65' ' ' VAL . 0.6 OUTLIER -71.75 -50.2 32.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' HA ' ' CE1' ' A' ' 58' ' ' HIS . 76.9 m-20 -54.8 -26.08 32.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 111.085 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -60.41 -53.95 51.39 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -141.27 3.68 1.76 Allowed 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.396 0.888 . . . . 0.0 113.396 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 55' ' ' ASP . 1.6 p-80 -50.27 -25.74 4.03 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 122.043 -0.41 . . . . 0.0 111.313 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' HG3' ' CE1' ' A' ' 58' ' ' HIS . 3.1 mt-10 -60.87 -43.51 98.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.926 0.393 . . . . 0.0 110.699 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.5 t -90.95 -32.59 15.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.682 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.431 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 20.7 mtmt -70.8 -28.43 64.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.872 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.23 62.35 2.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.525 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 20.5 m-30 -121.79 170.83 9.37 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.583 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -141.09 138.67 33.71 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.304 0.573 . . . . 0.0 111.179 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.034 HG21 HD11 ' A' ' 50' ' ' LEU . 82.4 t -116.04 115.34 48.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.949 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 87' ' ' LEU . 53.5 t -89.59 145.05 7.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 3.0 t80 -91.37 102.3 14.99 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.814 0.34 . . . . 0.0 111.228 -179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 12.6 m -90.86 110.59 21.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.128 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.541 ' O ' HG11 ' A' ' 97' ' ' VAL . 6.6 t -71.54 162.84 28.8 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.029 0.442 . . . . 0.0 111.415 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.449 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -146.68 40.15 1.08 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.072 179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.57 177.73 4.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.231 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.39 -26.3 10.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.621 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.98 134.39 54.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.91 -44.24 66.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.553 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.5 -22.93 23.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.337 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -71.52 -55.98 7.12 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.461 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.46 -37.88 82.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.985 0.421 . . . . 0.0 110.906 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' O ' ' CD1' ' A' ' 81' ' ' PHE . . . -51.25 -53.51 34.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.145 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -57.3 -14.53 12.71 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -93.35 -4.92 50.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.747 -0.727 . . . . 0.0 111.612 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.421 ' CD1' ' O ' ' A' ' 78' ' ' ALA . 0.1 OUTLIER -58.48 -19.52 37.76 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.09 -20.36 9.61 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -48.51 176.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.099 0.476 . . . . 0.0 111.875 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.626 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 16.1 mmm -46.65 171.59 0.06 OUTLIER Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.474 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 61.4 Cg_endo -74.95 -14.87 21.15 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.54 2.16 . . . . 0.0 112.971 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.626 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.8 OUTLIER -44.22 165.25 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.851 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 66' ' ' VAL . 0.7 OUTLIER -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.402 -178.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -126.28 148.4 49.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.159 -179.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.794 HG13 HE21 ' A' ' 93' ' ' GLN . 60.2 t -73.8 116.32 50.74 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.297 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.404 ' HB3' ' HD3' ' A' ' 15' ' ' ARG . 38.9 Cg_endo -66.36 164.11 29.59 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.25 1.967 . . . . 0.0 111.625 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -53.46 -30.23 39.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.968 0.413 . . . . 0.0 110.615 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.37 -37.1 64.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.209 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.794 HE21 HG13 ' A' ' 89' ' ' VAL . 1.5 mt-30 -112.61 26.19 10.77 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.685 0.279 . . . . 0.0 110.838 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 p -67.17 -42.22 84.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -53.86 -30.01 43.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.077 0.465 . . . . 0.0 110.193 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -66.74 -36.34 82.23 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.862 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG11 ' O ' ' A' ' 69' ' ' THR . 81.9 t -59.71 -35.86 62.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.971 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -81.73 -31.58 31.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.672 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.06 -33.09 33.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.996 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.57 -50.42 10.02 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.11 0.481 . . . . 0.0 109.776 179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.556 ' OG ' HG21 ' A' ' 106' ' ' VAL . 34.0 t -55.63 -33.4 63.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.211 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -27.94 54.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.158 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -65.48 -27.39 68.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.205 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.756 ' CE1' HG21 ' A' ' 122' ' ' VAL . 7.5 m-85 -94.7 5.82 50.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.551 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 51.92 34.74 14.2 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.752 0.31 . . . . 0.0 111.251 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG21 ' OG ' ' A' ' 101' ' ' SER . 49.3 t -47.94 101.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.207 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -53.5 -47.17 70.1 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 36.7 p -169.3 150.32 4.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.537 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.3 OUTLIER -82.03 161.36 60.69 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.132 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.537 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.5 Cg_endo -75.07 165.56 85.6 Favored 'Cis proline' 0 C--N 1.348 0.525 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.714 0.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.78 167.16 25.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.748 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 32' ' ' PHE . 0.0 OUTLIER -147.0 124.82 11.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.235 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 104' ' ' PHE . 21.6 mm -132.07 126.22 56.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.148 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.451 ' CA ' ' CD1' ' A' ' 32' ' ' PHE . . . -99.55 128.09 9.46 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.679 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.491 HG12 HG13 ' A' ' 122' ' ' VAL . 1.5 m -133.21 142.32 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.64 119.95 39.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.518 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.03 93.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.214 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.12 -45.27 20.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 -179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.6 p -58.95 -44.3 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.212 -179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.69 -110.18 0.6 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.033 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -87.9 -169.92 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.876 0.37 . . . . 0.0 111.449 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 104' ' ' PHE . 22.4 t -55.02 140.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.662 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -111.89 -12.49 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.969 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -153.58 168.45 26.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.792 0.33 . . . . 0.0 110.269 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.432 ' O ' HD13 ' A' ' 113' ' ' ILE . 40.3 p -142.59 -56.2 0.43 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.832 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.566 ' HG3' HG23 ' A' ' 130' ' ' THR . 7.8 ptt85 -75.12 42.27 0.19 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.846 0.355 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -68.36 -21.6 64.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.503 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.492 ' O ' HG12 ' A' ' 132' ' ' VAL . 0.3 OUTLIER -55.47 -49.55 72.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.19 -179.877 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.56 -41.04 16.86 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.566 HG23 ' HG3' ' A' ' 126' ' ' ARG . 80.9 p -69.86 -44.36 69.99 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.54 ' CD1' HD22 ' A' ' 50' ' ' LEU . 8.6 tt -52.26 -37.07 54.36 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.524 -0.47 . . . . 0.0 110.394 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 128' ' ' ARG . 1.4 p -89.14 -49.9 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.355 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 24.7 mmtp -80.11 15.08 1.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 130' ' ' THR . 25.5 t0 -117.99 78.82 13.31 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.804 0.335 . . . . 0.0 110.456 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -85.25 16.63 1.93 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.866 2.377 . . . . 0.0 113.329 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.418 ' CB ' ' HG3' ' A' ' 138' ' ' GLU . 6.0 mm-40 -114.32 -27.05 7.74 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.848 0.356 . . . . 0.0 110.608 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 59.61 26.3 62.17 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.759 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.418 ' HG3' ' CB ' ' A' ' 136' ' ' GLU . 1.6 mt-10 -81.57 -27.96 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.589 0.233 . . . . 0.0 111.442 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.66 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -122.43 22.22 10.05 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.433 -179.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.767 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.2 p90 -28.85 -47.26 0.23 Allowed Pre-proline 0 N--CA 1.466 0.34 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.596 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 37.6 Cg_endo -63.56 5.84 0.31 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 CA-C-N 120.567 1.238 . . . . 0.0 111.21 177.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.767 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER 4.89 66.63 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.39 1.076 . . . . 0.0 112.772 -179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -50.98 179.29 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.267 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -57.9 -21.57 43.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.271 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.35 107.67 0.91 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.22 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.57 102.84 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.48 2.12 . . . . 0.0 112.325 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 63.24 -82.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.67 179.27 9.26 Favored 'General case' 0 C--O 1.249 1.042 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.799 0 O-C-N 123.547 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.857 0.36 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.89 -36.35 87.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.556 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.731 ' H ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -70.58 -18.58 62.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.625 0.25 . . . . 0.0 111.099 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.693 ' OD1' HG21 ' A' ' 23' ' ' VAL . 1.4 t70 -87.12 -41.23 13.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.866 0.365 . . . . 0.0 110.673 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -72.55 -25.8 61.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.406 ' CD1' ' CD1' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -56.78 -46.96 81.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.801 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.991 HD13 ' HB1' ' A' ' 96' ' ' ALA . 1.2 mt -136.35 79.62 42.0 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.828 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -50.95 120.89 7.28 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.54 2.16 . . . . 0.0 112.44 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.33 -9.31 4.39 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.005 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 34.3 mm -68.42 -41.37 83.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.693 0.282 . . . . 0.0 111.248 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.705 ' O ' HG23 ' A' ' 23' ' ' VAL . 0.3 OUTLIER 66.41 -73.96 0.07 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.756 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -136.96 162.49 33.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.492 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.645 ' CB ' HD22 ' A' ' 87' ' ' LEU . 55.6 mt -100.87 165.13 11.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -99.08 101.06 12.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.622 0.725 . . . . 0.0 110.651 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.862 ' HG3' HG22 ' A' ' 21' ' ' VAL . 3.9 mtp180 -90.05 -176.76 4.99 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.517 -1.22 . . . . 0.0 110.864 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -71.99 -92.28 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.491 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -43.71 -34.47 1.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.839 0.352 . . . . 0.0 111.532 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.69 -129.29 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.17 153.2 51.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.718 0.294 . . . . 0.0 110.837 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.862 HG22 ' HG3' ' A' ' 16' ' ' ARG . 27.4 m -129.05 132.9 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -59.06 152.7 19.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.755 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 12' ' ' GLU . 71.3 t -55.91 -27.83 23.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -51.84 -27.63 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.326 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.579 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 t -60.57 -17.85 48.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.261 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 25' ' ' SER . 3.7 mt -108.62 47.71 0.89 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 109.999 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.94 87.74 2.72 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 121.986 0.898 . . . . 0.0 111.147 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.76 48.88 1.88 Allowed Glycine 0 C--N 1.303 -1.258 0 CA-C-N 114.018 -1.446 . . . . 0.0 112.979 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 167.63 25.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.584 0.23 . . . . 0.0 110.527 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 115' ' ' VAL . 18.0 tp -95.46 96.11 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.948 0.404 . . . . 0.0 110.051 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG21 HD13 ' A' ' 26' ' ' LEU . 10.1 t -85.7 122.48 38.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.072 0.463 . . . . 0.0 111.123 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -85.87 158.7 19.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.802 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -136.24 105.52 6.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.119 0.485 . . . . 0.0 110.085 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.576 ' HB2' HD22 ' A' ' 112' ' ' LEU . 63.5 t80 -96.66 119.71 35.63 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.811 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.82 ' HB2' HG22 ' A' ' 111' ' ' THR . 78.4 m-85 -98.75 126.62 44.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.403 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -174.4 164.33 3.83 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.66 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -129.31 133.46 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.96 0.41 . . . . 0.0 111.386 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 t -49.35 -26.57 3.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.392 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.528 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -101.07 22.72 11.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.597 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -77.79 163.23 64.5 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 110.28 -0.266 . . . . 0.0 110.28 179.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.58 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 11.5 Cg_exo -66.47 -58.52 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.179 1.919 . . . . 0.0 113.148 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 14.5 Cg_exo -67.42 -75.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 121.826 1.684 . . . . 0.0 112.239 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.423 ' SG ' ' O ' ' A' ' 37' ' ' ALA . 61.7 m 32.2 86.97 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.993 0.425 . . . . 0.0 111.621 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 ttm105 -173.0 -62.8 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.896 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.35 -178.29 41.44 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.574 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 112' ' ' LEU . 33.6 t80 70.03 -61.13 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.698 0.285 . . . . 0.0 111.295 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.486 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -44.49 -51.59 20.02 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.53 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 47' ' ' THR . 72.7 Cg_endo -75.54 -7.11 18.41 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.396 2.064 . . . . 0.0 112.907 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.48 -41.23 40.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.89 0.376 . . . . 0.0 110.079 179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.641 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.51 -48.55 68.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.893 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.448 ' CD1' ' CE3' ' A' ' 86' ' ' TRP . 34.3 mm -55.84 -42.45 70.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.405 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -68.31 -51.08 48.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.781 0.324 . . . . 0.0 110.925 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -67.64 -27.98 67.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.83 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.481 ' O ' ' N ' ' A' ' 58' ' ' HIS . 4.4 t80 -86.09 -54.01 4.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -57.49 -26.86 61.93 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -94.18 -12.42 28.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CD2' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -132.55 3.07 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 54' ' ' TYR . 13.8 p-80 -50.89 -31.21 16.76 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.22 -51.19 62.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.856 0.36 . . . . 0.0 111.918 -179.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.0 t -80.96 -37.34 29.53 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.163 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 57' ' ' PHE . 10.4 mmpt? -78.99 -38.54 36.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.28 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 58' ' ' HIS . 8.7 t-20 45.22 74.9 0.12 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.437 ' CZ ' ' CD1' ' A' ' 54' ' ' TYR . 23.9 p90 -141.11 170.62 15.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.487 ' HG2' HD12 ' A' ' 87' ' ' LEU . 0.4 OUTLIER -131.46 126.71 35.74 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.795 -179.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG21 ' CD1' ' A' ' 50' ' ' LEU . 39.7 t -100.84 114.24 39.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.183 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -91.03 147.31 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.54 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -99.51 96.92 8.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.969 0.414 . . . . 0.0 111.329 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.404 ' HB3' HG13 ' A' ' 97' ' ' VAL . 1.9 m -83.61 103.4 12.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.814 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.693 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.2 t -76.43 157.1 32.57 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.15 0.5 . . . . 0.0 111.166 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.44 ' CZ2' ' HA ' ' A' ' 98' ' ' GLN . 1.4 m95 -137.03 30.62 2.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.6 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -93.24 164.53 13.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.892 0.377 . . . . 0.0 110.989 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.68 -30.06 11.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.663 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -89.8 137.19 32.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 91' ' ' PHE . 7.0 mm-40 -73.17 -26.36 61.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -76.11 -41.54 49.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.433 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -56.02 -56.25 25.03 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.722 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -60.51 -26.83 67.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.711 0.291 . . . . 0.0 110.978 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.66 -53.62 7.34 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.11 0.481 . . . . 0.0 111.87 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.78 -14.44 22.73 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.81 -7.55 27.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.905 -0.647 . . . . 0.0 111.936 -179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -48.79 -26.69 2.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.649 0.261 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.69 -29.4 11.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.487 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 3.6 ptmt -61.65 -167.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.945 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.471 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 9.7 mmt -45.21 104.49 0.4 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.139 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.493 ' O ' ' C ' ' A' ' 86' ' ' TRP . 92.3 Cg_endo -86.12 -13.61 5.37 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.848 2.366 . . . . 0.0 113.87 -179.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.493 ' C ' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -21.08 -81.68 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.645 HD22 ' CB ' ' A' ' 14' ' ' LEU . 9.8 mt -140.04 132.71 28.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.1 127.78 8.72 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.6 t -62.36 133.2 94.4 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.014 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.45 137.58 48.13 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.147 1.898 . . . . 0.0 111.262 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 4.6 p90 -47.59 -29.59 3.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.972 0.415 . . . . 0.0 110.44 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.39 -37.16 67.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.863 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -107.69 23.13 14.94 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.243 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 p -60.84 -26.93 67.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.698 0.285 . . . . 0.0 110.514 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -54.0 -32.34 53.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.081 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.991 ' HB1' HD13 ' A' ' 8' ' ' LEU . . . -61.11 -32.49 72.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.522 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.693 HG11 ' O ' ' A' ' 69' ' ' THR . 73.2 t -68.59 -31.34 50.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.057 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.44 ' HA ' ' CZ2' ' A' ' 70' ' ' TRP . 87.0 mt-30 -77.06 -39.0 51.51 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.369 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -81.12 -42.49 20.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.662 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.718 ' HB2' HD11 ' A' ' 8' ' ' LEU . 10.8 tp -62.8 -27.93 69.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.658 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 35' ' ' PHE . 3.3 m -59.59 -49.5 77.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -56.34 -34.61 66.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.827 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -77.97 -25.9 48.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.804 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.664 ' CZ ' HG11 ' A' ' 115' ' ' VAL . 0.6 OUTLIER -92.32 16.87 10.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.292 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 54.46 28.32 9.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.424 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.583 HG13 HG21 ' A' ' 111' ' ' THR . 21.9 t -67.98 99.5 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.897 0.38 . . . . 0.0 110.892 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.32 -46.83 63.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.979 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.5 m -163.02 164.17 25.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.043 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.818 ' O ' HD12 ' A' ' 109' ' ' ILE . 1.8 pp -105.57 156.34 36.6 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.037 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -75.39 147.31 88.37 Favored 'Cis proline' 0 C--N 1.349 0.589 0 C-N-CA 123.677 -1.385 . . . . 0.0 112.722 0.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.82 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -137.15 167.46 21.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.74 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.856 ' HB3' ' HB3' ' A' ' 127' ' ' ALA . 0.0 OUTLIER -147.06 125.04 12.01 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.134 179.345 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.763 HG23 ' O ' ' A' ' 124' ' ' THR . 45.4 mt -136.08 135.33 50.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.671 0.272 . . . . 0.0 111.235 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.08 138.38 14.73 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.747 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.664 HG11 ' CZ ' ' A' ' 104' ' ' PHE . 30.3 m -133.24 163.1 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 121.09 0.471 . . . . 0.0 110.747 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.516 ' OD2' HG22 ' A' ' 123' ' ' VAL . 1.9 p30 -105.5 110.42 22.75 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.753 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.656 ' HB2' HD11 ' A' ' 4' ' ' LEU . . . -56.11 -34.61 66.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.225 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.69 -63.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.55 -38.59 91.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.028 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 97.43 -51.02 1.4 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.608 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -64.05 159.73 19.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.048 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.523 HG13 HG12 ' A' ' 115' ' ' VAL . 17.8 t -67.35 149.54 11.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.081 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.565 HG13 ' HB2' ' A' ' 145' ' ' ALA . 28.3 t -103.28 -40.84 6.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.081 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.763 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.2 OUTLIER -162.01 148.52 13.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.714 179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.432 ' HA ' HG23 ' A' ' 113' ' ' ILE . 20.9 p -132.33 64.92 1.59 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.972 0.415 . . . . 0.0 110.96 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.58 47.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.582 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.856 ' HB3' ' HB3' ' A' ' 112' ' ' LEU . . . -77.04 -14.01 59.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.761 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.494 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.7 OUTLIER -51.49 -43.31 62.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.631 0.253 . . . . 0.0 110.948 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.32 -58.14 2.79 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.532 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 29.0 p -51.48 -51.49 54.63 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.69 -32.62 43.48 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.474 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.84 -39.37 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.241 0.543 . . . . 0.0 111.225 179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -96.67 22.14 8.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.871 -178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 130' ' ' THR . 4.4 t0 -148.79 71.29 10.46 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.113 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.49 7.92 4.22 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.731 2.287 . . . . 0.0 113.355 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.455 ' HG3' ' CG ' ' A' ' 138' ' ' GLU . 2.1 pt-20 -99.89 -20.28 16.23 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.472 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 53.16 25.35 24.98 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.18 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.455 ' CG ' ' HG3' ' A' ' 136' ' ' GLU . 1.0 OUTLIER -84.18 -14.42 50.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.573 0.225 . . . . 0.0 111.583 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 142' ' ' TRP . 18.4 mm-40 -126.35 5.04 6.97 Favored 'General case' 0 C--O 1.225 -0.227 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.719 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.6 OUTLIER -22.01 -50.82 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -177.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.681 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 75.4 Cg_endo -73.6 35.52 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 CA-C-N 120.995 1.391 . . . . 0.0 109.777 176.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.719 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.0 OUTLIER -26.83 -73.7 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.741 -1.118 . . . . 0.0 113.111 -178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 124' ' ' THR . 1.4 mtpt -58.93 -179.39 0.07 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.804 0.335 . . . . 0.0 111.144 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -49.1 125.74 11.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.232 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.565 ' HB2' HG13 ' A' ' 123' ' ' VAL . . . -139.6 89.68 11.68 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.111 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.663 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.0 Cg_endo -68.85 108.6 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.539 2.159 . . . . 0.0 112.245 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.663 HD22 ' O ' ' A' ' 146' ' ' PRO . 1.0 OUTLIER -138.63 -81.01 0.32 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.923 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.8 mp0 -131.16 113.15 13.52 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.892 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.248 -3.822 0 O-C-N 123.494 0.496 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.803 0.335 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -61.11 -23.6 62.04 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.608 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.798 HD21 HG21 ' A' ' 115' ' ' VAL . 7.6 mt -50.05 -26.61 4.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.738 0.304 . . . . 0.0 111.045 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -61.31 -26.95 68.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.208 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -19.02 63.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.276 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.41 ' OH ' HG11 ' A' ' 115' ' ' VAL . 3.1 m-85 -56.68 -48.0 78.6 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.799 0.333 . . . . 0.0 110.697 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.028 HD22 ' HB2' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -166.66 129.82 1.49 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.819 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 8' ' ' LEU . 2.7 Cg_exo -76.42 7.48 3.39 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.658 2.239 . . . . 0.0 113.104 -179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.35 36.52 4.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.594 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.474 HG23 ' OE1' ' A' ' 93' ' ' GLN . 20.0 mm -118.0 150.07 20.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 111.066 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.67 ' O ' HG23 ' A' ' 23' ' ' VAL . 5.0 pt-20 -144.87 -53.32 0.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.36 160.99 41.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 87' ' ' LEU . 1.5 mt -100.92 131.8 46.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 88' ' ' ALA . 14.6 mtt180 -50.78 -20.76 1.37 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.822 ' HG2' HD23 ' A' ' 87' ' ' LEU . 0.0 OUTLIER 35.46 35.36 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.933 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.1 -131.58 11.93 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.354 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -45.03 -47.68 11.66 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.064 0.459 . . . . 0.0 111.342 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 16' ' ' ARG . . . -125.68 152.98 18.12 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.006 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 2.0 pm0 -96.98 151.05 20.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.746 0.308 . . . . 0.0 111.279 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' HG3' ' A' ' 16' ' ' ARG . 11.0 m -117.36 163.15 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.341 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -75.45 146.59 40.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.833 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 12' ' ' GLU . 69.7 t -58.53 -27.64 34.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.267 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.5 -27.3 10.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.598 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -60.53 -17.26 44.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.543 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.841 HD13 HG21 ' A' ' 31' ' ' VAL . 7.0 mt -98.78 43.3 1.06 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.139 0.495 . . . . 0.0 110.217 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.8 87.84 2.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.879 0.847 . . . . 0.0 110.895 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.73 52.0 1.46 Allowed Glycine 0 C--N 1.303 -1.254 0 CA-C-N 113.934 -1.485 . . . . 0.0 112.971 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.67 153.77 21.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.632 0.253 . . . . 0.0 110.594 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.766 HD23 ' CE2' ' A' ' 32' ' ' PHE . 5.6 tp -86.98 118.77 26.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.724 0.297 . . . . 0.0 110.569 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.841 HG21 HD13 ' A' ' 26' ' ' LEU . 4.4 t -100.27 115.26 41.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.986 0.422 . . . . 0.0 111.186 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.768 ' O ' HG22 ' A' ' 66' ' ' VAL . 22.3 m-85 -85.89 147.78 26.1 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.413 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.511 ' HB2' HG22 ' A' ' 113' ' ' ILE . 2.5 m-85 -125.98 106.31 9.53 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.218 0.532 . . . . 0.0 110.682 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.404 ' CE2' ' OG ' ' A' ' 36' ' ' SER . 22.0 t80 -94.06 108.78 20.58 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.826 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.562 ' HB2' HG22 ' A' ' 111' ' ' THR . 82.3 m-85 -96.52 123.48 40.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.628 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -172.74 175.52 3.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.015 0.436 . . . . 0.0 111.058 -179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.15 160.32 37.56 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.348 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -89.42 9.2 27.2 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.942 -0.303 . . . . 0.0 110.871 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -109.78 -29.71 8.19 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.73 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 p -67.76 115.06 23.77 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.596 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' N ' ' CD ' ' A' ' 42' ' ' PRO . 58.9 Cg_exo -50.95 -44.01 44.33 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.681 2.254 . . . . 0.0 113.2 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' CD ' ' N ' ' A' ' 41' ' ' PRO . 35.4 Cg_exo -56.56 -46.14 32.14 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.102 1.868 . . . . 0.0 111.709 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 12.3 m -56.26 -22.12 28.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.295 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -57.86 -46.04 85.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.838 0.351 . . . . 0.0 110.676 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -67.13 -78.21 0.27 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.376 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' O ' ' A' ' 128' ' ' ARG . 6.1 t80 -58.97 113.19 1.97 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.679 0.276 . . . . 0.0 110.725 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.518 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 2.8 m -173.6 -58.52 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.878 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 58.6 Cg_endo -71.04 6.66 1.64 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.399 2.066 . . . . 0.0 113.405 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -77.06 -37.46 54.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 109.85 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -61.79 -49.06 77.87 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.643 179.579 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.4 mt -57.66 -45.18 86.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -68.83 -51.02 45.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 131' ' ' LEU . 59.2 t80 -65.67 -29.15 69.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.898 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 58' ' ' HIS . 15.1 t80 -85.94 -56.21 3.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.383 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -57.13 -26.74 61.0 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.21 -12.28 28.57 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.07 2.82 3.11 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.512 ' N ' ' O ' ' A' ' 54' ' ' TYR . 3.5 p80 -59.25 -39.57 83.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 111.545 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 58' ' ' HIS . 3.2 mt-10 -69.22 -29.87 67.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.528 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.7 p -86.63 -48.87 7.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.648 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.03 -27.51 28.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.713 -179.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 49.05 79.09 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.925 0.393 . . . . 0.0 111.193 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.446 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -135.13 170.92 15.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.073 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' CG ' HD12 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -130.07 128.89 42.82 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.612 -179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.695 HG21 HD11 ' A' ' 50' ' ' LEU . 33.9 t -103.88 114.22 42.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.778 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.768 HG22 ' O ' ' A' ' 32' ' ' PHE . 15.4 m -90.72 132.27 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.83 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.02 131.42 42.12 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.077 0.465 . . . . 0.0 111.642 -179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 35' ' ' PHE . 7.0 m -134.01 113.6 12.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.021 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.635 ' O ' HG11 ' A' ' 97' ' ' VAL . 15.1 t -84.43 171.61 12.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.232 0.539 . . . . 0.0 111.523 -179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.559 ' CG ' HG21 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -154.56 46.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.201 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -124.17 162.36 23.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.882 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -100.9 14.1 32.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.029 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -126.71 134.4 50.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.773 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -73.01 -26.2 61.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.165 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -76.05 -26.61 56.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.091 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.07 -56.04 4.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.775 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.16 -40.22 70.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.932 0.396 . . . . 0.0 111.046 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -53.87 49.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.389 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.75 -14.5 58.29 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 6.7 t80 -88.89 -24.21 22.56 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.381 -0.91 . . . . 0.0 111.513 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -79.05 -13.03 60.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.542 0.211 . . . . 0.0 111.249 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -50.45 -39.98 49.37 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 111.459 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 84' ' ' MET . 2.7 mmpt? -75.01 146.69 41.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.583 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.7 OUTLIER 23.86 91.0 0.05 OUTLIER Pre-proline 0 N--CA 1.469 0.495 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.075 179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' O ' ' C ' ' A' ' 86' ' ' TRP . 98.5 Cg_endo -83.51 -8.36 10.5 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.895 2.397 . . . . 0.0 114.115 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.583 ' CE2' ' HB2' ' A' ' 84' ' ' MET . 0.0 OUTLIER -9.84 -75.95 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.822 HD23 ' HG2' ' A' ' 16' ' ' ARG . 14.1 mt -140.48 136.63 33.17 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.549 ' C ' HD23 ' A' ' 14' ' ' LEU . . . -146.06 155.65 42.92 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.387 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 93' ' ' GLN . 43.4 t -94.58 120.03 65.49 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.583 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -62.09 152.51 75.21 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.278 1.985 . . . . 0.0 111.941 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -48.06 -28.51 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.903 0.382 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.06 51.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.862 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.474 ' OE1' HG23 ' A' ' 11' ' ' ILE . 8.3 mt-30 -109.88 24.39 13.1 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.674 0.273 . . . . 0.0 111.078 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -59.77 -34.21 72.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.845 0.355 . . . . 0.0 110.632 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 98' ' ' GLN . 21.8 tt0 -53.95 -29.63 43.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.091 0.472 . . . . 0.0 110.428 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 1.028 ' HB2' HD22 ' A' ' 8' ' ' LEU . . . -67.62 -39.05 84.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.203 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.635 HG11 ' O ' ' A' ' 69' ' ' THR . 92.0 t -57.47 -36.5 53.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.466 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' HG3' ' N ' ' A' ' 99' ' ' LYS . 4.4 pt20 -73.03 -42.0 63.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.272 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 98' ' ' GLN . 22.0 mmmt -81.9 -33.35 30.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.478 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' A' ' 96' ' ' ALA . 14.1 tp -54.31 -42.5 70.19 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.778 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.03 -38.42 79.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -29.1 64.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.72 -36.95 65.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.434 ' CE2' ' HG ' ' A' ' 100' ' ' LEU . 7.8 m-85 -91.67 12.61 20.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.341 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 53.09 31.56 11.49 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.319 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 HG21 ' A' ' 111' ' ' THR . 32.7 t -56.67 98.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -55.07 -50.77 68.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.604 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.6 m -169.22 150.19 4.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.838 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.559 HG21 ' CG ' ' A' ' 70' ' ' TRP . 0.3 OUTLIER -81.28 159.93 66.47 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.194 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.479 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 89.4 Cg_endo -80.21 153.66 85.39 Favored 'Cis proline' 0 C--N 1.346 0.43 0 C-N-CA 123.628 -1.405 . . . . 0.0 112.814 0.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.562 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.8 t -148.05 174.3 12.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.459 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 113' ' ' ILE . 3.8 tp -147.31 135.87 21.88 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.48 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.796 ' N ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -130.91 157.19 43.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 111.779 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.91 133.88 7.14 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.641 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.798 HG21 HD21 ' A' ' 4' ' ' LEU . 10.9 m -133.25 159.14 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.177 0.513 . . . . 0.0 110.978 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -104.98 110.07 22.32 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.954 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.56 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -62.99 -38.45 91.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.99 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.29 -56.93 15.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.839 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.7 t -72.47 -44.04 62.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.79 65.76 1.29 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.636 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -179.58 171.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.832 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 38.5 t -80.06 127.19 39.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.945 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 143' ' ' LYS . 3.3 t -110.59 -9.67 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.874 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -154.52 169.66 23.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.792 0.33 . . . . 0.0 110.4 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 35.2 p -143.85 -56.31 0.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.57 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.456 ' NE ' ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -82.28 50.35 1.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.095 0.474 . . . . 0.0 110.276 179.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.686 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -73.77 -2.79 24.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.207 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.403 ' O ' ' CZ ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -75.74 -43.72 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.857 0.361 . . . . 0.0 110.803 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.79 -38.42 19.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.094 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 73.6 p -70.7 -43.78 68.3 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.562 HD13 HD21 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -52.77 -37.44 59.59 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.549 -179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.26 -49.15 14.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.366 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 17.6 mmtp -78.66 15.69 0.99 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.425 ' CB ' ' O ' ' A' ' 130' ' ' THR . 40.9 t0 -110.74 87.64 6.97 Favored Pre-proline 0 C--N 1.332 -0.192 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -81.71 9.17 4.03 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.7 2.267 . . . . 0.0 113.713 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' HB3' ' HG3' ' A' ' 138' ' ' GLU . 64.4 mm-40 -116.29 -29.82 6.11 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.831 0.348 . . . . 0.0 110.568 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.0 19.54 30.85 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.746 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HG3' ' HB3' ' A' ' 136' ' ' GLU . 61.0 mt-10 -84.45 -38.8 19.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.951 0.405 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.611 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -93.92 9.51 37.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.331 -179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.785 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 4.6 p90 -25.94 -48.43 0.15 Allowed Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.59 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 29.7 Cg_endo -61.33 3.49 0.34 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 120.822 1.329 . . . . 0.0 111.341 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.785 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.3 m0 6.0 66.78 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 112.797 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 123' ' ' VAL . 2.8 ptmm? -56.11 162.89 1.76 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.363 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.418 ' O ' ' O ' ' A' ' 143' ' ' LYS . 1.9 t0 38.43 -164.92 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.167 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.805 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -150.55 -67.26 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.032 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.805 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 65.8 Cg_endo -73.3 -166.57 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.287 1.992 . . . . 0.0 112.185 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.505 ' N ' HD12 ' A' ' 147' ' ' LEU . 0.7 OUTLIER -129.55 126.1 37.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.857 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -135.39 -51.72 0.76 Allowed 'General case' 0 C--O 1.249 1.037 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.871 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.721 0 O-C-N 123.518 0.511 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.75 0.31 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.7 -23.34 72.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.624 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.436 HD11 ' CG2' ' A' ' 31' ' ' VAL . 16.1 mt -52.81 -26.24 13.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.827 0.346 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -56.21 -37.89 70.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.685 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -52.96 -47.68 67.95 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.564 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.422 ' HB3' HD13 ' A' ' 100' ' ' LEU . 32.5 m-85 -85.76 -6.5 59.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.421 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.68 HD22 ' CD1' ' A' ' 11' ' ' ILE . 4.4 mt -116.67 88.85 26.27 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.78 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.06 112.35 3.39 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.928 2.419 . . . . 0.0 112.902 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.789 ' O ' HD13 ' A' ' 11' ' ' ILE . . . 65.13 86.83 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.046 -0.597 . . . . 0.0 113.452 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.789 HD13 ' O ' ' A' ' 10' ' ' GLY . 35.4 mm -133.03 127.24 54.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.754 0.311 . . . . 0.0 110.817 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -90.4 -73.41 0.53 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.027 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.889 ' HD3' HG23 ' A' ' 23' ' ' VAL . 33.7 mmtm -140.7 166.82 23.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.774 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.838 ' HB2' HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -100.45 165.36 11.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.143 -179.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 ' C ' HD23 ' A' ' 87' ' ' LEU . 34.7 mtp85 -112.45 104.22 12.34 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.764 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.5 ttt-85 -80.44 -5.03 55.93 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.283 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.0 -129.01 5.99 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.34 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -44.96 -31.34 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 0.0 111.318 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -133.97 167.3 23.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.361 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -100.07 156.81 16.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.822 0.344 . . . . 0.0 110.914 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.764 HG11 ' HD3' ' A' ' 16' ' ' ARG . 27.6 m -133.42 163.15 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.11 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -77.51 140.3 39.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.189 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.889 HG23 ' HD3' ' A' ' 13' ' ' LYS . 74.7 t -55.63 -27.77 22.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.168 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.8 ptpt -51.5 -27.42 10.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.24 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.737 ' C ' HD23 ' A' ' 26' ' ' LEU . 38.8 t -60.74 -16.71 42.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.408 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.737 HD23 ' C ' ' A' ' 25' ' ' SER . 1.5 mt -114.09 49.1 1.03 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.101 0.477 . . . . 0.0 110.303 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.38 91.19 3.56 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.877 0.846 . . . . 0.0 110.992 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.86 51.94 1.45 Allowed Glycine 0 C--N 1.303 -1.268 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.893 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -152.4 153.08 32.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.552 0.215 . . . . 0.0 110.488 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 115' ' ' VAL . 16.4 tp -74.57 99.22 3.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 0.0 110.216 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG1' HG23 ' A' ' 66' ' ' VAL . 12.1 t -85.8 116.76 29.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 13.6 m-85 -85.98 161.1 19.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.457 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 100' ' ' LEU . 21.3 m-85 -137.93 106.61 5.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.994 0.426 . . . . 0.0 111.097 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 36' ' ' SER . 1.9 t80 -94.94 109.66 21.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.838 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 89.1 m-85 -94.88 124.85 39.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.058 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 54.3 p -174.44 172.57 3.13 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.745 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.71 167.4 18.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.3 p -73.99 -28.18 61.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.198 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -88.23 2.88 51.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.472 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.4 p -55.54 152.47 17.71 Favored Pre-proline 0 CA--C 1.532 0.262 0 CA-C-O 120.669 0.271 . . . . 0.0 111.202 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 37.8 Cg_exo -55.56 -50.2 13.48 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.742 2.294 . . . . 0.0 113.432 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.479 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.18 1.92 . . . . 0.0 111.077 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 46.6 m 43.91 30.68 0.42 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.358 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -171.12 34.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -145.3 -64.49 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.488 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.04 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.022 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.428 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -55.42 -60.63 7.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.065 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.561 ' HA ' HD12 ' A' ' 51' ' ' ILE . 45.6 Cg_endo -68.32 -9.39 25.76 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.512 2.142 . . . . 0.0 112.853 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.31 -40.99 42.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.968 0.413 . . . . 0.0 110.274 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -55.98 -48.86 75.06 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 121.371 0.605 . . . . 0.0 110.834 179.239 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 48' ' ' PRO . 3.6 mt -55.63 -44.88 78.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.702 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -67.04 -51.5 53.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.614 -0.267 . . . . 0.0 111.399 -179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -63.62 -30.53 71.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.909 0.385 . . . . 0.0 110.642 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' A' ' 58' ' ' HIS . 8.7 t80 -82.79 -59.31 2.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.371 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.18 -26.49 62.84 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mmpt? -91.78 -11.47 36.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.454 ' HB3' ' HG3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -137.83 3.01 2.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.605 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.45 ' HB3' ' CD1' ' A' ' 54' ' ' TYR . 24.7 p80 -57.46 -49.06 77.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.922 -0.311 . . . . 0.0 111.488 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 58' ' ' HIS . 6.9 pt-20 -59.96 -50.92 71.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.73 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.67 -69.89 0.29 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.404 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HB2' ' CD1' ' A' ' 63' ' ' PHE . 5.8 mmpt? -58.61 -19.58 39.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.738 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 3.1 t-20 48.47 69.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 61' ' ' LYS . 2.5 p90 -142.04 170.83 14.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.886 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.653 ' OE2' HD12 ' A' ' 87' ' ' LEU . 1.3 tp10 -137.7 137.64 38.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.178 0.514 . . . . 0.0 110.524 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 50' ' ' LEU . 94.0 t -106.69 124.74 62.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.538 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 40.4 t -104.88 135.22 43.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.755 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.466 ' CE1' ' CZ2' ' A' ' 86' ' ' TRP . 3.3 t80 -77.93 144.7 36.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 121.19 0.519 . . . . 0.0 111.837 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 38.7 m -134.05 104.42 6.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.326 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.6 t -79.28 157.75 27.68 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.354 0.597 . . . . 0.0 111.82 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -143.59 38.14 1.36 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.336 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -109.08 163.7 13.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.958 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -104.44 -18.76 14.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.973 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -105.97 116.93 32.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.91 -44.59 67.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.263 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -55.57 -24.53 33.18 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.29 -56.41 4.34 Favored Glycine 0 CA--C 1.519 0.287 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.136 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.98 -27.32 43.4 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 81' ' ' PHE . . . -61.92 -54.13 46.1 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.76 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.25 -14.52 66.5 Favored Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -73.85 -39.57 63.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.448 -0.876 . . . . 0.0 111.53 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.48 ' CD2' ' HA ' ' A' ' 78' ' ' ALA . 4.3 p90 -79.16 -12.79 59.99 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -45.95 -40.24 10.01 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.432 ' O ' ' CG ' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -115.63 47.61 1.32 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.529 ' O ' ' HG3' ' A' ' 84' ' ' MET . 0.4 OUTLIER -117.85 120.58 32.59 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.412 ' CG ' HG12 ' A' ' 51' ' ' ILE . 91.1 Cg_endo -80.07 -34.87 0.78 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.524 2.149 . . . . 0.0 111.75 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.466 ' CZ2' ' CE1' ' A' ' 67' ' ' PHE . 3.3 p90 -61.84 162.85 8.27 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.091 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.838 HD22 ' HB2' ' A' ' 14' ' ' LEU . 1.1 mt -83.47 148.71 27.09 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.662 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HB2' ' CE ' ' A' ' 84' ' ' MET . . . -140.27 149.19 42.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.789 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.4 t -75.14 128.42 84.79 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.308 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.56 147.31 79.74 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.27 1.98 . . . . 0.0 111.842 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -47.91 -31.33 5.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.028 0.442 . . . . 0.0 110.751 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.12 64.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.824 -0.626 . . . . 0.0 112.106 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -113.48 24.14 12.5 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.9 m -61.79 -28.07 69.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.739 0.304 . . . . 0.0 110.532 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -53.86 -31.37 49.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.094 0.473 . . . . 0.0 110.356 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 100' ' ' LEU . . . -58.05 -39.11 77.61 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.64 179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 88.3 t -57.64 -33.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.558 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -70.91 -45.66 63.89 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.1 -37.69 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.741 ' O ' HD12 ' A' ' 100' ' ' LEU . 2.8 tp -69.41 -31.24 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.374 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 106' ' ' VAL . 6.2 m -69.42 -50.12 48.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.7 tttm -63.46 -30.1 71.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -28.8 67.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.996 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.629 ' HD2' HG21 ' A' ' 113' ' ' ILE . 3.8 m-85 -91.97 14.96 14.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.8 t30 52.96 33.32 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.559 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 101' ' ' SER . 46.7 t -53.66 103.89 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.7 -47.73 73.35 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.5 p 179.33 150.67 0.32 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.5 154.6 62.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.013 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.32 136.46 24.87 Favored 'Cis proline' 0 C--N 1.346 0.429 0 C-N-CA 123.473 -1.47 . . . . 0.0 112.693 0.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.644 HG21 HG13 ' A' ' 106' ' ' VAL . 2.1 t -129.74 174.39 9.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.874 ' CD2' HD13 ' A' ' 131' ' ' LEU . 1.9 tp -147.3 127.94 14.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.462 179.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.679 ' N ' HD12 ' A' ' 112' ' ' LEU . 31.0 mt -136.09 142.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.508 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -118.85 139.87 14.74 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.44 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 122' ' ' VAL . 22.2 m -133.24 163.12 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-O 121.042 0.449 . . . . 0.0 110.767 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 p30 -103.61 111.72 24.32 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.86 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -63.75 -42.98 97.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.18 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -55.64 -63.09 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.071 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -64.27 -44.09 92.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.843 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.0 69.44 1.32 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -178.86 164.19 1.48 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.978 0.418 . . . . 0.0 110.707 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.663 ' HA ' HG12 ' A' ' 115' ' ' VAL . 24.0 t -85.67 111.63 21.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.009 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.3 t -92.74 -37.29 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.647 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -116.7 155.32 29.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.304 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.42 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -156.34 41.03 0.36 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.098 0.475 . . . . 0.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.504 ' HG2' ' HB1' ' A' ' 145' ' ' ALA . 0.0 OUTLIER -173.68 37.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.238 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.644 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.31 -5.19 37.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.94 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.644 ' HG2' ' N ' ' A' ' 129' ' ' ALA . 0.6 OUTLIER -60.62 -40.74 93.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.09 0.472 . . . . 0.0 110.377 179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.644 ' N ' ' HG2' ' A' ' 128' ' ' ARG . . . -85.37 -57.54 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.424 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 69.7 p -49.12 -50.82 35.48 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.874 HD13 ' CD2' ' A' ' 112' ' ' LEU . 7.7 tt -52.21 -33.18 39.92 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.748 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.88 -38.19 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.799 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -101.03 19.34 17.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 130' ' ' THR . 6.4 m-20 -127.88 79.05 74.31 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.759 0.314 . . . . 0.0 110.667 179.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.76 6.04 5.91 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.708 2.272 . . . . 0.0 113.115 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -113.66 -26.58 8.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.709 0.29 . . . . 0.0 110.892 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 60.73 21.57 58.41 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.773 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.459 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.9 pt-20 -62.32 -14.86 43.8 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.525 0.202 . . . . 0.0 111.457 -179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -133.84 20.01 3.84 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.788 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 28.7 t80 -19.27 -55.72 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.735 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.569 ' O ' HG22 ' A' ' 124' ' ' THR . 18.6 Cg_endo -59.35 4.2 0.15 Allowed 'Trans proline' 0 CA--C 1.533 0.44 0 CA-C-N 119.907 1.003 . . . . 0.0 111.281 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.788 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 9.3 64.1 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.958 0.903 . . . . 0.0 112.478 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.592 ' O ' ' O ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -74.85 -169.08 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.138 -179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.592 ' O ' ' O ' ' A' ' 143' ' ' LYS . 30.9 p-10 16.79 120.28 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.834 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -147.3 -67.88 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.179 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.834 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 61.4 Cg_endo -72.63 -168.29 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.266 1.977 . . . . 0.0 112.294 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 147' ' ' LEU . 7.3 mp -72.0 -78.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -148.42 22.06 1.05 Allowed 'General case' 0 C--O 1.249 1.061 0 CA-C-O 118.242 -0.885 . . . . 0.0 110.941 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.786 0 O-C-N 123.553 0.533 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.8 m . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.854 0.359 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.97 -12.05 84.55 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.84 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.521 HD22 HG21 ' A' ' 115' ' ' VAL . 16.1 mt -65.73 -30.21 70.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.792 0.329 . . . . 0.0 110.933 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.16 -42.7 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.898 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.7 ttmm -51.89 -47.58 64.5 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.766 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 m-30 -69.81 -32.21 70.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.827 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.996 HD21 HD23 ' A' ' 100' ' ' LEU . 3.1 mt -126.19 76.23 72.43 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.938 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.78 112.9 1.94 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.604 2.202 . . . . 0.0 112.236 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.98 74.43 0.99 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.818 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 8' ' ' LEU . 16.8 mm -133.53 153.61 37.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.748 0.308 . . . . 0.0 110.995 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' O ' HG23 ' A' ' 23' ' ' VAL . 17.0 tp10 -145.38 -56.35 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.047 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -143.03 153.55 43.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.024 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.619 ' CB ' HD22 ' A' ' 87' ' ' LEU . 42.3 mt -102.24 165.54 11.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.032 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 7.0 mtp-105 -101.84 102.15 12.71 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.734 0.778 . . . . 0.0 110.788 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.631 ' HD3' HG11 ' A' ' 21' ' ' VAL . 4.0 ttt180 -99.21 169.92 9.03 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.473 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.06 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.518 0.269 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.911 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -42.9 -36.57 1.56 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.819 0.342 . . . . 0.0 111.658 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.25 -140.21 3.57 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.331 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -103.78 151.16 23.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 111.064 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.919 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -123.98 134.85 65.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.945 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.04 143.03 39.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.054 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 12' ' ' GLU . 73.6 t -55.95 -27.55 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.027 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.48 -27.06 9.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.374 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.47 -16.9 41.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.429 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.475 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 6.0 mt -102.27 43.71 1.05 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.04 0.448 . . . . 0.0 110.327 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.15 93.4 4.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.847 0.832 . . . . 0.0 110.806 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.1 49.77 1.7 Allowed Glycine 0 C--N 1.304 -1.249 0 CA-C-N 114.142 -1.39 . . . . 0.0 112.698 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HE3' ' CA ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -167.64 150.99 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.717 HD22 ' CZ ' ' A' ' 32' ' ' PHE . 1.0 OUTLIER -73.98 157.58 35.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.536 -179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG12 ' CE1' ' A' ' 33' ' ' PHE . 11.0 t -138.13 118.06 15.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.603 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.717 ' CZ ' HD22 ' A' ' 30' ' ' LEU . 8.6 m-85 -94.76 160.04 14.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.112 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' CE1' HG12 ' A' ' 31' ' ' VAL . 12.8 m-85 -136.09 106.72 6.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.902 0.382 . . . . 0.0 111.288 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -92.88 113.41 25.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.619 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.638 ' CE2' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -98.72 128.85 45.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -174.32 173.29 3.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.885 0.374 . . . . 0.0 111.12 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.552 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -141.15 168.15 20.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.873 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.45 13.04 20.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.213 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -120.18 -12.42 9.07 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.615 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 14.8 p -51.56 152.57 4.64 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 120.717 0.294 . . . . 0.0 111.203 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 39.9 Cg_exo -55.28 -50.26 13.56 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.756 2.304 . . . . 0.0 113.383 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.7 Cg_exo -74.65 -69.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.203 1.935 . . . . 0.0 110.902 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 m 44.26 30.1 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.399 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.61 31.45 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -134.85 -1.49 3.32 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.166 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -177.11 114.28 0.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.968 0.384 . . . . 0.0 111.103 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 1.2 m -176.38 -64.65 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 87.2 Cg_endo -81.92 9.46 3.93 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.57 2.18 . . . . 0.0 112.769 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -77.48 -29.8 52.83 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.835 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.559 HD11 ' CD2' ' A' ' 54' ' ' TYR . 0.0 OUTLIER -85.25 -27.07 26.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.726 -178.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.819 HD11 ' HB3' ' A' ' 84' ' ' MET . 43.1 mm -52.35 -45.03 44.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.969 -0.292 . . . . 0.0 111.411 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -61.54 -41.99 98.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CD1' ' O ' ' A' ' 53' ' ' PHE . 2.0 t80 -72.46 -42.32 65.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.758 0.313 . . . . 0.0 111.838 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.559 ' CD2' HD11 ' A' ' 50' ' ' LEU . 3.0 m-30 -86.21 -34.04 20.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.627 ' CG ' HG23 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -76.17 -26.8 56.58 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.421 -179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -84.98 -10.7 56.77 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.405 ' CD2' ' OG ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -130.97 2.76 4.36 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.489 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 0.3 OUTLIER -50.76 -30.07 13.12 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.147 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.411 ' HG3' ' CD2' ' A' ' 58' ' ' HIS . 28.7 mt-10 -80.11 -30.07 39.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.739 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.405 ' OG ' ' CD2' ' A' ' 57' ' ' PHE . 69.2 p -78.16 -70.22 0.5 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.367 . . . . 0.0 111.779 -179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 17.5 mtpt -68.43 -7.66 33.68 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.929 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 p-10 45.92 82.6 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.424 0.631 . . . . 0.0 111.737 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.535 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -142.13 170.79 15.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.911 -179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.809 ' CG ' HD12 ' A' ' 87' ' ' LEU . 4.0 tp10 -140.11 138.67 35.46 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.176 0.512 . . . . 0.0 110.833 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.734 HG11 ' CZ2' ' A' ' 86' ' ' TRP . 61.8 t -112.93 128.67 69.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.451 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 18.2 t -102.2 140.9 19.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.142 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' LEU . 77.7 t80 -107.26 96.86 6.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.87 0.367 . . . . 0.0 111.261 -179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.518 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -90.63 149.19 22.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.073 179.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.798 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -97.83 160.36 14.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.12 0.486 . . . . 0.0 111.513 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.552 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -142.37 35.14 1.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.008 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.5 177.21 5.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.902 0.382 . . . . 0.0 111.004 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -101.98 -29.44 11.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.731 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -116.78 161.7 18.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.797 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HG2' ' CE2' ' A' ' 91' ' ' PHE . 25.8 mt-10 -73.06 -27.12 61.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.159 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -56.04 -43.02 77.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.185 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 80' ' ' TYR . . . -65.07 -56.3 16.81 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.436 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -54.33 -26.79 31.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.48 -54.53 10.3 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.164 0.507 . . . . 0.0 111.649 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.8 -14.68 81.29 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 6.9 t80 -94.16 -7.25 42.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.414 -0.893 . . . . 0.0 111.582 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.434 ' HE1' ' HB3' ' A' ' 88' ' ' ALA . 79.5 t80 -79.0 -27.45 43.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.685 0.279 . . . . 0.0 111.139 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.29 -31.29 61.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.504 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -68.88 134.91 50.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.975 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.819 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.4 ptp 30.17 75.65 0.38 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.961 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -76.31 5.71 4.45 Favored 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.521 2.814 . . . . 0.0 114.658 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.773 ' CH2' HD13 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -39.59 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 117.864 0.302 . . . . 0.0 111.713 -178.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.919 HD21 ' CG2' ' A' ' 21' ' ' VAL . 9.7 mt -139.51 134.11 31.8 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.434 ' HB3' ' HE1' ' A' ' 81' ' ' PHE . . . -147.86 126.93 12.85 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.565 HG12 ' OE1' ' A' ' 93' ' ' GLN . 28.0 t -62.01 113.93 9.97 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.318 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -51.92 158.76 4.4 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.381 2.054 . . . . 0.0 112.168 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' A' ' 74' ' ' GLU . 28.0 t80 -53.34 -24.31 11.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.994 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.81 -37.26 50.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.827 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.565 ' OE1' HG12 ' A' ' 89' ' ' VAL . 3.4 mp0 -112.1 26.83 10.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.653 0.263 . . . . 0.0 111.012 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.5 p -53.87 -32.65 53.91 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.773 0.32 . . . . 0.0 110.662 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -58.86 -33.65 70.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.072 0.463 . . . . 0.0 110.234 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.848 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -59.99 -37.84 80.84 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.772 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.798 HG11 ' O ' ' A' ' 69' ' ' THR . 99.1 t -57.9 -37.38 60.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.89 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -82.94 -29.18 29.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.723 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.9 mtpp -81.31 -31.34 33.59 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.52 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.996 HD23 HD21 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -79.8 -50.62 10.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.122 0.487 . . . . 0.0 109.894 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.48 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 2.3 m -50.9 -37.5 44.1 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.059 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 23.9 ttpp -64.56 -30.99 72.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -72.43 -30.75 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.485 ' CG ' HD12 ' A' ' 113' ' ' ILE . 6.4 m-85 -85.05 3.55 38.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.432 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.7 t30 54.02 29.82 10.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.77 0.319 . . . . 0.0 111.075 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.2 t -52.69 99.79 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -54.6 -37.1 65.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.719 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 33.3 p 179.04 150.17 0.28 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.897 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -80.02 159.82 69.99 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.151 179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 6.5 Cg_exo -74.46 165.44 85.45 Favored 'Cis proline' 0 C--N 1.348 0.519 0 C-N-CA 123.822 -1.324 . . . . 0.0 112.537 0.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -153.04 153.7 33.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.577 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 11.8 tp -147.12 123.56 11.02 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.596 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.516 HG23 ' HA ' ' A' ' 125' ' ' THR . 22.5 mt -136.7 154.14 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.094 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -116.57 135.52 12.1 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.678 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.521 HG21 HD22 ' A' ' 4' ' ' LEU . 7.7 m -133.24 154.51 39.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.828 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.2 127.18 35.73 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 26' ' ' LEU . . . -69.82 -49.23 54.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -77.91 -51.37 10.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.033 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.93 -44.03 91.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.014 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 88.68 -50.63 3.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.554 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -57.86 151.09 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.805 0.336 . . . . 0.0 111.003 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.3 t -64.61 124.25 19.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -94.81 -37.3 7.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.172 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.432 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -137.76 163.83 30.37 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.466 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.516 ' HA ' HG23 ' A' ' 113' ' ' ILE . 32.7 p -154.39 39.87 0.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.067 0.46 . . . . 0.0 110.762 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 130' ' ' THR . 0.0 OUTLIER -179.6 49.29 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.059 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.697 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -73.32 -7.7 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.673 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.461 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -82.58 -40.51 20.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.35 -38.05 19.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.217 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 126' ' ' ARG . 80.7 p -67.55 -50.28 59.31 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -177.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 50' ' ' LEU . 3.7 tt -53.06 -34.26 55.71 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.283 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.95 -40.58 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.229 0.537 . . . . 0.0 111.212 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -96.04 23.27 6.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.796 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -157.21 69.4 4.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.855 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.66 12.89 2.44 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.977 2.452 . . . . 0.0 113.458 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -104.9 -23.33 13.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.23 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 56.77 20.02 30.9 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.006 -179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 4.7 pt-20 -66.26 -14.71 62.4 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.644 0.259 . . . . 0.0 111.327 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.67 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -135.71 19.95 3.3 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.78 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 0.1 OUTLIER -19.5 -57.34 0.06 OUTLIER Pre-proline 0 N--CA 1.474 0.757 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 -178.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.0 Cg_endo -60.68 8.01 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.456 0 CA-C-N 119.979 1.028 . . . . 0.0 111.386 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.78 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.8 OUTLIER 4.42 64.96 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.307 1.043 . . . . 0.0 112.811 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 145' ' ' ALA . 16.0 pttm -106.75 158.7 16.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.5 t70 56.41 -4.42 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -60.16 -52.79 70.83 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-O 120.698 0.285 . . . . 0.0 111.125 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 94.5 Cg_endo -84.31 14.0 2.56 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.73 2.287 . . . . 0.0 113.042 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.743 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -58.4 -21.86 51.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.815 0.34 . . . . 0.0 111.158 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.7 166.19 2.66 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.968 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.25 -3.748 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.817 0.342 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.82 -16.35 80.12 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.747 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.724 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mt -50.87 -27.58 7.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.905 0.383 . . . . 0.0 110.596 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -52.63 -48.17 66.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.859 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 -27.47 10.88 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.299 -179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 100' ' ' LEU . 2.5 t80 -60.66 -69.9 0.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.864 0.364 . . . . 0.0 110.38 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.76 HD22 ' HB2' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -173.68 105.5 0.3 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.931 179.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -73.8 7.69 2.28 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.765 2.31 . . . . 0.0 113.228 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.92 -37.01 6.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.399 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.498 ' CG1' ' HG3' ' A' ' 93' ' ' GLN . 23.0 mt -64.39 103.59 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.865 0.364 . . . . 0.0 110.961 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' O ' HG23 ' A' ' 23' ' ' VAL . 3.8 pt-20 -102.35 -28.38 12.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.108 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -132.82 147.52 52.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 111.084 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD22 ' N ' ' A' ' 14' ' ' LEU . 1.6 mm? -106.53 165.1 11.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.778 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.417 ' HA ' ' HG3' ' A' ' 20' ' ' GLU . 5.0 mtp85 -78.92 -0.19 29.89 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.976 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.681 ' CA ' HD23 ' A' ' 87' ' ' LEU . 0.7 OUTLIER 31.35 -94.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.92 0.39 . . . . 0.0 111.9 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -154.7 -101.23 0.19 Allowed Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -48.8 -30.63 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.037 0.446 . . . . 0.0 110.742 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -147.86 -125.47 1.54 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.348 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.417 ' HG3' ' HA ' ' A' ' 15' ' ' ARG . 3.6 mt-10 -144.14 158.1 43.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.717 0.294 . . . . 0.0 110.923 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG22 ' CD2' ' A' ' 87' ' ' LEU . 13.1 m -141.97 163.16 19.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.313 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -76.28 153.13 36.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.346 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 12' ' ' GLU . 78.4 t -64.82 -27.08 41.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.258 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -50.9 -27.2 7.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.409 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.681 ' C ' HD23 ' A' ' 26' ' ' LEU . 65.8 m -60.56 -14.8 22.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.438 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.681 HD23 ' C ' ' A' ' 25' ' ' SER . 2.2 mt -111.85 49.66 0.89 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.289 0.566 . . . . 0.0 110.089 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -104.68 90.81 3.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.955 0.884 . . . . 0.0 110.772 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.97 1.08 Allowed Glycine 0 C--N 1.301 -1.366 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.897 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -160.16 150.7 18.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.676 0.274 . . . . 0.0 110.554 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 HD23 ' CE2' ' A' ' 32' ' ' PHE . 26.6 tp -73.79 100.29 3.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.886 0.374 . . . . 0.0 110.438 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 115' ' ' VAL . 4.4 t -85.97 113.27 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.395 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CE2' HD23 ' A' ' 30' ' ' LEU . 45.4 m-85 -87.45 157.98 19.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.557 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -142.18 106.98 4.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.996 0.427 . . . . 0.0 111.276 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 43.5 t80 -93.04 121.98 34.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.846 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' HG22 ' A' ' 111' ' ' THR . 85.2 m-85 -99.19 122.32 42.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.413 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -174.52 167.4 3.89 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.973 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.8 ' HB2' ' O ' ' A' ' 70' ' ' TRP . . . -120.0 151.96 38.2 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.763 0.316 . . . . 0.0 110.841 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 80' ' ' TYR . 93.1 p -64.17 -34.62 78.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.579 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.415 ' NE1' ' OD1' ' A' ' 71' ' ' ASP . 19.3 p-90 -96.84 16.54 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.798 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -71.31 162.45 72.64 Favored Pre-proline 0 C--N 1.33 -0.28 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.322 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.589 ' CB ' ' HD3' ' A' ' 42' ' ' PRO . 10.3 Cg_exo -67.78 -58.2 0.14 Allowed 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 122.026 1.818 . . . . 0.0 113.134 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 41' ' ' PRO . 21.2 Cg_exo -64.81 -76.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.013 1.809 . . . . 0.0 113.198 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.55 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.6 OUTLIER 5.25 74.22 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.431 0.634 . . . . 0.0 112.225 -179.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -167.69 -42.52 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.582 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.29 -51.26 2.79 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.292 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CE2' ' HA ' ' A' ' 128' ' ' ARG . 5.8 t80 -98.86 104.0 16.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.884 0.373 . . . . 0.0 110.706 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.89 -58.2 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.803 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.18 9.84 2.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.813 2.342 . . . . 0.0 113.063 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.482 ' CG ' HD23 ' A' ' 131' ' ' LEU . 8.7 tp-100 -77.04 -36.17 56.28 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -53.57 -48.04 69.53 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.298 0.57 . . . . 0.0 110.494 179.038 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.0 mm -55.21 -44.58 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.49 -51.0 63.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.173 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -68.62 -27.84 66.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.5 ' O ' ' N ' ' A' ' 58' ' ' HIS . 59.1 t80 -82.9 -53.46 5.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.353 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -55.61 -26.43 44.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -94.2 -16.62 23.5 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.2 2.91 2.35 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.5 ' N ' ' O ' ' A' ' 54' ' ' TYR . 41.7 p-80 -55.61 -32.9 63.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.761 0.315 . . . . 0.0 111.496 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -71.57 -29.91 65.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.291 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 26.2 t -91.53 -42.04 10.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.214 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 21.4 mtmt -84.0 -31.96 25.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.358 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.1 t30 47.09 71.91 0.28 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.905 0.383 . . . . 0.0 111.097 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 3.2 p90 -130.03 170.79 13.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.051 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.708 ' CD ' HD12 ' A' ' 87' ' ' LEU . 6.5 tm-20 -132.68 137.99 47.13 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.341 0.591 . . . . 0.0 110.717 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.814 HG21 ' HG ' ' A' ' 50' ' ' LEU . 87.2 t -112.32 140.09 33.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.233 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.769 HG13 ' O ' ' A' ' 87' ' ' LEU . 46.1 t -119.08 142.53 33.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.99 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.64 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -93.61 98.47 11.17 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-O 120.841 0.353 . . . . 0.0 111.163 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 8.8 m -85.86 108.87 18.34 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.765 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.1 t -69.95 158.23 35.98 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.115 0.483 . . . . 0.0 111.159 -179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.8 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -150.26 51.34 0.9 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.913 179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.415 ' OD1' ' NE1' ' A' ' 39' ' ' TRP . 22.3 t0 -105.62 -98.99 0.33 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.633 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 169.44 -34.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.21 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -122.61 137.37 54.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' CG ' ' CG ' ' A' ' 91' ' ' PHE . 4.8 mt-10 -52.89 -25.9 13.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.237 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -55.79 -38.85 70.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.727 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.04 -56.8 4.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.01 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -61.58 -31.96 72.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.297 . . . . 0.0 111.059 -179.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 74' ' ' GLU . . . -60.84 -53.74 53.64 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 121.038 0.447 . . . . 0.0 111.699 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.94 -14.77 25.4 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -93.83 -8.17 41.21 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.659 -0.771 . . . . 0.0 111.501 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -53.07 -28.66 26.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.772 0.32 . . . . 0.0 111.15 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.38 -9.8 57.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.495 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.417 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 1.4 mmpt? -52.43 -176.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.852 0.358 . . . . 0.0 111.474 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.425 ' SD ' ' CH2' ' A' ' 86' ' ' TRP . 0.0 OUTLIER -38.72 156.82 0.12 Allowed Pre-proline 0 N--CA 1.463 0.185 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.186 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.85 -14.46 32.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.925 2.417 . . . . 0.0 113.581 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.4 OUTLIER -43.31 161.02 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.96 -0.109 . . . . 0.0 111.065 -179.666 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.769 ' O ' HG13 ' A' ' 66' ' ' VAL . 1.4 mt -83.99 126.06 32.66 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.617 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -115.22 136.62 52.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -62.26 123.21 77.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.514 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.63 154.61 47.5 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.255 1.97 . . . . 0.0 112.098 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.46 ' CG ' ' CG ' ' A' ' 74' ' ' GLU . 54.4 t80 -50.98 -26.52 6.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.98 -37.01 51.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.037 -0.528 . . . . 0.0 112.081 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.498 ' HG3' ' CG1' ' A' ' 11' ' ' ILE . 10.3 mm-40 -121.6 45.09 2.39 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.07 -28.88 62.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 0.0 110.427 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -53.92 -36.94 63.3 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.426 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.833 ' HB1' ' CE1' ' A' ' 7' ' ' TYR . . . -56.14 -37.37 69.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.748 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.765 HG11 ' O ' ' A' ' 69' ' ' THR . 96.3 t -63.16 -33.36 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.593 -179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -73.05 -44.08 61.16 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.94 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.4 -38.85 25.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.976 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 7' ' ' TYR . 16.5 tp -65.4 -28.04 68.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.743 0.306 . . . . 0.0 110.815 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 89.5 p -60.14 -47.47 85.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.729 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.86 -48.0 78.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.763 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -62.13 -27.11 68.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.761 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.701 ' CE1' HD11 ' A' ' 100' ' ' LEU . 2.6 m-85 -91.97 18.72 7.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.276 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 57.19 29.39 16.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.412 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.413 HG13 HG21 ' A' ' 111' ' ' THR . 12.3 t -90.0 99.38 9.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.807 0.337 . . . . 0.0 110.815 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -88.74 -30.65 18.91 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.002 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 70.9 m -158.76 150.69 21.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.021 0.439 . . . . 0.0 111.364 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' HB ' ' HA ' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -99.26 161.25 25.31 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.958 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 2.3 Cg_endo -85.81 149.86 46.62 Favored 'Cis proline' 0 C--N 1.346 0.412 0 C-N-CA 124.108 -1.205 . . . . 0.0 112.515 0.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.532 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 t -142.61 172.39 12.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.579 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.614 ' HG ' ' CB ' ' A' ' 127' ' ' ALA . 1.9 tp -147.26 125.88 12.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.435 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 104' ' ' PHE . 33.5 mt -131.66 142.86 42.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.293 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 32' ' ' PHE . . . -112.42 137.02 13.95 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.221 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.918 ' CG1' HG22 ' A' ' 122' ' ' VAL . 1.8 m -133.09 146.36 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 110.667 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -105.49 112.46 25.57 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.645 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.724 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -57.48 -52.03 67.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.695 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -58.41 -57.16 14.16 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.717 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.3 t -58.51 -44.2 89.4 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.279 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 148.38 -122.36 1.49 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.003 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -82.5 -166.72 1.36 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.342 . . . . 0.0 111.306 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.918 HG22 ' CG1' ' A' ' 115' ' ' VAL . 46.3 t -55.03 136.47 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.478 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.48 -23.08 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.344 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.609 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -150.07 143.85 25.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.263 -179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' HG23 ' A' ' 113' ' ' ILE . 51.9 p -123.15 26.72 7.9 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.935 0.398 . . . . 0.0 111.278 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 46.17 2.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.827 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.614 ' CB ' ' HG ' ' A' ' 112' ' ' LEU . . . -80.49 -10.63 59.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.994 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.423 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 0.0 OUTLIER -73.6 -36.68 65.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.849 0.357 . . . . 0.0 110.087 179.356 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.89 -49.66 8.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.741 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 76.3 p -57.57 -48.65 78.76 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.927 -178.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.566 ' CD1' HD22 ' A' ' 50' ' ' LEU . 0.6 OUTLIER -52.46 -34.45 48.97 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.829 -179.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -89.91 -38.59 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 121.246 0.546 . . . . 0.0 111.819 179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -99.93 18.93 17.17 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.85 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 130' ' ' THR . 74.3 m-20 -146.45 66.07 10.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.876 0.37 . . . . 0.0 110.317 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.54 20.64 1.2 Allowed 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.899 2.399 . . . . 0.0 112.925 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -107.92 -29.71 8.89 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.889 0.376 . . . . 0.0 110.203 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 71.56 34.5 63.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.472 -0.87 . . . . 0.0 111.636 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -83.36 -27.52 29.62 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.753 ' O ' ' CD1' ' A' ' 142' ' ' TRP . 1.3 mm-40 -141.79 37.32 1.62 Allowed 'General case' 0 C--O 1.222 -0.378 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.898 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.739 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 13.5 p90 -39.25 -41.1 1.46 Allowed Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.624 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 55.8 Cg_endo -71.09 7.73 1.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 CA-C-N 120.564 1.237 . . . . 0.0 110.72 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.753 ' CD1' ' O ' ' A' ' 139' ' ' GLN . 0.5 OUTLIER 3.62 65.78 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.169 0.987 . . . . 0.0 112.328 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 7.8 mmtp -48.95 150.7 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.428 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -126.5 -11.05 6.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.586 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 41.92 64.71 5.45 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.812 0.339 . . . . 0.0 111.872 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.64 -178.92 3.71 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.688 2.259 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.0 mt 56.3 -174.76 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -66.25 89.41 0.13 Allowed 'General case' 0 C--O 1.249 1.079 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.924 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.788 0 O-C-N 123.5 0.5 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.857 0.361 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -58.99 -24.54 58.4 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.629 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.904 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.8 mt -49.93 -26.86 4.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.884 0.373 . . . . 0.0 110.832 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -55.29 -35.38 65.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.819 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG3' ' CD1' ' A' ' 7' ' ' TYR . 0.2 OUTLIER -81.95 -7.03 59.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.407 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CE2' ' CG ' ' A' ' 103' ' ' HIS . 51.2 m-85 -95.7 -55.57 2.97 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.738 0.304 . . . . 0.0 111.168 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.697 HD23 ' CB ' ' A' ' 96' ' ' ALA . 0.4 OUTLIER -170.05 -54.36 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.353 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.673 ' HG2' HD13 ' A' ' 4' ' ' LEU . 88.8 Cg_exo -47.56 148.68 5.32 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.204 1.936 . . . . 0.0 112.396 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.96 26.33 9.02 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.644 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 HG21 ' HG2' ' A' ' 93' ' ' GLN . 56.7 mt -94.37 -80.79 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.717 0.294 . . . . 0.0 110.9 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' O ' HG23 ' A' ' 23' ' ' VAL . 2.1 mm-40 -150.41 -80.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.896 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -148.73 160.51 43.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.972 0.415 . . . . 0.0 111.014 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 89' ' ' VAL . 85.0 mt -111.63 165.3 12.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.781 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.4 mtp85 -91.41 98.75 11.88 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.739 0.78 . . . . 0.0 110.667 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -107.63 163.48 13.04 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.677 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.99 139.45 24.48 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.728 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t0 67.58 -55.03 0.48 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.857 0.361 . . . . 0.0 111.859 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.61 -172.92 18.94 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.035 -0.603 . . . . 0.0 112.343 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -96.72 157.99 15.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.314 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.795 ' CG2' HD21 ' A' ' 87' ' ' LEU . 4.3 m -121.74 138.01 53.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.139 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -58.06 135.5 57.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 12' ' ' GLU . 77.3 t -55.86 -28.06 23.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.069 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.1 mmpt? -51.83 -27.37 12.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.356 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 m -60.38 -18.33 49.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.358 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.565 HD13 HG21 ' A' ' 31' ' ' VAL . 6.6 mt -99.71 42.59 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 110.212 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.68 84.79 2.46 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.907 0.861 . . . . 0.0 111.161 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.63 56.0 1.12 Allowed Glycine 0 C--N 1.303 -1.302 0 CA-C-N 113.982 -1.463 . . . . 0.0 113.164 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -152.29 166.19 32.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.675 0.274 . . . . 0.0 110.735 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HE1' ' A' ' 32' ' ' PHE . 19.4 tp -93.27 91.55 7.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 110.79 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 HG21 HD13 ' A' ' 26' ' ' LEU . 13.8 t -87.9 118.56 33.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.247 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.497 ' HE1' HD23 ' A' ' 30' ' ' LEU . 34.8 m-85 -88.23 152.62 21.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.423 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -129.66 106.78 8.95 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.0 111.065 -179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.99 ' CE1' HG23 ' A' ' 47' ' ' THR . 16.3 t80 -92.7 125.23 37.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.411 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.609 ' HB2' HG22 ' A' ' 111' ' ' THR . 2.3 m-85 -104.66 135.22 46.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.839 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -174.2 163.37 3.85 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-O 121.008 0.433 . . . . 0.0 111.25 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.637 ' HB2' ' C ' ' A' ' 70' ' ' TRP . . . -132.37 168.2 18.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.579 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.453 ' HA ' ' CE2' ' A' ' 80' ' ' TYR . 13.1 p -90.03 3.35 53.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.443 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 12.2 p-90 -120.79 -3.72 9.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 111.799 0.296 . . . . 0.0 111.799 -179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 13.2 p -58.13 154.93 27.75 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-O 120.716 0.293 . . . . 0.0 111.157 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HB2' ' HD3' ' A' ' 42' ' ' PRO . 35.6 Cg_exo -57.83 -51.75 7.39 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.698 2.265 . . . . 0.0 113.505 -178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 41' ' ' PRO . 2.8 Cg_exo -74.56 -69.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.181 1.92 . . . . 0.0 111.078 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' ARG . 48.0 m 46.49 28.13 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.46 178.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 43' ' ' CYS . 4.0 ttm-85 177.41 94.76 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.951 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 147.99 39.66 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.403 -0.903 . . . . 0.0 113.135 179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.503 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.4 t80 175.31 -52.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.822 0.311 . . . . 0.0 111.488 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.99 HG23 ' CE1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -40.86 -53.25 6.18 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.858 ' HA ' HD12 ' A' ' 51' ' ' ILE . 89.5 Cg_endo -79.2 3.06 7.77 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.488 2.125 . . . . 0.0 113.408 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' CG ' ' HA ' ' A' ' 46' ' ' PHE . 30.6 mm100 -77.71 -29.98 51.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 111.015 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD22 HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -77.72 -24.94 48.99 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.581 -179.123 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.858 HD12 ' HA ' ' A' ' 48' ' ' PRO . 6.3 mt -51.03 -45.93 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -65.63 -39.81 91.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.14 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' HA ' ' HG2' ' A' ' 56' ' ' LYS . 84.1 t80 -65.78 -27.68 68.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.542 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 52.9 t80 -84.87 -63.15 1.38 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.729 -179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 1.4 t70 -55.04 -26.67 38.99 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -59.81 -47.06 87.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' SER . 0.1 OUTLIER -132.82 4.01 3.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.51 -25.94 3.05 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.403 -178.701 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.75 -31.84 67.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.821 0.343 . . . . 0.0 110.925 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 2.3 t -92.45 -49.76 5.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.745 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HD3' ' CD2' ' A' ' 140' ' ' PHE . 79.0 mttt -62.6 -25.45 68.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.863 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 47.86 63.53 1.99 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.655 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' CE1' ' HB2' ' A' ' 61' ' ' LYS . 10.2 p90 -131.75 170.5 14.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.527 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.4 168.27 15.82 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.683 0.754 . . . . 0.0 110.486 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.541 ' HB ' ' CE3' ' A' ' 86' ' ' TRP . 62.1 t -140.81 129.98 25.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.019 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.733 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 13.0 t -103.97 141.75 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.451 ' CZ ' ' HD3' ' A' ' 83' ' ' LYS . 12.9 t80 -101.31 98.12 8.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.849 0.357 . . . . 0.0 111.351 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -81.87 155.44 25.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.959 179.287 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.6 t -114.97 157.6 23.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.118 0.485 . . . . 0.0 111.081 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.637 ' C ' ' HB2' ' A' ' 37' ' ' ALA . 1.7 m95 -143.09 38.13 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.429 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -108.3 167.62 9.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.83 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -101.54 -27.05 13.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.001 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -107.58 142.77 36.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.898 0.38 . . . . 0.0 111.083 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -73.1 -30.33 63.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.999 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -56.05 -36.37 67.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.129 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -76.06 -56.2 4.51 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.616 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -52.15 -28.23 17.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.86 0.362 . . . . 0.0 111.057 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.1 -53.48 6.36 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.589 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -59.02 -14.49 24.63 Favored Glycine 0 N--CA 1.443 -0.895 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -95.32 -6.58 40.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.798 -0.701 . . . . 0.0 111.623 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -54.65 -21.83 11.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.617 0.246 . . . . 0.0 111.456 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.11 -29.56 1.57 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.66 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.558 ' CE ' HG21 ' A' ' 47' ' ' THR . 75.0 mttt -58.54 -175.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.81 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.577 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 0.2 OUTLIER -47.43 123.08 8.7 Favored Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.435 ' O ' ' C ' ' A' ' 86' ' ' TRP . 94.6 Cg_endo -88.6 -11.23 4.15 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.782 2.322 . . . . 0.0 113.769 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.577 ' CE2' ' HB3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -28.05 -77.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -178.516 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.795 HD21 ' CG2' ' A' ' 21' ' ' VAL . 25.5 mt -139.6 131.65 27.91 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.963 -0.461 . . . . 0.0 110.083 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -149.03 135.23 19.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.923 0.392 . . . . 0.0 112.007 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.722 HG22 ' CD2' ' A' ' 14' ' ' LEU . 32.6 t -87.22 117.21 68.29 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.53 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.11 157.6 16.84 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.114 1.876 . . . . 0.0 111.809 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -53.49 -23.39 10.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.95 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.97 -37.2 52.19 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.973 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.531 ' OE1' HG12 ' A' ' 89' ' ' VAL . 7.3 mp0 -106.02 39.31 1.82 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -33.11 74.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.588 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -54.02 -32.15 53.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.191 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.697 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -73.08 -38.61 66.35 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.906 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG13 ' SG ' ' A' ' 68' ' ' CYS . 61.9 t -60.2 -36.29 67.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.433 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -81.41 -34.12 31.79 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.286 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mmmm -75.06 -35.12 61.88 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.619 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.691 ' C ' HD12 ' A' ' 100' ' ' LEU . 0.1 OUTLIER -80.15 -49.9 11.04 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 100' ' ' LEU . 45.0 t -50.85 -43.42 59.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.95 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -57.04 -29.76 63.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.491 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.501 ' CG ' ' CE2' ' A' ' 7' ' ' TYR . 2.0 t-160 -77.98 -24.71 47.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.867 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.578 ' CD2' HD12 ' A' ' 113' ' ' ILE . 5.5 m-30 -89.6 10.01 24.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.375 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.25 31.8 0.61 Allowed 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.8 0.333 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.5 101.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.54 -42.02 77.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.7 m -179.64 154.45 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.929 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -87.64 157.12 52.79 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.808 179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 83.9 Cg_endo -77.5 157.5 95.87 Favored 'Cis proline' 0 C--N 1.347 0.482 0 C-N-CA 123.557 -1.434 . . . . 0.0 112.674 0.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.609 HG22 ' HB2' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -151.37 166.53 30.72 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.667 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 113' ' ' ILE . 1.5 tp -147.24 127.96 14.29 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.972 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 112' ' ' LEU . 35.8 mt -136.59 155.03 33.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.748 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 124' ' ' THR . . . -126.27 135.8 9.23 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.334 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 4' ' ' LEU . 25.0 m -133.38 163.05 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 121.127 0.489 . . . . 0.0 110.97 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -103.47 113.75 27.5 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.756 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 4' ' ' LEU . . . -62.7 -35.13 78.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.185 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.89 -63.06 1.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.17 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.5 p -80.55 -43.43 20.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.64 -35.14 5.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.508 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -59.1 131.6 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.772 0.32 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.429 HG11 ' CG2' ' A' ' 125' ' ' THR . 21.7 t -56.73 117.66 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.206 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -87.05 -37.99 11.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.233 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 114' ' ' GLY . 0.1 OUTLIER -128.71 163.62 24.74 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.066 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.488 ' HA ' HD13 ' A' ' 113' ' ' ILE . 41.5 p -157.49 38.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.742 0.306 . . . . 0.0 111.431 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.431 ' HG3' ' C ' ' A' ' 125' ' ' THR . 0.0 OUTLIER 176.26 55.89 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.498 179.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -76.32 -4.06 40.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.391 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.503 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -61.41 -40.65 95.18 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.695 0.283 . . . . 0.0 110.491 179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.9 -58.04 2.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.155 0.502 . . . . 0.0 111.995 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.501 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 34.2 p -51.68 -49.02 63.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.768 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' A' ' 50' ' ' LEU . 0.5 OUTLIER -52.35 -33.98 45.41 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.077 -179.724 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.03 -38.83 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-O 121.174 0.511 . . . . 0.0 111.725 179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 38.2 mttm -97.26 19.19 13.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.553 -0.749 . . . . 0.0 113.015 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 130' ' ' THR . 5.5 m-20 -126.92 72.95 76.12 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.786 0.327 . . . . 0.0 110.368 178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -84.6 14.48 2.44 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.757 2.304 . . . . 0.0 113.398 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -114.38 -26.87 7.79 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.883 0.373 . . . . 0.0 110.655 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 57.14 20.21 34.4 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.953 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 7.4 pt-20 -66.66 -15.07 63.22 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.573 0.225 . . . . 0.0 111.512 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.676 ' O ' ' N ' ' A' ' 142' ' ' TRP . 1.8 mt-30 -142.23 23.44 2.01 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.625 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.782 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 8.9 t80 -14.98 -58.14 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.75 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.5 ' O ' ' C ' ' A' ' 142' ' ' TRP . 19.1 Cg_endo -58.97 5.79 0.09 OUTLIER 'Trans proline' 0 CA--C 1.533 0.427 0 CA-C-N 119.777 0.956 . . . . 0.0 111.478 178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.782 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m0 5.96 67.35 0.0 OUTLIER 'General case' 0 C--N 1.348 0.525 0 C-N-CA 124.064 0.945 . . . . 0.0 112.592 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -70.47 179.37 2.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.209 -179.78 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 143' ' ' LYS . 4.5 t0 38.31 -162.65 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.021 179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.866 ' O ' HD12 ' A' ' 147' ' ' LEU . . . -146.72 -68.38 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.328 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 56.0 Cg_endo -69.95 63.91 1.91 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.229 1.953 . . . . 0.0 112.148 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 145' ' ' ALA . 4.1 mp -56.11 111.27 0.91 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.064 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 61.64 11.21 3.77 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.913 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.794 0 O-C-N 123.571 0.544 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.852 0.358 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -78.92 -25.26 60.37 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.597 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.9 -27.51 5.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.726 0.298 . . . . 0.0 111.325 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -57.71 -47.03 83.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.796 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.5 -25.79 65.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.699 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.538 ' O ' HD12 ' A' ' 8' ' ' LEU . 41.6 m-85 -77.24 -63.11 1.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.926 HD11 ' HB1' ' A' ' 96' ' ' ALA . 0.6 OUTLIER -169.75 -57.22 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.159 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 92.2 Cg_exo -45.11 112.16 0.36 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.362 2.041 . . . . 0.0 112.338 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' HG21 ' A' ' 23' ' ' VAL . . . 136.88 -16.08 3.74 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.384 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.532 HG21 ' HG3' ' A' ' 93' ' ' GLN . 96.7 mt -61.72 83.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.579 0.228 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 55.49 -79.79 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.433 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.2 OUTLIER -155.7 166.01 34.8 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.793 0.33 . . . . 0.0 111.226 -179.618 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.84 HD13 ' HB3' ' A' ' 87' ' ' LEU . 52.0 mt -100.91 165.25 11.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.677 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -88.61 -0.03 56.85 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.15 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.661 ' HD2' HG11 ' A' ' 21' ' ' VAL . 4.8 ttt180 25.33 -139.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 122.727 0.411 . . . . 0.0 111.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.63 111.85 2.99 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.709 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.9 t70 59.18 12.67 2.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 111.562 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -170.92 162.29 35.19 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.106 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -102.91 152.89 20.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.811 0.339 . . . . 0.0 111.157 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.864 ' CG2' HD21 ' A' ' 87' ' ' LEU . 28.3 m -139.65 163.16 25.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.355 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -72.1 153.11 41.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.53 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.555 HG21 ' HA2' ' A' ' 10' ' ' GLY . 75.2 t -69.38 -27.16 33.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.276 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.64 -27.06 6.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.314 -179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.728 ' C ' HD23 ' A' ' 26' ' ' LEU . 3.8 m -60.49 -16.23 34.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.238 179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.728 HD23 ' C ' ' A' ' 25' ' ' SER . 1.9 mt -112.97 48.87 0.98 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.085 0.469 . . . . 0.0 110.245 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.42 89.66 3.06 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.946 0.879 . . . . 0.0 111.094 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.95 46.94 2.16 Favored Glycine 0 C--N 1.304 -1.25 0 CA-C-N 113.959 -1.473 . . . . 0.0 112.979 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.4 ' CE ' ' HB2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -143.87 161.8 37.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.645 0.259 . . . . 0.0 110.661 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.477 HD23 ' HE2' ' A' ' 32' ' ' PHE . 19.6 tp -80.88 96.78 7.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.74 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 33' ' ' PHE . 4.4 t -86.32 116.67 29.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.305 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 15.4 m-85 -95.09 155.4 16.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.592 ' CE1' HG12 ' A' ' 31' ' ' VAL . 19.2 m-85 -140.0 106.54 5.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.887 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.76 ' HB3' HD13 ' A' ' 112' ' ' LEU . 19.3 p90 -108.5 119.06 38.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.653 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.459 ' HB3' ' CD1' ' A' ' 70' ' ' TRP . 58.8 m-85 -88.63 135.3 33.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.214 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 69' ' ' THR . 3.4 p -174.16 167.67 4.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.667 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.36 157.96 38.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.778 0.323 . . . . 0.0 111.054 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.5 p -69.26 -42.54 75.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.452 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 59.4 p-90 -68.05 -33.49 74.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.264 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.33 104.92 0.44 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.424 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 67.8 Cg_exo -50.81 -47.16 26.54 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.81 2.34 . . . . 0.0 113.604 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 58.0 Cg_endo -74.17 6.05 3.24 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.98 1.786 . . . . 0.0 113.381 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 93.3 m -100.41 26.46 6.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.908 0.385 . . . . 0.0 111.048 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -109.88 18.21 20.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.51 18.25 1.48 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.651 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -120.06 -41.63 2.63 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.878 0.371 . . . . 0.0 110.683 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.643 ' O ' HD12 ' A' ' 51' ' ' ILE . 0.0 OUTLIER -54.36 -55.5 36.57 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.079 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' THR . 23.3 Cg_endo -61.93 -14.27 36.01 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.463 2.109 . . . . 0.0 112.695 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -77.75 -37.23 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.884 0.373 . . . . 0.0 110.248 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.015 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -63.83 -49.21 73.71 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.122 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.866 HD11 ' HG3' ' A' ' 84' ' ' MET . 3.4 mp -55.85 -48.1 78.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.336 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 20.8 mm-40 -63.45 -51.14 66.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.661 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CE2' ' NZ ' ' A' ' 61' ' ' LYS . 90.9 t80 -64.05 -27.67 69.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.98 0.419 . . . . 0.0 110.449 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 47.1 t80 -81.01 -61.46 1.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.292 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.496 ' HA ' ' CD2' ' A' ' 58' ' ' HIS . 7.4 t0 -55.55 -26.43 43.25 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -61.9 -45.31 94.27 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -178.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HB2' ' CE ' ' A' ' 56' ' ' LYS . 0.2 OUTLIER -133.45 3.68 3.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.496 ' CD2' ' HA ' ' A' ' 55' ' ' ASP . 0.3 OUTLIER -49.72 -26.55 3.9 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.476 -178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -64.82 -50.02 68.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.822 0.344 . . . . 0.0 111.054 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.3 m -87.06 -29.68 21.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' O ' ' CE1' ' A' ' 63' ' ' PHE . 16.7 mtmt -72.77 -24.77 60.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.1 p30 43.76 52.45 6.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 120.97 0.414 . . . . 0.0 111.845 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CE1' ' O ' ' A' ' 61' ' ' LYS . 18.4 m-85 -124.09 170.89 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.21 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.808 ' HG2' HD12 ' A' ' 87' ' ' LEU . 6.2 tp10 -143.06 140.57 30.99 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.4 0.619 . . . . 0.0 111.215 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.015 HG21 HD11 ' A' ' 50' ' ' LEU . 83.6 t -114.24 130.51 68.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.743 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.654 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.6 t -100.53 139.22 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 120.784 -0.366 . . . . 0.0 111.574 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 1.6 t80 -81.22 109.76 16.06 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.846 0.355 . . . . 0.0 110.939 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.44 ' HB3' ' CD1' ' A' ' 35' ' ' PHE . 7.7 m -102.95 107.23 17.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.064 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.821 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.2 t -83.31 160.47 21.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.261 0.553 . . . . 0.0 111.843 -178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -144.53 38.56 1.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.1 179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -79.31 164.64 23.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.336 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -107.58 -28.33 9.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.557 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.43 168.48 11.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.857 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -73.03 -41.96 63.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.353 0.597 . . . . 0.0 110.63 179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -55.63 -21.58 18.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.653 -179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -73.9 -56.37 5.39 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.809 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.472 ' CE1' ' CE1' ' A' ' 67' ' ' PHE . 14.9 t80 -66.24 -26.78 67.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.0 111.126 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.83 -53.6 56.04 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.807 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.82 -14.63 56.02 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.78 -0.42 48.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.405 -0.897 . . . . 0.0 111.334 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 81' ' ' PHE . 50.2 t80 -52.24 -14.25 0.43 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.267 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.447 ' O ' ' C ' ' A' ' 83' ' ' LYS . . . -45.81 -21.8 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' A' ' 82' ' ' ALA . 3.7 mtmp? 19.75 99.53 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.866 ' HG3' HD11 ' A' ' 51' ' ' ILE . 26.2 mmm -62.18 162.63 17.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.859 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 84' ' ' MET . 3.3 Cg_exo -36.37 -42.45 0.67 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.531 2.821 . . . . 0.0 113.226 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.673 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.58 162.98 0.06 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.756 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.864 HD21 ' CG2' ' A' ' 21' ' ' VAL . 2.7 mt -83.54 153.17 24.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.907 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -141.39 160.16 40.71 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.046 -178.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.428 HG21 HD23 ' A' ' 8' ' ' LEU . 54.5 t -94.72 123.94 56.38 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.347 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.69 147.11 81.85 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.088 1.859 . . . . 0.0 111.634 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -47.76 -30.49 3.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.934 0.397 . . . . 0.0 110.624 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.0 -37.08 63.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.942 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.532 ' HG3' HG21 ' A' ' 11' ' ' ILE . 23.7 mm-40 -110.95 24.53 12.82 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.686 0.279 . . . . 0.0 111.361 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 p -62.79 -28.64 70.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.861 0.362 . . . . 0.0 110.513 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -53.74 -41.39 67.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.246 0.546 . . . . 0.0 110.66 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.926 ' HB1' HD11 ' A' ' 8' ' ' LEU . . . -52.63 -39.94 62.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.095 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.821 HG11 ' O ' ' A' ' 69' ' ' THR . 92.5 t -57.9 -33.01 44.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.113 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -73.41 -43.54 60.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.654 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 mmpp? -77.36 -38.7 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.689 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.776 ' O ' HD12 ' A' ' 100' ' ' LEU . 1.2 tp -66.92 -34.01 76.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.21 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 t -57.59 -40.36 78.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.6 -28.54 69.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.002 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.0 -28.53 64.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.999 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.02 17.65 11.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.314 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 43.64 37.07 1.39 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.653 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.3 t -69.98 99.33 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.98 -45.79 89.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.73 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 65.8 m -165.15 150.39 9.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.92 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.549 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -82.16 159.39 65.27 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.367 -179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 77.2 Cg_endo -89.23 159.11 37.52 Favored 'Cis proline' 0 C--N 1.347 0.474 0 C-N-CA 123.783 -1.341 . . . . 0.0 112.579 0.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -148.72 167.77 24.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.767 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.838 ' CD2' HD13 ' A' ' 131' ' ' LEU . 2.6 tp -147.28 127.34 13.7 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.473 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.628 HG23 ' O ' ' A' ' 124' ' ' THR . 39.6 mt -136.09 141.79 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.566 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -114.61 142.91 17.86 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.464 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 13.6 m -133.43 163.01 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 CA-C-O 121.102 0.477 . . . . 0.0 110.729 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.754 ' OD1' HG21 ' A' ' 123' ' ' VAL . 2.5 m-20 -105.73 112.73 25.92 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.585 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.53 ' HA ' HD11 ' A' ' 4' ' ' LEU . . . -65.43 -44.92 85.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.134 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -39.36 94.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 m -77.04 -44.04 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.048 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 82.64 41.51 8.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.49 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -161.96 152.87 17.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.795 0.331 . . . . 0.0 110.919 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -64.74 123.96 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.198 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.754 HG21 ' OD1' ' A' ' 116' ' ' ASP . 21.7 t -104.62 -32.89 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.378 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -127.81 159.52 34.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.57 -179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.7 p -156.28 40.43 0.36 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.978 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -175.31 38.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.285 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -72.12 -5.22 33.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.109 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 132' ' ' VAL . 5.0 tmm_? -63.68 -46.67 84.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.085 0.469 . . . . 0.0 109.964 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.62 -53.35 5.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.856 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.596 ' OG1' ' HA ' ' A' ' 127' ' ' ALA . 49.1 p -54.82 -24.95 25.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' CD2' ' A' ' 112' ' ' LEU . 6.1 tt -74.7 -32.52 62.2 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.694 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -90.17 -38.92 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.554 179.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -95.22 21.38 7.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.438 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 130' ' ' THR . 0.5 OUTLIER -150.55 66.88 7.83 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.435 179.07 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -83.28 14.13 2.46 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.916 2.411 . . . . 0.0 112.96 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -101.48 -24.92 14.09 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 66.0 29.62 75.37 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.927 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -74.32 -26.57 60.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.864 0.364 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.605 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.0 OUTLIER -132.62 31.99 3.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.795 -179.557 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 9.3 p90 -28.83 -46.95 0.23 Allowed Pre-proline 0 N--CA 1.466 0.367 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 30.4 Cg_endo -61.29 4.43 0.24 Allowed 'Trans proline' 0 CA--C 1.532 0.415 0 CA-C-N 120.604 1.252 . . . . 0.0 111.49 177.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.2 m0 6.02 65.07 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.125 0.97 . . . . 0.0 112.735 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -90.49 -179.34 5.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.903 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 36.1 p-10 -84.58 153.18 23.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' A' ' 146' ' ' PRO . . . -74.05 -60.84 1.39 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.108 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 145' ' ' ALA . 63.5 Cg_endo -73.58 162.95 38.7 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.508 2.139 . . . . 0.0 112.323 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 147' ' ' LEU . 12.3 mt -157.82 31.69 0.26 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 9.4 tp10 -173.83 169.1 4.2 Favored 'General case' 0 C--O 1.249 1.068 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.458 ' N ' ' HG3' ' A' ' 148' ' ' GLU . . . . . . . . 0 C--N 1.249 -3.791 0 O-C-N 123.547 0.529 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.786 0.327 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' O ' ' HG2' ' A' ' 6' ' ' LYS . . . -79.03 -34.98 31.94 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.54 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.737 HD22 HG21 ' A' ' 115' ' ' VAL . 0.5 OUTLIER -49.74 -26.73 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.961 0.41 . . . . 0.0 110.651 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 7.6 t70 -56.19 -31.88 63.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.097 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -81.93 -6.9 59.5 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.4 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -87.83 -55.07 3.92 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.627 0.251 . . . . 0.0 111.472 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.869 HD11 ' CG2' ' A' ' 89' ' ' VAL . 3.4 tm? -175.84 -45.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.32 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 25.0 Cg_exo -63.87 10.31 0.12 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.5 2.134 . . . . 0.0 113.692 -179.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -143.79 33.61 1.74 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.132 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.843 HD12 HD22 ' A' ' 8' ' ' LEU . 43.9 mt -94.74 100.22 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.726 0.298 . . . . 0.0 111.402 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 47.22 -85.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.035 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -145.41 166.2 26.3 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.978 0.418 . . . . 0.0 111.466 -179.309 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 87' ' ' LEU . 76.5 mt -110.1 165.3 11.85 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.86 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.413 ' O ' ' C ' ' A' ' 16' ' ' ARG . 8.1 mtp85 -80.45 0.11 34.86 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.87 ' HA ' HD23 ' A' ' 87' ' ' LEU . 30.0 ttt85 32.47 -96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.942 0.401 . . . . 0.0 111.559 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' N ' ' HG2' ' A' ' 16' ' ' ARG . . . -140.08 -113.65 1.09 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.98 -29.71 5.15 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.138 0.494 . . . . 0.0 110.399 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.49 -167.01 12.53 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.772 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.06 155.83 16.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.812 0.339 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -139.47 161.66 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.31 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.432 ' N ' HG13 ' A' ' 21' ' ' VAL . 2.2 mt-10 -66.29 148.42 51.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.06 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.408 HG11 ' HA2' ' A' ' 10' ' ' GLY . 60.1 t -76.24 -26.81 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.244 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.27 -26.66 4.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.47 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.819 ' C ' HD23 ' A' ' 26' ' ' LEU . 48.0 t -60.24 -15.02 20.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.711 0.291 . . . . 0.0 111.076 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.819 HD23 ' C ' ' A' ' 25' ' ' SER . 0.7 OUTLIER -117.37 52.75 0.95 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.17 0.509 . . . . 0.0 109.633 179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.12 91.06 3.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.947 0.879 . . . . 0.0 111.165 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.12 56.15 1.08 Allowed Glycine 0 C--N 1.303 -1.286 0 CA-C-N 113.964 -1.471 . . . . 0.0 113.267 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -151.35 177.21 10.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.651 0.263 . . . . 0.0 110.452 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 tp -96.3 90.97 5.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.858 0.361 . . . . 0.0 110.142 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 64' ' ' GLU . 6.0 t -85.84 123.63 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.432 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.469 ' CD1' HD12 ' A' ' 112' ' ' LEU . 9.3 m-85 -96.66 162.0 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.541 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.731 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 30.5 m-85 -146.84 106.29 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.739 ' CB ' HD22 ' A' ' 112' ' ' LEU . 4.0 p90 -97.23 130.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.749 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 111' ' ' THR . 42.8 m-85 -101.12 124.22 46.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.782 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 61.7 p -174.62 168.87 3.71 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.756 0.312 . . . . 0.0 110.985 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' CD1' ' A' ' 39' ' ' TRP . . . -126.0 158.6 34.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.719 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.63 -38.44 67.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.67 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CD1' ' HB1' ' A' ' 37' ' ' ALA . 35.2 p-90 -67.08 -30.19 70.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 0.0 110.126 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.7 t -54.2 107.91 0.99 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.215 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 51.8 Cg_exo -53.96 -48.18 23.09 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.766 2.31 . . . . 0.0 113.365 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 41' ' ' PRO . 61.5 Cg_endo -74.86 7.96 2.57 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.121 1.88 . . . . 0.0 113.315 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 90.4 m -104.48 28.66 6.75 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.792 0.329 . . . . 0.0 110.94 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.39 -24.64 8.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.232 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.38 -2.92 72.81 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.128 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.443 ' O ' ' CG ' ' A' ' 46' ' ' PHE . 61.8 t80 -125.76 8.69 7.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.853 0.327 . . . . 0.0 111.408 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.566 ' HB ' ' HD3' ' A' ' 48' ' ' PRO . 93.4 m -78.46 -47.48 1.95 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.264 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 47' ' ' THR . 57.9 Cg_endo -85.12 11.68 3.3 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.687 2.258 . . . . 0.0 113.062 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -77.44 -38.72 48.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.95 0.405 . . . . 0.0 110.447 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.909 ' CD1' HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -69.19 -49.58 55.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.712 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.429 HD13 ' HA ' ' A' ' 51' ' ' ILE . 12.6 mm -51.73 -37.13 19.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.996 -179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -51.03 40.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.858 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -68.21 -28.24 67.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.79 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' HIS . 35.9 t80 -81.48 -54.7 5.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.084 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -55.78 -26.29 45.37 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.702 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.5 mmtp -94.31 -17.14 22.9 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -136.86 2.88 2.66 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 54' ' ' TYR . 4.3 p80 -57.88 -30.49 65.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.741 0.305 . . . . 0.0 111.163 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -80.13 -29.83 38.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.013 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.0 m -72.57 -75.68 0.13 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HE2' ' HB3' ' A' ' 63' ' ' PHE . 21.3 ptmt -75.14 -11.84 60.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 5.0 t30 49.79 80.35 0.07 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.873 0.368 . . . . 0.0 111.19 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.441 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 5.2 p90 -131.44 170.43 14.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.084 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -140.07 125.57 19.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.084 0.469 . . . . 0.0 111.264 -179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.909 HG21 ' CD1' ' A' ' 50' ' ' LEU . 54.9 t -102.9 117.33 48.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.15 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 87' ' ' LEU . 64.4 t -90.2 145.66 7.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 121.068 -0.253 . . . . 0.0 110.495 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.706 ' HB3' ' HB2' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -88.94 112.32 23.18 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 121.064 0.459 . . . . 0.0 111.341 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 35' ' ' PHE . 0.6 OUTLIER -103.49 104.61 14.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.444 179.005 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.844 ' O ' HG11 ' A' ' 97' ' ' VAL . 5.8 t -76.94 158.96 30.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.473 0.654 . . . . 0.0 111.933 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 35' ' ' PHE . 1.1 m95 -144.29 39.38 1.3 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.731 179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -115.81 164.17 14.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.212 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.98 -21.18 15.75 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.605 179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -90.81 135.76 33.51 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.774 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.24 -28.99 62.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -71.83 -25.09 61.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.472 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.38 -56.17 4.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.548 -0.835 . . . . 0.0 112.814 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.58 -39.39 70.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.885 0.374 . . . . 0.0 111.171 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -71.77 -53.46 13.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.656 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.01 -14.56 17.77 Favored Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -80.12 -56.71 4.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.792 -0.704 . . . . 0.0 111.312 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.474 ' HB3' ' CD2' ' A' ' 67' ' ' PHE . 0.3 OUTLIER -79.14 -12.88 60.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.566 -179.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -46.5 -31.53 2.79 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -112.28 33.06 5.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.343 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.494 ' HB3' ' CE2' ' A' ' 86' ' ' TRP . 2.0 mmt -134.97 134.46 21.78 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.897 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.85 -32.25 0.6 Allowed 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.681 2.254 . . . . 0.0 113.022 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.827 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.2 p90 -47.63 158.72 0.18 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.583 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.87 HD23 ' HA ' ' A' ' 16' ' ' ARG . 1.0 OUTLIER -84.87 128.19 34.5 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.145 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.706 ' HB2' ' HB3' ' A' ' 67' ' ' PHE . . . -114.98 156.74 24.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.463 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.869 ' CG2' HD11 ' A' ' 8' ' ' LEU . 39.0 t -75.73 126.92 86.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.008 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.68 159.04 49.54 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.31 2.007 . . . . 0.0 111.821 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -48.9 -35.45 14.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.078 0.466 . . . . 0.0 110.695 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.47 -37.06 62.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.122 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.461 ' CG ' HG21 ' A' ' 11' ' ' ILE . 13.4 mm-40 -115.31 24.07 11.93 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.623 0.249 . . . . 0.0 111.386 -179.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 p -65.43 -30.09 70.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.855 0.36 . . . . 0.0 110.595 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -56.1 -34.25 65.85 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.373 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.754 ' CB ' HD23 ' A' ' 8' ' ' LEU . . . -58.05 -38.61 76.6 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.769 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.844 HG11 ' O ' ' A' ' 69' ' ' THR . 79.3 t -57.72 -33.69 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.685 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.69 -44.3 64.46 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.397 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.42 -34.91 31.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.861 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD11 ' CE2' ' A' ' 104' ' ' PHE . 14.0 tp -55.01 -46.11 75.18 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.915 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 106' ' ' VAL . 90.7 p -57.37 -50.12 73.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.151 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.67 -27.96 65.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -77.61 -25.59 49.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.335 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.611 ' CE1' HG21 ' A' ' 122' ' ' VAL . 20.8 m-85 -106.36 16.8 24.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.704 0.288 . . . . 0.0 111.39 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 49.01 78.05 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.305 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 101' ' ' SER . 25.2 t -104.99 99.63 8.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -57.81 -50.77 72.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.006 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 71.2 m -166.01 151.23 8.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.447 ' H ' HD13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -85.47 158.38 57.47 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.965 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 90.5 Cg_endo -84.95 156.68 64.6 Favored 'Cis proline' 0 C--N 1.347 0.47 0 C-N-CA 123.482 -1.466 . . . . 0.0 112.876 0.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 35' ' ' PHE . 3.8 t -141.39 179.28 6.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.59 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.739 HD22 ' CB ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -146.89 122.76 10.64 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.082 179.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.977 HG23 HG22 ' A' ' 125' ' ' THR . 48.4 mt -123.33 132.25 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.915 0.388 . . . . 0.0 111.56 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -109.98 129.51 9.42 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.254 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.907 HG12 HG13 ' A' ' 122' ' ' VAL . 6.1 m -133.21 155.1 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 CA-C-O 121.174 0.511 . . . . 0.0 111.017 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.791 ' OD2' HG21 ' A' ' 123' ' ' VAL . 3.5 m-20 -106.02 114.99 29.47 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.492 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -58.24 -40.38 81.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.349 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.91 -38.15 46.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.109 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 116' ' ' ASP . 8.0 t -58.94 -44.06 91.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.979 -179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.45 -53.98 0.57 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.565 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -105.22 166.34 10.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.907 HG13 HG12 ' A' ' 115' ' ' VAL . 24.1 t -66.57 141.72 17.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.22 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.791 HG21 ' OD2' ' A' ' 116' ' ' ASP . 23.9 t -103.64 -35.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.3 145.65 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.977 HG22 HG23 ' A' ' 113' ' ' ILE . 45.6 p -141.18 53.36 1.56 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.957 0.408 . . . . 0.0 110.801 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.2 44.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.551 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.413 ' HA ' ' OG1' ' A' ' 130' ' ' THR . . . -95.11 28.93 2.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.6 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -74.78 -54.88 6.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.91 0.386 . . . . 0.0 110.974 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 133' ' ' LYS . . . -84.15 -36.18 23.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.064 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 47.9 p -69.79 -45.4 68.05 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' HA ' ' CH2' ' A' ' 142' ' ' TRP . 4.7 tt -52.52 -36.58 55.71 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.455 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -88.84 -49.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.264 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 29.5 mmtt -79.11 16.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 130' ' ' THR . 24.7 t70 -114.41 80.35 5.94 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-O 120.769 0.318 . . . . 0.0 110.496 179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -85.83 15.48 2.19 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.91 2.407 . . . . 0.0 113.376 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -113.74 -24.15 9.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.746 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 54.44 23.12 25.99 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.937 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.7 pt-20 -77.44 -14.49 59.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.54 0.21 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.602 ' O ' ' N ' ' A' ' 142' ' ' TRP . 0.2 OUTLIER -137.42 29.7 2.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.778 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 12.1 p90 -31.08 -46.05 0.31 Allowed Pre-proline 0 N--CA 1.463 0.201 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.583 ' HD3' ' CG ' ' A' ' 140' ' ' PHE . 33.1 Cg_endo -62.81 4.35 0.39 Allowed 'Trans proline' 0 CA--C 1.535 0.574 0 CA-C-N 120.768 1.31 . . . . 0.0 111.166 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.778 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 1.1 m-90 7.71 64.71 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.158 0.983 . . . . 0.0 112.741 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.429 ' HB3' HG12 ' A' ' 123' ' ' VAL . 51.2 pttt -113.13 -168.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.568 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.25 -169.84 2.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.803 0.335 . . . . 0.0 110.87 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.27 81.78 1.41 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.69 -168.11 0.3 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.514 2.143 . . . . 0.0 112.332 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mt -115.88 85.39 2.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.877 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.5 149.44 40.28 Favored 'General case' 0 C--O 1.249 1.062 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.871 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.796 0 O-C-N 123.507 0.504 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.721 0.296 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -79.18 -37.99 23.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.83 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -49.84 -35.64 23.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.886 0.374 . . . . 0.0 110.824 -179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.465 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -51.71 -47.05 64.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.176 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.78 -6.68 54.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.035 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -90.17 -56.46 3.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.533 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.847 HD12 HD12 ' A' ' 11' ' ' ILE . 3.0 tp -174.15 -51.05 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 8' ' ' LEU . 35.6 Cg_exo -59.0 11.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.728 2.285 . . . . 0.0 114.318 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 8' ' ' LEU . . . -117.24 37.81 3.2 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.121 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.847 HD12 HD12 ' A' ' 8' ' ' LEU . 16.7 mt -117.58 160.19 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.663 0.268 . . . . 0.0 111.258 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.526 ' N ' HG22 ' A' ' 11' ' ' ILE . 5.5 mp0 -8.12 -85.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -152.92 166.33 32.69 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.992 0.425 . . . . 0.0 111.366 -179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 26' ' ' LEU . 72.3 mt -106.48 165.57 11.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' NH2' ' CG ' ' A' ' 81' ' ' PHE . 5.8 mmm-85 -99.1 99.84 10.9 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.529 0.681 . . . . 0.0 111.032 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' HG11 ' A' ' 21' ' ' VAL . 2.8 ttt180 -84.39 177.57 8.09 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.452 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -50.95 -88.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.484 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -46.8 -49.61 19.63 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.948 0.404 . . . . 0.0 111.461 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.12 -145.88 4.48 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.537 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -97.27 157.28 16.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.004 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG11 ' HD3' ' A' ' 16' ' ' ARG . 35.7 m -145.07 163.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.332 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.59 138.11 58.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.443 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 11' ' ' ILE . 73.9 t -61.36 -27.77 42.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.683 179.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.55 -27.23 10.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.211 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.598 ' C ' HD23 ' A' ' 26' ' ' LEU . 5.2 t -60.38 -15.48 26.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.536 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 14' ' ' LEU . 3.0 mt -109.66 47.77 0.92 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.07 0.462 . . . . 0.0 110.141 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.2 91.69 3.75 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.84 0.828 . . . . 0.0 111.065 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.9 54.62 1.19 Allowed Glycine 0 C--N 1.303 -1.265 0 CA-C-N 114.082 -1.417 . . . . 0.0 113.001 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' CD ' ' HB2' ' A' ' 64' ' ' GLU . 16.3 ptpt -156.11 148.38 23.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.699 0.285 . . . . 0.0 110.638 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' A' ' 32' ' ' PHE . 13.9 tp -66.85 103.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.201 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.6 t -92.05 110.09 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.759 -179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CZ ' ' CZ3' ' A' ' 142' ' ' TRP . 38.2 m-85 -85.97 162.27 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.913 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -140.65 106.36 5.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.074 0.464 . . . . 0.0 111.512 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -94.01 109.04 20.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.58 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 68' ' ' CYS . 83.9 m-85 -88.48 127.56 35.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.018 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.64 179.23 1.76 Allowed 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.943 0.401 . . . . 0.0 111.19 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.5 161.54 36.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.652 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.416 ' HB3' ' CD1' ' A' ' 80' ' ' TYR . 0.8 OUTLIER -86.14 -2.35 58.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.574 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -131.89 -4.17 3.6 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 p -51.33 166.47 0.34 Allowed Pre-proline 0 CA--C 1.531 0.235 0 CA-C-O 120.811 0.339 . . . . 0.0 111.33 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' CD ' ' HD3' ' A' ' 42' ' ' PRO . 31.8 Cg_exo -58.15 -47.1 21.46 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.735 2.29 . . . . 0.0 113.673 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 40' ' ' CYS . 20.7 Cg_endo -87.31 -83.79 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.494 2.129 . . . . 0.0 113.245 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.459 ' C ' ' O ' ' A' ' 42' ' ' PRO . 0.1 OUTLIER 25.2 82.74 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.236 0.541 . . . . 0.0 112.099 -179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -45.3 0.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.23 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -107.09 172.78 18.39 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.021 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 128' ' ' ARG . 10.7 t80 63.32 17.16 10.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.61 0.243 . . . . 0.0 111.192 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.491 ' N ' ' CD ' ' A' ' 48' ' ' PRO . 0.2 OUTLIER -90.75 -43.98 0.39 Allowed Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.489 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 47' ' ' THR . 98.1 Cg_endo -85.01 6.87 5.48 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.318 2.012 . . . . 0.0 112.758 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' OE1' HG23 ' A' ' 132' ' ' VAL . 10.1 mm-40 -77.7 -34.33 52.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.941 0.4 . . . . 0.0 109.998 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.975 HD11 HG21 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -67.49 -49.29 64.15 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.394 179.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mt -64.26 -47.38 90.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.104 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -59.81 -50.91 71.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.249 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CE2' ' A' ' 57' ' ' PHE . 9.0 t80 -62.61 -56.91 13.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.605 -0.516 . . . . 0.0 109.605 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' HIS . 75.2 t80 -49.72 -53.25 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.792 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.72 -26.86 47.46 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -94.87 -13.05 25.84 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.537 ' CE2' ' CD2' ' A' ' 53' ' ' PHE . 1.9 p90 -133.05 2.16 3.6 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.459 0.572 . . . . 0.0 112.32 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' ASN . 1.5 p-80 -72.88 -26.62 61.51 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.915 -179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.24 -51.33 9.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.024 0.44 . . . . 0.0 112.103 -179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 p -69.61 -69.18 0.36 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.58 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HB3' ' CD2' ' A' ' 63' ' ' PHE . 0.7 OUTLIER -64.78 -14.3 58.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.914 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 58' ' ' HIS . 8.5 p-10 42.43 72.53 0.17 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 61' ' ' LYS . 22.3 m-85 -131.28 170.74 14.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.219 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.426 ' CG ' HD12 ' A' ' 87' ' ' LEU . 16.7 tp10 -133.07 139.45 47.16 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 121.488 0.661 . . . . 0.0 111.097 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.975 HG21 HD11 ' A' ' 50' ' ' LEU . 61.9 t -111.6 127.61 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.156 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 21.9 t -109.91 142.26 22.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' ' NE1' ' A' ' 86' ' ' TRP . 5.3 t80 -100.97 110.09 22.08 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.835 0.35 . . . . 0.0 111.473 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 35' ' ' PHE . 0.9 OUTLIER -84.69 115.69 22.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.891 ' O ' HG11 ' A' ' 97' ' ' VAL . 4.7 t -77.39 156.71 31.02 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.184 0.516 . . . . 0.0 111.459 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -138.82 33.68 2.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.021 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -100.07 173.58 6.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.016 0.436 . . . . 0.0 111.341 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.86 -27.69 9.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.826 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -103.96 131.14 51.5 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.017 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -59.03 -44.05 91.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.407 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -55.47 -43.06 75.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.06 -56.02 27.62 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.554 -0.832 . . . . 0.0 112.696 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.406 ' O ' ' CD1' ' A' ' 77' ' ' PHE . 2.4 t80 -63.39 -26.87 68.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.734 0.302 . . . . 0.0 111.156 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.27 -53.35 20.23 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.017 0.437 . . . . 0.0 111.967 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -56.73 -14.45 9.8 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 38' ' ' SER . 0.1 OUTLIER -89.46 -20.46 23.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.822 -0.689 . . . . 0.0 111.593 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' CG ' ' NH2' ' A' ' 15' ' ' ARG . 3.0 t80 -79.16 -12.86 59.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.716 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -78.57 -9.83 59.5 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 mtmm -114.48 -20.36 10.8 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.545 ' HB2' ' CE2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -95.24 123.03 58.26 Favored Pre-proline 0 C--N 1.329 -0.319 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -80.99 -37.61 0.3 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.678 2.252 . . . . 0.0 112.049 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.624 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 6.2 p90 -50.5 162.52 0.23 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.577 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' O ' ' HA ' ' A' ' 66' ' ' VAL . 1.6 mt -83.17 128.84 34.84 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.186 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.53 138.19 54.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.42 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 8' ' ' LEU . 57.0 t -67.04 133.88 93.78 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.78 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.52 146.89 86.04 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.114 1.876 . . . . 0.0 111.637 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.01 -28.56 2.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.903 0.382 . . . . 0.0 110.69 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.46 -37.05 56.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.818 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.522 ' HB3' HD13 ' A' ' 11' ' ' ILE . 8.8 mt-30 -105.66 23.8 13.28 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 120.596 0.236 . . . . 0.0 111.193 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.5 p -57.44 -25.41 59.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.339 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -55.03 -34.24 63.34 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.041 0.448 . . . . 0.0 110.237 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.56 ' CB ' HD13 ' A' ' 8' ' ' LEU . . . -65.75 -41.08 92.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.484 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.891 HG11 ' O ' ' A' ' 69' ' ' THR . 98.9 t -60.42 -33.55 54.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.587 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -44.11 63.97 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.802 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -81.04 -39.51 25.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.525 HD11 ' CE2' ' A' ' 104' ' ' PHE . 19.3 tp -69.31 -27.92 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.4 p -67.1 -50.09 62.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.864 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -58.07 -48.02 81.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -60.63 -23.09 64.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.009 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.4 m-85 -88.2 15.14 7.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.519 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 44.07 44.37 6.16 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.815 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.8 t -86.34 96.9 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -55.99 -40.15 72.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.765 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 32.7 p 179.99 150.67 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.873 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' ILE . 0.3 OUTLIER -78.9 157.94 75.78 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.009 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.409 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 74.4 Cg_endo -74.93 156.09 99.93 Favored 'Cis proline' 0 C--N 1.348 0.513 0 C-N-CA 123.57 -1.429 . . . . 0.0 112.677 0.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 96.1 m -155.91 159.5 39.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.257 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.78 ' HG ' ' HB3' ' A' ' 127' ' ' ALA . 4.0 tp -147.14 130.76 16.86 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.734 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 104' ' ' PHE . 29.2 mt -136.11 155.4 35.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.446 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 32' ' ' PHE . . . -126.43 140.04 11.76 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.532 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.4 m -133.36 157.82 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 121.086 0.469 . . . . 0.0 110.632 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.864 ' OD1' HG21 ' A' ' 123' ' ' VAL . 0.4 OUTLIER -103.57 117.1 33.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.567 179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.549 ' O ' HD21 ' A' ' 4' ' ' LEU . . . -66.39 -52.16 49.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.248 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.73 -27.58 69.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.017 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.0 t -76.86 -44.09 33.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.161 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 84.91 40.24 8.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.527 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -176.38 166.5 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.845 0.355 . . . . 0.0 111.03 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -72.87 134.03 30.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.17 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.864 HG21 ' OD1' ' A' ' 116' ' ' ASP . 18.6 t -106.99 -28.71 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.718 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 125' ' ' THR . 0.5 OUTLIER -141.97 170.98 14.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.764 0.316 . . . . 0.0 110.519 -179.802 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.471 ' HA ' HG23 ' A' ' 113' ' ' ILE . 44.0 p -157.07 44.74 0.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.798 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.6 54.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.185 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.78 ' HB3' ' HG ' ' A' ' 112' ' ' LEU . . . -87.12 8.01 25.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.097 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -66.29 -53.42 36.85 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.723 0.297 . . . . 0.0 111.165 -179.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 132' ' ' VAL . . . -84.65 -38.84 19.34 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 134' ' ' ASP . 58.4 p -66.86 -47.88 70.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD13 HD21 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -52.24 -34.89 47.99 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.411 -0.515 . . . . 0.0 110.424 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 129' ' ' ALA . 1.4 p -88.98 -49.72 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.218 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 129' ' ' ALA . 10.4 mtmm -81.69 16.0 1.94 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 130' ' ' THR . 27.3 t70 -119.35 76.61 17.62 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.785 0.326 . . . . 0.0 110.541 179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -83.29 10.33 3.71 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.786 2.324 . . . . 0.0 113.222 -179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -114.81 -25.61 8.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.667 0.27 . . . . 0.0 110.754 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 55.97 23.21 37.83 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 139' ' ' GLN . 1.3 pt-20 -74.59 -14.54 60.79 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' C ' ' HD2' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -136.83 27.3 2.99 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.662 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.793 ' HA ' ' NE1' ' A' ' 142' ' ' TRP . 10.2 p90 -29.53 -46.56 0.25 Allowed Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.593 ' HD2' ' C ' ' A' ' 139' ' ' GLN . 34.8 Cg_endo -62.12 3.95 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.556 0 CA-C-N 120.611 1.254 . . . . 0.0 111.309 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.793 ' NE1' ' HA ' ' A' ' 140' ' ' PHE . 0.9 OUTLIER 5.29 63.93 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.097 0.959 . . . . 0.0 112.779 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.0 OUTLIER -90.17 -177.56 5.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.932 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -57.54 -173.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.003 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -51.19 107.08 0.74 Allowed Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.74 -174.42 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.529 2.152 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 147' ' ' LEU . 1.1 pt? -56.99 -169.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 155.56 31.77 Favored 'General case' 0 C--O 1.248 1.003 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.913 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.249 -3.772 0 O-C-N 123.548 0.53 . . . . 0.0 . . . . . . . . . . 0 0 . 1 stop_ save_